Studies on growth and the nutritional, metabolic, and hormonal status of children with chronic renal failure on regular haemodialysis by El Beshty, Mohamed Mahmud
STUDIES ON GROWTH AND THE NUTRITIONAL, METABOLIC,
AND HORMONAL STATUS OF CHILDREN
WITH CHRONIC RENAL FAILURE
ON REGULAR HAEMODIALYSIS.
Mohamed Mahmud El Beshty
A Thesis submitted for the Degree of Doctor of Medicine




The purpose of this study was to assess the nutritional, metabolic
and hormonal status of children with chronic renal failure, and to study
the pathogenesis of the growth retardation which is an important
clinical problem affecting these children. Sixteen children on
regular haemodialysis were observed over a period of one year.
Growth was subnormal in most patients with delay in skeletal
maturation, and growth potential fell with advancing bone age. Body
weight was less affected than height presumably because all children
received energy supp1ementsin their diet. Puberty was delayed but
a
pubertal children grew better and had/more normal body cell mass than
prepubertal children. Significant increases were found in the fasting
levels of blood glucose, plasma insulin, growth hormone, glucagon,
Cortisol, luteinizing hormone, prolactin, triglycerides, cholesterol,
glycine and alanine, and significant decreases were observed in plasma
thyroxine, triiodothyronine, testosterone, branched-chain amino acids,
free fatty acids and glycerol. Growth velocity correlated positively
with plasma valine, leucine and gonadotrophin levels. In boys, growth
velocity correlated positively with plasma testosterone and inversely
with prolactin levels. Plasma triglyceride concentration was related
to both carbohydrate intake and plasma insulin level. There were
also positive correlations between growth hormone and fatty acids,
growth hormone and the branched-chain amino acids, serum somatomedin
and plasma transferrin, and between transferrin and the % deficit in
weight for height and for age. Extracellular water was increased
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normal or increased in most patients. Glucose intolerance with
hyperinsulinaemia, non-suppressable hyperg1ucagonaemia and paradoxical
a
rises in plasma growth hormone levels after/glucose load were observed.
Fasting plasma alanine concentration correlated inversely with glucose
disappearance rate (Kg). The fall in plasma free fatty acids was more
marked than normal and was related to plasma insulin response. Basal
oxygen consumption was increased particularly in the more wasted
children. Manipulation of the diet for a further period of one year by
increasing the ratio of polyunsaturated to saturated fats lowered
plasma cholesterol level but not plasma triglycerides.
On the basis of the findings, it is suggested that the primary
defect is a peripheral resistance to insulin with respect to glucose
utilization accompanied by a decrease in the mobilization of endogenous
fat for energy production and a diversion of amino acids for energy
purposes with an increase in hepatic g1uconeogenesis and body protein
depletion. It was also suggested that energy and protein requirements
of uraemic children may be increased, and that energy supplements as
carbohydrate would increase body fat without affecting cell mass.
It is hoped that the information obtained from the study will
be helpful in further understanding the pathogenesis of growth retardation
in children with chronic renal failure and their nutritional needs,
and will provide guidelines for future research.
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The Clinical Problem and Aims of the Study
A variety of metabolic and endocrine disturbances are known to
occur in adults with chronic renal failure. While many of the bio¬
chemical changes associated with the uraemic state are reversed or
ameliorated by haemodialysis, some persist despite adequate treatment.
It is now clearly established that haemodia 1ysis can, technically,
be applied to children as successfully as to adults, and an increasing
number of children with end-stage renal failure are being treated by
long term regular haemodialysis both in hospital and in the home in
preparation for renal transplantation. The survival rate is probably
better in this age group than similarly treated adult patients. However,
poor growth and development affecting children with chronic renal failure
both before and after the institution of regular haemodialysis continues
to be a major problem in dialysis and transplantation programmes as it
can have a tremendous psychological effect on the child interfering with
the quality of his life. Between 1972 and 1976, k0% of the children
accepted for haemodialysis and renal transplantation at Guy's Hospital,
London were below the third percentile for height. Although a number
of factors such as renal osteodystrophy and calorie deficiency are
known to contribute, the pathogenesis of this disorder remains
obscure.
Of the various factors that are known to affect growth, nutritional,
hormonal and metabolic factors play a dominant role. Information
regarding the effects of chronic renal failure and dialysis on these
determinants of growth have been fragmentary and in most instances
derived from studies on either adult patients or experimental animals.
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Studies on uraemic children are scanty and often a single parameter
was measured in a group of patients whereas the need is to study all
parameters in the same child so as to assess inter-re 1 ationships.
in view of the complexity of growth mechanisms, it is difficult
to approach the problem from one aspect only. This thesis, therefore,
does not aim to define one specific abnormality by detailed study of a
confined area, but is a general view of the nutritional, hormonal and
metabolic status of uraemic children on haemodialysis in order to
(1) shed light on the possible mechanisns underlying the abnormal
growth in chronic renal failure, (2) to further our understanding
of the needs of these children particularly in respect of their
nutritional care, and (3) to define specific areas for future research.
a
Historical perspectives and/critical review of the relevant
literature are presented in the first part of the thesis. Clinical
and analytical methods are presented in a separate section (Part II)
because similar methods were used in more than one study.
The main study (Chapter 7) was designed to monitor prospectively
the growth pattern, sexual maturation, nutritional status, hormonal
balance and measurements of carbohydrate, lipids and protein
metabolism over a period of one year in order to identify any
abnormalities, their possible inter-relationships and relevance to
growth. Particular emphasis was placed on the relation of energy
metabolism to endocrine function which was further assessed (Chapter 8)
by determining the dynamic responses of energy substrates and the
metabolically important hormones to intravenous glucose, and evaluating
hormone-fuel inter-relationships • Measurements of the
whole body composition and basal oxygen consumption were undertaken
(Chapter 9) in order to assess the impact of chronic renal failure
on body composition and to determine basal energy expenditure in
relation to the metabolically active tissues. Finally (Chapter 10),
the effect of diet and its manipulation on the plasma lipid profile was
investigated so that deductionscould be made regarding some aspects
of dietary management of these children.
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The term uraemia was first introduced into Medical Literature in
1840 by Piorry and L'Hertier. They regarded the manifestations of
renal failure as a form of poisoning of the blood due to reabsorption
of urine; but it was Richard Bright (1836) who focussed clinical
interest on the uraemic syndrome by his description of glomerulo¬
nephritis and the pathological changes in renal failure. Bostock
(1827), who carried out the chemical examinations of serum from
Bright's patients, was first to draw attention to the raised blood urea
concentration in chronic renal failure. The test was crude and
insensitive and Rees (1840) failed to detect urea in the blood of
normal subjects.
The similarity between the uraemic syndrome and intoxications
such as opium poisoning and alcoholism maintained the concept of
uraemia as an intoxication. Retention of urea remained the predominant
theory and various other urinary constituents were implicated during
the subsequent years. In 1892 Bradford experimentally produced the
uraemic syndrome clinically and chemically by excision of 75% of the
kidney tissue in dogs which was later confirmed by Pearce in 1908.
Renal insufficiency thus became established as the underlying
mechanism of the uraemic syndrome. Further studies aetiologica11y
broadened the category of renal failure, and uraemia came to be understood
as the clinical syndrome resulting from loss of normal renal function.
The viewpoint of the uraemic syndrome as a distinct entity
dates from 1918 when Vol hard separated from true uraemia two
syndromes which are not dependent on renal insufficiency; acute
"pseudouraemia" characterised by signs of increased intracranial
pressure and chronic "pseudouraemia" meant the manifestations of
disturbed cerebral circulation including motor, sensory and psychic
disturbances. In 1928 Oppenheimer and Fishberg described hyper¬
tensive encephalopathy overlapping Volhard's "pseudouraemia" and
separated this entity from uraemia. The work of Peters (1932)
contributed substantially to the understanding of electrolyte and
water metabolism in renal failure. True uraemia was then separated
from numerous conditions and became a more specific clinical,
biochemical and pathogenetic syndrome.
The extensive studies of renal psysiology by Smith (1951) and
others have shown the complexity of urine formation and it was
realised that uraemia is not equivalent to the addition of urine to
the blood. The concept then evolved that uraemia is the clinical
syndrome caused by the biochemical alterations resulting from the
loss of normal kidney tissue.
Since Paediatrics as a specialty started approximately at the
same time as Bright was making his historical observation at a time
when infant and child mortality was extremely high, the clinical
concept of chronic renal failure in children did not arise. Golding
Bird (1845), a London physician, took particular interest in children
with scarletinal nephritis. He observed a rise in blood urea as a
complication of the illness and considered it as contributing to the
clinical problem.
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At this stage, however, uraemia was recorded as an acute
complication of nephritis, or as an end-stage problem preceding
death in patients with established renal disease. The numerous
reports of clinical observations and biochemical findings in
patients with uraemia made no special mention of the syndrome as
it affects children. Indeed children were considered small adults
and the profound differences in body composition, metabolism and
requirements of growth were not appreciated until relatively
recently.
TheSearch for Uraemic "Toxin"
Much attention has been given to the role of urea in the past
150 years as a toxic factor causing the uraemic syndrome. The
controversial role of urea was first raised by Bright in 1831 who
concluded that the elevated blood urea concentration was only partly
responsible for the symptoms of renal failure. The inadequacy of the
urea hypothesis became apparent later and other urinary constituents
and various compounds such as creatinine, indican, phenols,etc. were
incriminated at one time or another. After detailed historical
review Fishberg (195^0 supported what Smith (1950 called the
combination of ingredients theory; he wrote: "The century old search
for a uraemic toxin has been fruitless. We do not yet knew any
single substance, the retention of which, as a result of renal
insufficiency, produces uraemia - Uraemia is the complex
multiplicity of mechanisms set in motion by impairment of renal
function".
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The worldwide experience that terminal uraemic coma is
reversible by dialysis has quickened once again the search
for uraemic "toxin". Guanidine compounds were implicated and
Giovanetti et al. (1969) showed that chronic administration of
methyl-guanidine to dogs could produce a uraemia-like syndrome.
A year later Cohen (1970) reported that guanidino succinic acid
was retained in renal failure in proportion to the degree of renal
insufficiency and considered it as an important uraemic toxin.
Research continued into the nature of uraemic toxins,and in recent years
much
Attention has been paid to the role of "middle molecules". It was
first suggested by Babb et al. (1972) that some dialysis schedules
permit the accumulation in body fluids of molecules in the range of
1000 to 2000 daltons, and that these cause some of the uraemic
problems still encountered by patients receiving dialysis. Furst
et al. (1975) identified groups of polypeptides of molecular weight about 1000 ir
the blood of a large group of uraemic patients; they bore no
relationship to the glomerular filtration rate and their
accumulation was considered to be due to increased production rather
than simple retention.
Haemodialysis Therapy
Although the clinical use of an artificial kidney was introduced
by Kolff in 19^> chronic dialysis in adult uraemic patients became
possible only after the introduction of the Quinton-Scribner Arterio¬
venous shunt in 1960. Subsequent development of the treatment and
its combined use with transplantation altered the fate of patients
with end-stage renal failure.
Haemodialysis in children is of relatively recent origin.
The first successful haemodialysis in a child was reported by
Mateer et al. in 1955 but its use was limited to short term
dialysis for acute disorders for the subsequent ten years or so.
The first pre-pubertal child started chronic dialysis in 1962 and
the first children's dialysis centre was founded in Los Angeles
in 1967 (Fine et al., 1968).
The primary reasons why the practice of regular haemodialysis
developed so much later in children than in adults are the technical
difficulties related to body size and adequate vascular access,and
haemodialysis was considered at one time to be too great a
psychological stress for children. Now the technical problems of
dialysis in children have been solved and experience from many
centres throughout the world has demonstrated that regular haemo-
dialysis is as successful in children as it is in adults
(Potter et al., 1970; Wass et al., 1977).
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CHAPTER 2
GROWTH IN CHILDREN WITH CHRONIC RENAL FAILURE
Chronic renal failure is commonly associated with growth
retardation (Chantler and Holliday, 1973; Schyrer e.t al., 1976).
This association was first noted with respect to rickets. Lucas
(1883) was first to describe rickets in children with 'nephritis1,
but uraemia in childhood was considered at that time to be an acute
problem and the long term effects on growth and development were not
appreciated. Although fourteen years later Guthrie (1897) described
short stature in children with chronic renal insufficiency it was not
until Fletcher (1911) described a boy with "infantalism and polyuria"
that interest in the retardation of physical development in children
with renal disease was aroused. Within a few years many similar
cases were described. The children became known as "renal dwarfs"
(Barber, 1920) and the bone disease as "renal rickets" because of the
clinical and radiological similarities to nutritional rickets
(Paterson, 1920). For many years attention was focussed on rickets
as the cause of short stature, since with advanced renal disease
the skeletal abnormalities provided an obvious explanation (Barber,
1926; Sheldon, 1936).
The growth failure of renal disease in the absence of clinical
rickets was not appreciated until relatively late (McCune, 19*+3;
Watson and Lowrey, 195*0- Although no specific explanations were
offered by these authors, it was appreciated that the alteration
in cellular environment and metabolism as a consequence of lost renal
function lead to growth failure. It was West and Smith (1956) who
were first to approach the problem systematically and considered the
possible role of various manifestations and complications of renal
failure including infection, acidosis, retention of nitrogenous
waste products and malnutrition. They concluded that in the
absence of rickets, and chronic acidosis, calorie deficiency was
the most important cause. However, as the prognosis for children
with chronic uraemia was so poor that retardation of growth seemed
of little importance, this crucial problem received little attention
until the advent of successful treatment with intermittent haemo-
dialysis and renal transplantation, which highlighted its impact on
psychosocial rehabilitation of these children. Since then factors
contributing to growth failure in children with chronic renal
insufficiency have been investigated by several groups (Simmon et
al., 1971; Broyer et al., 197^; Betts and Magrath, 197^) and the
subject was reviewed in some detail (Bergstrdm et al . , 196;
Chantler and Holliday, 1973; Stickler et al., 1973; Lewy and
New, 1975).
The factors involved in its pathogenesis are very little
understood. Attention in the past was focussed on factors known to
affect growth either in clinical or experimental settings, particular
bone disease and metabolic acidosis. More recently, calorie
deficiency was considered to be the most important factor (Chantler
and Holliday, 1973). Hormones known to regulate normal growth have
been little investigated in these children. Disturbances in energy
metabolism and their possible adverse effects on somatic growth have
been overlooked. The search for a single cause for the growth failu
in uraemic children has, to a large extent, been fruitless.
This is not surprising because normal growth is a highly complex
affair and although many of its determinants are known, the
mechanisms whereby these factors control growth are i11-understood.
Moreover,the aetiology of growth failure of uraemia is more likely
to be multifactorial and previous attempts to elucidate its
pathogenesis were usually concerned with the study of a single
variable in a small group of patients.
Of the various factors that are known to affect growth,
nutritional, hormonal and metabolic factors play a dominant role.
The pathogenesis of growth failure in children with chronic renal




1. Calorie requirements, body size and growth.
In relation to body weight, the calorie requirements of children
are greater than those of adults. This is because children have
relatively higher basal metabolic rates, greater activity and the
additional requirement of growth (Holliday, 1972). When satisfying
energy needs, other nutrients which need to be excreted such as
potassium, sodium and nitrogen are ingested in excess, and it is
interesting to note, in this respect, that the glomerular filtration
rate relative to body weight is greater in children than in adults
(Holliday, 1970). In renal failure when the excretion of excess
nutrients as well as the products of body catabolism can only be
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achieved by altering body composition (greatly expanding extra¬
cellular volume), the impact on the child is greater. To reduce
this relatively larger excretory load, anorexia is common and results
in energy malnutrition which is of a greater magnitude than noted
in uraemic adults.
2. Calorie intake and growth
Calorie intake in health is regulated by appetite to meet
energy requirements for basal metabolism, physical activity, thermal
regulation and, in children, growth. Calorie deficiency due to
depression of appetite in pathological states such as uraemia will
then be a limiting factor to activity and growth. Growth is very
sensitive to calorie deficiency and although the cost of calories
is small, estimated to be about 10% of total energy intake (Holliday,
1972), a positive calorie balance must exist for growth to take
place. This is very evident in protein energy malnutrition (PEM).
A mild degree of calorie deficiency affects growth in the absence
of overt clinical malnutrition (McLaren, 1976). This was clearly
demonstrated by the slow growth rate of Japanese children during
World War II when food was rationed (Tsuchiya, cited by Holliday,
1972). It has been shown (Key et al, 1950 ;Ashworth et al., 1968) that
the calorie cost of recovery from malnutrition to restore body
composition to normal and for 'catch-up' growth to occur may be
very high. It was also demonstrated (Waterlow, 1961) that the
rate of weight gain in both lean body mass and fat in children
recovering from protein energy malnutrition was significantly
influenced by the level of calorie intake rather than that of protein.
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Nitrogen balance studies (Calloway and Spector, 195*0 showed
that efficiency of dietary protein utilization depends on the
adequacy of calorie intake. However, the efficiency of growth
(weight gain per kilocalorie) seems to depend on the type of
and the degree of malnutrition. Ashworth et al. (1968) have
shown that the efficiency of growth was much less in the
predominantly protein malnourished children than those with
mainly calorie deficiency. This implies that the latter
utilize energy more efficiently, perhaps due to better adaptation
or that metabolic and hormonal disturbances associated with
protein deficiency affect energy exchange to a greater degree.
3. Energy requirements and supply in catabolic states
Under normal conditions nitrogen excretion equals intake and
for this to occur a sufficient dietary supply of calories and
protein is required. A positive nitrogen balance indicates
overall predominance of synthesis over degradation of body protein.
The reverse is true when nitrogen balance is negative. Various
studies have shown calorie needs to be greater than normal in
catabolic states such as sepsis, trauma and burns (Duke et al.,
1970; Hinton et al., 1971)• These increased requirements cannot always
be met by increased intake as illness is often associated with
anorexia and disruption of the gastrointestinal tract. In these
instances, endogenous energy stores such as glycogen, fat and
tissue protein are mobilized for energy production. Protein
sparing depends on the efficiency of metabolic adaptations to
minimise protein catabolism. These adaptive processes are very
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effective in normal man during starvation (Cahill et al., 1966).
In contrast, during disease or trauma, the body is much less
efficient in conserving its protein even with normal calorie
intake (Border, 1970). It is only by providing considerably
more calories than normal with adequate protein intake that
nitrogen balance becomes positive and wasting is prevented
(Stephens et al., 1969; Dudrick et al., 1970)•
Patients with uraemia are often poorly nourished and have
reduced body protein mass (Coles, 1972). The utilization of
dietary nitrogen for protein synthesis is impaired and most of
these patients catabolize their body protein (Hendon et al., 1958;
Robson et al., 1968). Energy requirement for anabolism may be
increased (Abitbol and Holliday, 1976) and the efficiency of
utilization of dietary protein is improved with high energy intake
(Hyne, 1972). This is of particular relevance to uraemic
children as a positive nitrogen and energy balance is a pre-
requisite to growth.
(b) Association of Calorie Deficiency and
Growth Failure in Uraemia
1. CIinica1 Studies
Because of the known adverse effect of malnutrition on growth
in children suffering from PEM, and since anorexia and consequent
decrease of food intake is a prominent clinical feature of uraemia,
it was only natural to look for a nutritional cause of the growth
failure in children with chronic renal insufficiency. As stated
earlier, West and Smith (1956) were first to point out the importance
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of malnutrition as a major cause of growth failure in these children.
Unfortunately, their study was retrospective and the subjects were
a hetrogenous group of children with differing degrees of renal
impairment. Their assessment of renal function was based on blood
urea nitrogen levels in the majority of cases. They also used
weight for height index ( actual weight ^
ideal weight for height age
as an index of nutritional status, and a value of <0.95 was taken
as evidence of calorie deficiency. The use of such an index is
fallacious as the body composition is drastically altered in chronic
renal failure (Coles, 1972; Co mty, 1968). The cell mass is
grossly reduced and the extracellular fluid volume increased, so that
simple changes in weight may not reflect nutritional status accurately.
Moreover, children may have stunted growth and have reduced fat stores
yet have normal weight for height (Talbot et al., 19^7). Even with
the use of such a crude index, a number of children in this study
were growth retarded yet had an index of unity or more. Stickler
and Bergen (1973) used the same index as West and Smith and found
no significant difference in weight for height index between
uraemic children of normal height and those with short stature.
Their study was also retrospective and blood urea levels of
50 mg/100 ml or more were used as a measure of renal function.
Both West and Smith (1956) and Stickler and Bergen (1973)
utilized a single measurement of height for each patient and
compared it to normal growth curves. This is unsatisfactory as
an assessment of growth performance (Marshall, 1971). Stickler
and Bergen's study also included children over the age of 11 years
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without taking into account their stage of puberty when assessing
their height - the error of such an omission is enormous
(Marshal and Tanner, 1970).
A relationship between calorie intake and growth has, however,
been demonstrated. Simmons et al. (1971) observed a reduced
growth rate of five children on regular haemodia 1ysis whose calorie
intake was 67% of recommended dietary allowance (RDA) for height
age compared to ten children with calorie intakes greater than RDA.
They also observed an increased growth velocity in four out of five
of the children with poor growth when their diet was supplemented
with extra calories. However, growth increment was measured
over periods which were too short to be meaningful, as was shown by
Marshal (1971). Similar results were reported by Grushkin et al.
0972), Holliday (1975) and Arnold et al . (1977). Betts and
Magrath (197*0 studied children in chronic renal failure treated
conservatively and demonstrated a correlation between energy
intake and growth velocity. They also pointed out that growth
retardation was only manifest when the glomerular filtration
2
rate fell below 25 ml per 1.73m , and when it was present it was
associated with energy intakes of 80% of RDA or less. In seventeen
children on long-term haemodialysis Broyer et al. (197*0 found no
close relationship between linear growth and calorie intake.
More recently, Betts et al. (1977) reported their observations
on a group of children with varying degrees of renal insufficiency
who were given energy supplements and failed to produce evidence
that reduced energy intake in children with chronic renal failure
was limiting to their growth. Although there is some doubt as to
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the author's interpretation of their data (Chantler et a 1. , 1977)>
it is clear that whilst growth may improve with energy supplements,
many children still grow poorly in spite of apparently adequate
intake (Chantler et al., 1976).
2. Animal Studies
Chantler et al. (197*0 demonstrated that rats rendered uraemic
by sub-total nephrectomy between AO and 70 days of age grew less
and gained less weight than controls and their calorie intake was
significantly decreased. They also pointed out that weight gain
per kilocalorie ingested was less in the uraemic rats, and
suggested a decreased efficiency in the use of energy for growth
and an increase in the calories required for maintenance metabolism.
Pair feeding studies (MacDonell et al., 1973; Diaz et al.,
1975) showed that the growth retardation of the uraemic rats
could be mimicked by feeding the control rats the same amount
of food as consumed by the uraemic rats. Moreover, calories
(Adelman and Holliday, 197*0 and calories plus essential amino
acids (Diaz et al., 1975) resulted in accelerated growth, though
in the latter study the rats were on low protein diet. Betts et
al. (1976), using a different animal model, namely new born
piglets to study the association of dietary intake and growth
in uraemia, demonstrated similar results to those obtained with
the rat mode 1.
From the above considerations, it may be concluded that
there is good evidence from animal studies implicating calorie
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deficiency as a major cause of growth retardation in chronic
uraemia, but clinical studies have yielded conflicting results.
The growth response to high calorie diet varies; whilst growth
may improve with energy supplement, many children grow poorly
in spite of apparently adequate intake. One reason for this
may be that results obtained at different stages of renal
insufficiency and consequently different degrees of metabolic
adjustment to a deranged biochemistry are not necessarily comparable.
Secondly, the initial nutritional status of the child before the
provision of extra energy may have bearing on the response to diet.
Thirdly, and perhaps the most important factor, is that the energy
requirements of man and his balance of intake and expenditure
are not known (Durnin et al., 1973) and therefore the assessment
of the adequacy of energy intake for growth in uraemic children
is difficult when the intakes of normal children of the same
size may vary considerably (Widdowson,19^7). Another interesting
point is whether the observed decrease in calorie intake in stunted
uraemic children is the consequence of their smallness or the
cause of it? Waterlow (1968) hypothesized that from the
nutritional point of view smallness in size may be a useful
adaptation and not necessarily an adverse effect of malnutrition
since the small person needs fewer calories and less protein. In
protein-energy malnutrition (PEM) when reduced food intake is
due to lack of food rather than depression of appetite, Waterlow's
hypothesis may be valid. By contrast the uraemic child has a poor appe¬
tite and by eating less reduces the excretory load but also reduces the
energy and protein available for growth. Furthermore, nitrogen
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retention for growth relieves the kidney of some of it excretory
load; McCance (1959) has described growth as the 'third kidney1,
and in this sense growth failure in uraemic children, by reducing
the protection from uraemia conferred by anabolism, could not be
thought of as an adaptive phenomenon to reduce food intake but
rather a result of malnutrition and other metabolic and hormonal
disturbances associated with renal failure.
Understanding energy homeostasis in uraemia and the various
metabolic and hormonal factors that affect anabolism will be of
great value in exploring the pathogenesis of the growth failure
in uraemia. No information is yet available about energy
metabolism in the uraemic patient.
Chronic Acidosis
Children with renal tubular acidosis without disturbance of
other renal function grow poorly (Soriano et al., 1967) and their
growth improves with correction of the acidosis (Nasb et al., 1972).
In a group of 41 children with chronic renal disease, West and
Smith (1956) found acidosis in 76% of 21 stunted patients and
none in those growing normally. Cooke et al. (1960) and several
others quoted by them have also noted the relationship between
growth failure and acidosis in experimental animals. However,
growth retardation was not proportional to the degree of acidosis:
acetazolomide administration to rats resulted in a severe metabolic
acidosis despite which growth was normal. The authors suggested
that the loss of fixed base consequent to the acidosis might be
responsible for the growth failure observed. However, the
acidotic rats ate less than normal rats and grew less than'
pair-fed controls (Cooke et al., I960; Bergstrom et al., 1964).
Reduced food intake and altered nutritional efficiency, as a
result of acidosis, might be an important cause of the growth
fai1ure.
Although chronic acidosis may affect growth, this is probably
of limited importance in the growth retardation of chronic renal
failure since children undergoing regular haemodia 1ysis are
usually not acidotic yet fail to grow. In additi on,the absence
of acidosis in non-dialysed children with chronic renal failure
does not ensure normal growth (Bergstrom et al., 1964).
Renal Bone Disease
Osteodystrophy is a common feature of advanced renal disease,
and the development and degree of bone changes seem to be related
to the duration of uraemia (Beale et al., 1976). The incidence
is higher in uraemic children than adults and those on maintenance
haemodialysis are particularly affected (Fine et al., 1972;
Potter et al., 1974).
The pathogenesis of renal bone disease is complex and not
wholly understood. Factors involved in its development include
disturbances in vitamin D, calcium and phosphate metabolism, and
secondary hyperparathyroidism (DeLuca, 1973). A point worthy of
mention is that it has been shown (Russell and Avioli, 1975) that
derangements in carbohydrate metabolism in uraemia resulting in a
defective energy production contribute directly or indirectly to
the defect in bone metabolism.
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Stunting of growth in children with nutritional rickets is
well known; cure of the rickets with vitamin D improves growth.
Likewise, the onset of renal osteodystrophy is associated with
cessation of growth (West and Smith, 1956; Stickl.er, 1973).
Vitamin D therapy (Dent et al., 1961) and parathyroidectomy
(Broyer et al., 197*0 were shown to accelerate growth in children
with renal osteodystrophy. However, many uraemic children fail
to grow in the absence of bone disease, and not all children with
bone disease necessarily have growth retardation (Betts and White,
1976). Wass et al. (1977) found no correlation between growth
velocity and degree of osteodystrophy in a group of children on
dialysis. Moreover, detailed studies (Mehls et al., 1977)
of skeletal changes in uraemic rats showed that longitudinal
growth can proceed normally despite the presence of bone disease.
There is no doubt that severe osteodystrophy affects growth
but other factors, perhaps more fundamental, are operative.
Duration of Renal Disease - Bone Maturation and Potential for Growth
Poor renal function early in life causes a more profound growth
failure; stunting is more pronounced in hereditary and
congenita] nephropathies than in acquired lesions such as glomerulo¬
nephritis (Sch^rer et al., 1976). Betts and Magrath (197*0 have
shown that infants with renal insufficiency have a rapid fall in
weight centile in the early months of life with little evidence of
subsequent catch-up growth. The same group (Betts and White,
1976) further demonstrated that the greatest delay in bone
maturation occurs in those children whose disease dates from
infancy rather than acquired disease but there was no extension
in the delay in bone age with advancing years and deteriorating
renal function. They also noted a fall of height centile with
increasing bone age and that bone maturation continues despite
severe osteodystrophy and growth arrest. They concluded that
with increasing age, children with chronic renal failure lose
potential for growth. This conclusion, however, was based on
a cross-sectional study and longitudinal study will be needed to
confirm this. Somewhat similar findings were reported by Broyer
et al. (197*0 in children on haemodialysis; the statural growth
rate was found to be slower than bone maturation in early child¬
hood, at puberty and in the presence of osteodystrophy. Thus
at puberty, there is a rapid increase in bone maturation with
only small increment in linear growth, with permanent loss of
growth potential. This conception is supported by observations
on growth of children after renal transplantation (Grushkin and
Fine, 1973; Najarian et al., 1971); Saenger et al., 197*0.
It is accepted that the degree of skeletal maturity is a
significant factor in deciding growth performance after
transplantation. The data so far suggest that a bone age of
12 years or less at the time of operation is associated with
satisfactory growth.
Why younger children with renal insufficiency are more
growth retarded is not clear. Growth velocity is greatest
early in life and therefore the earlier the 'insult' of renal
disease the greater the effect on growth.
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Hormonal factors
Patients with uraemia on and off dialysis display a variety
of endocrine derangements. These entail abnormalities of
either plasma hormone concentration or metabolism. The possible
role of such disturbances in the pathogenesis of growth
retardation in children with chronic renal failure will be
discussed in Chapter k.
Emotional and psychological stress
Children with chronic renal disease, particularly those on
regular haemodialysis, are subjected to profound emotional
and environmental stress (Korsch, 1971). The association of
emotional deprivation and poor growth is well recognised and
the subject is reviewed by Gardner (1972). The mechanism by
which psychological stress depresses growth is controversial.
Inhibition of growth hormone secretion is one possible mechanism
(Powell et al., 1967) and excess Cortisol production, even in
small amounts, is another. However, high basal growth hormone
levels have been reported in children with this condition
(Krieger and Mellinger, 1971) and as will be discussed later,
growth hormone concentration is raised in chronic renal failure.
Psychological stress may have its effect upon growth by
depressing appetite and food intake (Whitten et al., 1969), and
anorexia nervosa is an extreme example of this. Depression of
appetite is a common feature in uraemic children but its cause
is unknown. The central control of appetite in normal
individuals is equally ill-understood and failure of growth may
be the product of hormonal and nutritional disturbances
mediated through the effects of stress upon the hypothalamus.
Obviously, further research in this field is required.
Other Factors
A variety of factors, known to adversely affect growth
in different clinical conditions and may be present in renal
failure, have been considered as possible causes of impaired
growth in uraemic children. These include anaemia,
hypertension, chronic infection, sodium, phosphate and
potassium depletion and magnesium and zinc deficiency (West
and Smith, 1956; Bergstrom et al., 1964; Broyer et a 1.,
1974; reviewed by Chantler and Holliday, 1973). There is
no evidence to suggest that any of the above mentioned factors
play an important aetiological role since the absence or
correction of such abnormalities is not associated with a normal
growth performance in these children (Chantler et al. ,1976).
CHAPTER 3
METABOLIC DISTURBANCES IN URAEMIA
"The extensive changes during renal insufficiency may
disturb chemical reactions everywhere in the body and
ultimately lead to a fatal dislocation of the
metabolic balance".
S.E. Bradley 19^6.
A wide variety of metabolic disturbances are known to occur in
adult patients with chronic renal failure (Wills, 1971)- These
include alterations in the metabolism of carbohydrates, proteins an
lipids. The pathogenesis of these abnormalities is complex and
probably a sequence of altered cellular processes as a result of
uraemia per se and complicated further by the effects of mal¬
nutrition so commonly superimposed on the uraemic state. Chronic
haemodialysis may improve some abnormalities, but may also create
new ones.
Alterations in the metabolism of the carbohydrates, proteins
and lipids are of particular relevance to this thesis as they may
adversely affect hormonal balance, energy metabolism and substrate
availability for growth in uraemic children.
3.1. CARBOHYDRATE METABOLISM IN URAEMIA
Neubauer in 1910 first called attention to the occurrence of
fasting hyperglycaemia in uraemia. This was soon confirmed by
Hopkins in 1915. Shortly thereafter, Myers and Bailey (1916)
demonstrated an abnormality of glucose tolerance and defined
"renal diabetes". Although these abnormalities were noted over
a half a century ago, relatively little attention was paid to
these problems until the advent of dialysis and transplantation.
Indeed until the last decade, knowledge of the effect of chronic
renal insufficiency on glucose and insulin metabolism was
essentially limited to two somewhat paradoxical observations.
On one hand it was believed that hyperglycaemia developed in
patients with chronic renal failure (Williams and Humphreys,
1919); on the other hand, insulin requirements of patients with
diabetes mellitus was shown to decrease with the development of
renal insufficiency (Zubrod et al., 1951).
Although this metabolic abnormality is now a well known feature
of uraemic adults there is no report to date on its occurrence in
children with uraemia, and despite numerous investigations in the
past fifteen years or so, there is little agreement as to its
pathogenesis. This lack of agreement on the underlying defect
in carbohydrate metabolism is partly the result of heterogenecity
of patients studied, differing circumstances and investigative
approaches.
The principal characteristics of this abnormality is excessive
hyperglycaemia following oral or intravenous loading. The peak
glucose concentration is elevated and there is delayed return of
blood glucose to fasting levels. Such glucose intolerance occurs
in greater than 50% of uraemic patients (Perkoff et al., 1958;
Briggs et al., 1967; Horton et al., 1968; Hampers et al., 1968;
Spitz et al., 1970; Lowrie et al., 1970). Although fasting
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hyperglycaemia is present in some patients, the abnormality is
more commonly evident on glucose tolerance testing.
The main pathogenetic factors implicated are:
A) Peripheral insulin antagonism
B) Abnormal pancreatic insulin secretion
C) Prolonged circulating insulin half-life
D) Abnormal hepatic glucose metabolism
E) Abnormal cellular glucose metabolism
A. Peripheral insulin antagonism:
The presence of peripheral insulin antagonism in uraemia is
well established; evidence in support of this comes from the
following observations:
1) The ability of exogenous insulin to lower blood glucose
concentration is impaired in uraemia (Cerletty and Engbring,
19^7; Westervelt and Schreiner, 1962; Hampers et al., 1966;
Horton et al., 1968; Spitz et al., 1970).
2) The presence of normal or elevated fasting blood glucose in the
face of a raised fasting insulin concentration (Hutchings et al.,
1966; Cerletty and Engbring, 1967; Horton et al., 1968; Lowrie et
al., 1970; Samaan and Freeman, 1970; Spitz et al. , 1970). This
observation can only be explained by insulin antagonism or by an
abnormal circulating insulin. This latter possibility is unlikely
since the hypog1ycaemic effect of exogenous insulin is impaired.
3) Diminished and delayed fall of blood glucose following intra¬
venous tolbutamide (Hampers et al., 1966; Cerletty and Engbring,
1967; Cohen et al., 1968; Spitz et al., 1970).
k) The most direct evidence for peripheral insulin resistance
comes from the forearm perfusion studies of Westervelt (1969).
These studies showed blunted glucose and phosphate uptake in
muscle forearm tissue in response to exogenous insulin. They
do not, however, distinguish between a circulating insulin
antagonist, a defect in cell membrane transport of glucose, or
a defective glucose phosphorylation.
5) Swenson et al. (1973) carried out studies in dogs before
and after they were made uraemic by surgical diversions of both
ureters into the vena cava thereby producing uraemia in the presence
of normal kidneys. The effect of uraemia on insulin resistance
was studied by the steady state plasma glucose response to
continuous infusion of adrenaline, propranolol, glucose and
insulin. With this approach, endogenous insulin secretion and
hepatic glucose output were inhibited; similar steady state levels
of circulating insulin were achieved in all dogs, and the level of
the steady state plasma glucose response was a direct measure of
insulin resistance. They showed that steady state plasma glucose
concentration was significantly higher after uraemia had developed
indicating clearly the existence of insulin resistance.
Although there seems to be little doubt that insulin
resistance occurs in uraemia, the cause is far from clear. The
possible causes are:
1) Abnormal form of insulin:
There is no evidence that an abnormal form of insulin is
secreted by uraemic patients. The decrease in effectiveness of
exogenous insulin discussed above makes this an unlikely possibility.
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2) Circulating insulin antagonists:
(a) Hormones.
(i) Growth Hormone: The level of growth hormone, a well recognised
diabetogenetic substance, is raised in uraemia and significant
positive correlations between growth hormone and the degree of
uraemia have been described (Horton et al., 1968; Wright et al.,
1968; Orskov and Christensen, 1971; Reaven et al., 197^;
Davidson et al., 1976). An exaggerated rise in GH levels following
insulin administration has also been seen in uraemic patients.
However, most investigators (Horton et al., 1968; Wright et al.,
1968; Samaan and Freeman, 1970; Davidson et al., 1976), but not
all (Orskov and Christensen, 1971) have found no correlation between
the degree of GH elevation, either fasting or after glucose, and the
degree of glucose intolerance. The role of GH in carbohydrate
intolerance in uraemia remains uncertain. Its raised level may
even be the result rather than the cause of this abnormality.
(ii) Parathormone : More recently, excessive secretion of
parathyroid hormone has been suggested as a possible cause of
glucose intolerance and insulin resistance in patients with renal
failure (Lindall et al., 1971) since secondary hyperparathyroidism
is a common finding in such patients, and since hyperparathyroidism
seems to lead to insulin resistance and increased insulin secretion
(Kim et al., 1971) • It is possible that the role of parat¬
hormone could be related to its well known role in controlling
serum calcium. It is also known that insulin secretion is highly
dependent on calcium ions in the media bathing the islets of
Lengerhan (Curry et al., 1968). However, other investigators
have not found carbohydrate intolerance in patients with hyper¬
parathyroidism (Purnell et al., 1971). The role of increased
parath-hormone secretion in the mechanism of insulin resistance
in uraemia requires further study.
(iii) G1ucagon: Elevated fasting concentrationsof glucagon have
recently been demonstrated in chronic renal failure (Bi lbrey et
al., 1974; Sherwin et al., 1976). However, peripheral insulin
resistance cannot be explained on the basis of hyperglucagonaemia
since a diminished insulin effect on muscle characterises uraemia
and glucagon has no effect on insulin-stimulated glucose uptake
(Davidson et al. , 1976). On the other hand suppression of
glucagon secretion by glucose has been suggested as an essential
component of normal glucose tolerance (Unger et al., 1970) and
there is evidence that the hyperglucagcnaemia of uraemia is not
suppressable by glucose (Bilbrey et al., 1974). However, Sherwin
et al. (1976) have demonstrated that hyperglucagonaemia did not
cause glucose intolerance in normal subjects or bring about
deterioration of diabetic control when insulin was available.
The diabetogenic action of glucagon seemed to depend on insulin
deficiency rather than absolute increase in glucagon concentration.
Since haemodialysis improves glucose tolerance without altering
the high plasma glucagon levels (Bi lbrey et al., 1974), hyper¬
gl ucagonaemi a probably does not cause uraemic glucose intolerance.
Further studies are necessary to clarify the role of glucagon in
the abnormal glucose metabolism in uraemia.
(iv) G1ucocorticoids: Adrenocorticoids antagonise the action of
insulin primarily by increasing gluconeogenesis from protein
(reviewed by Levine, 1964). Hunk (1971) has also shown
that glucocorticoids inhibit peripheral glucose uptake. Plasma
adrenocorticoid levels were found to be normal or slightly elevated
and to bear no correlation to the glucose intolerance in patients
with chronic renal failure (Perkoff et al., 1958; Hutchings et
a 1 . , 1966) .
(v) Catechol amines: That the hyperglycaemic action of adrenaline
is primarily the result of glycogen breakdown is well known (Katzen
and Glitzer, 1968). While adrenaline raises cyclic AMP levels,
insulin, although possibly indirectly, lowers the levels of this
cofactor (Butcher et al., 1966). This action of adrenaline
may be the basis of its insulin antagonistic properties. However,
adrenaline may also inhibit insulin secretion (Kris et al., 1966).
Zileii et al. (1958) found elevated plasma catecholamine levels in
renal failure. They concluded, however, that this was a false
increase due to interfering substances such as phenols in the
method of analysis and by using a more specific method the values
were found to be normal. The Oxford Group (Ledingham, 1977;
Personal Communication) studying hypertension in renal failure
found plasma noradrenaline concentration to be raised and
adrenaline levels normal in a group of patients on regular haemo-
dialysis for chronic renal failure. They did not, however, study
glucose metabolism in their patients.
(vi) Prolactin: The diabetogenic action of prolactin is
analagous to that of growth hormone (Hussay and Penhos, 1956, cited
by Katazen and Glitzer, 1968). Recently elevated plasma prolactin
levels have been reported in adult patients with chronic renal
failure (Hagen et al., 1976), but the role this hormone plays
in insulin antagonism in uraemia is not known.
(b) Metabolic end products
Renal failure is characterised by the retention of many
substances, and it is possible that one or more of these is
responsible for the insulin antagonism. Urea has received the
most attention. Most authors have found a positive correlation
between elevated urea levels and glucose intolerance (Briggs et
al., 1967; Hutchings et al., 1966; Spitz et al., 1970). However,
others found no such correlation (Westervelt and Schreiner, 1962;
Cerletty and Engbring, 1967)- Studies on the effects of urea on
glucose transport and metabolism both in vivo (Perkoff et al.,
1958; Hutchings et al., 1966; Hampers et al., 1966) , and
in vitro (Perkoff et al., 1958; Davidson et al., 1969)» have
yielded conflicting results and it appears that urea alone is
not responsible for the glucose intolerance of uraemia. Various
other substances including creatinine (Balestri et al., 1970),
guadinosuccinic acid (Cohen and Horowitz, 1968), methylguanidine
(Balestri et al., 1972) have been implicated, but there is no
clear evidence that aiy of these metabolites is the cause.
The improvement of glucose tolerance by haemodialysis
(Hampers et al., 1966) coupled with a longer decline in blood
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glucose dur i ng/i nsul i n tolerance test suggest that haemodia 1ysis
removes inhibitors of glucose utilisation and/or of insulin
responsiveness. However, Davidson et al. (1969) found no
difference in the effects of pre- and post-dialysis serum on
insulin stimulated glucose uptake by rat diaphragm. On the other
hand, several other studies have shown that uraemic serum does
inhibit glucose uptake by rat hemidiaphragm (Balestri et al., 1972;
Dzurik and Valoricova, 1970; Westervelt and Schreiner, 1962) in
the absence of added insulin. This suggests that uraemia exerts
an effect through non-insulin dependent cellular mechanisms.
Dzurik et al. (1973) claimed the isolation of an inhibitor of
glucose utilisation from serum of uraemic subjects. This peptide
(mol.wt. 1000-1500) inhibits glucose utilisation in rat diaphragm,
brain and kidney cortex slices as well as in human erythrocytes.
This finding has not been confirmed but the molecular weight of
this peptide is of interest from the point of view of uraemic
toxicity, as it was suggested that 'Middle Molecules' (Mol. wt.
400 - 5000) are important uraemic toxins (Babb et al., 1972;
Furst et al., 1975).
Several other factors known to cause a deterioration in glucose
tolerance and insulin resistance have been suggested as possible
causes of uraemic glucose intolerance. These include acidosis,
malnutrition (Snyder et al., 1968), decreased total body potassium
(Spergel et al, 1967), and hypoca1caemia (Lisch et al., 1973).
Indeed, it is possible that there is no one cause of insulin
resistance in uraemia, and that several of these factors interact
to produce intolerance and insulin resistance.
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B. Effect of uraemia on insulin secretion
Studies on plasma insulin response to intravenous and oral
glucose have yielded conflicting results. Horton et al. (1968)
and Lowrie et al. (1970) have found the early insulin response to
be normal, while Hutchings et al. (1966) and
Hampers et al. (1966) found it to be decreased. Insulin levels
during the latter part of IVGTT have been found to be increased
by all authors (Hampers et al., 1966; 1968; Horton et al., 1968;
Hutchings et al., 1966; Lowrie et al., 1970; Samaan and Freeman,
1970). Similar discrepancies have been reported following oral
glucose tolerance test; the early response was found to be
normal (Briggs et al., 1967; Cerletty and Engbring, 1967; Hampers
et al. , 1968), or increased (Spitz et al., 1970; Sherwin et al.,
1976). Haemodia 1ysis increases the early insulin response to
normal (Hampers et al., 1966) , or even supranormal levels (Lowrie et al.,
1970). On the other hand, Sherwin et al. (1976) found the
response to be increased in the undialysed compared with the dialysed
uraemic patients.
The removal rate of insulin from plasma is decreased in patients
with renal insufficiency (see next section). Thus, the observation
that the plasma insulin concentrations are equal to or greater than
normal following a glucose stimulus in these patients does not
distinguish between an increase in pancreatic insulin secretion
rate or a decrease in insulin removal rate as being responsible.
Swenson et al. (1973) attempted to separate these two effects by
studying the insulin response by constant infusion of glucose in
dogs made uraemic by diversion of both ureters into the vena cava,
thus producing uraemia without the loss of renal mass. Glucose
concentrations were higher in uraemic dogs compared to controls,
but steady state insulin responses were similar in uraemic and
control dogs. Thus, the glucose intolerance demonstrated was
not associated with an actual decrease in insulin response.
They argued that since glucose intolerance was present, increased
amounts of insulin should have been secreted to prevent the hyper-
glycaemia and that the insulin response may, therefore, be blunted
in uraemia.
Two important considerations might explain the differences
reported: First, the magnitude of the early insulin response
following intravenous glucose load was overlooked by investigators
failing to draw blood samples before 10 minutes, since it has
been shown that insulin release in the first few minutes following
I.V. glucose is the most important determinant of glucose tolerance
(Porte and Bagdade, 1970), and second, failure to take into account
the basal insulin levels in interpreting the insulin response to
glucose. Absolute insulin levels after a variety of challenges
are directly related to the basal or prestimulated level
(Bagdade et al., 1967).
It is clear that glucose intolerance in uraemia is not
primarily due to a defect in insulin secretion for normal responses
or increases are the usual findings.
C. Effect of renal failure on insulin degradation rate
The normal kidney extracts and degrades 30-40% of the insulin
carried to it (Rubenstein and Spitz, 1968; Chamberlain and Stimmler
1967). The liver degrades at least 50% of the portal vein insulin
(Blachard and Nelson, 1971). Renal failure prolongs plasma
insulin half-life (O'Brian and Sharp, 1967; Spitz et al., 1970;
Horton et al., 1968), and decreases its metabolic clearance rate
(Fuss et al., 1974). These abnormalities could account for the
protracted hyperinsulinaemia found in uraemic patients following
insulin administration or endogenous insulin stimulation, as well
as the decreased insulin requirements in diabetic patients who
develop renal disease. On the other hand, it has been shown that
even in anephric patients the insulin half-life can be shortened
by haemodialysis (O'Brian and Sharp, 1967; Hampers et al., 1970).
Since the liver normally degrades most of the insulin released
by the pancreas into the portal circulation, a reversible defect
in hepatic insulin degradation may also exist in uraemia.
While there is a reasonable agreement that insulin catabolism
is impaired in uraemia, the mechanism of this metabolic change is
still controversial. According to one view the slow
degradation rate is due to a decrease in functioning renal tissue
and to the other view it is independent of the presence of renal
tissue per se and may reflect the retention of some dialysable
metabolite interfering with insulin metabolism. In a study by
Swenson et al. (1971) an attempt was made to distinguish between
these two possibilities by calculating the fractional irreversible
loss rate of labelled insulin administered to dogs when the kidneys
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were intact and then immediately after bilateral nephrectomy and
a few days later after the development of uraemia. Following
nephrectomy the insulin irreversible loss rate fell significantly,
and no further decrease was found after the development of uraemia.
They concluded that loss of renal mass is responsible for the
prolongation of insulin half-life in patients with renal insufficiency.
D. Role of the 1iver
Shoemaker et al. (1963) and Kipnis (1969) have estimated that
during absorption of glucose from the intestine about two thirds is
taken up by the liver. Since the liver plays such an important
role in carbohydrate metabolism, it is surprising that little
attention has been paid to its possible role in the abnormal glucose
tolerance of uraemia. Linder et al. (1925), using the respiratory
quotient as a measure of glucose oxidation, were first to suggest
that impaired hepatic glycogenesis was a likely cause of carbohydrate
intolerance in uraemic patients. More recent work implicating
the liver was that of Cohen et a 1 . (1961) and Cohen (1962). They
described blood glucose non responsiveness to exogenous glucagon and
adrenaline and suggested that there was a decrease in liver glycogen content
as a result of a failure of liver glycogenesis, and that the
excessive hyperg1ycaemia following glucose loading was a result
of a reduced hepatic uptake of glucose. This has not been the
general finding, however, and most authors have noted a normal
blood glucose response to glucagon injection in these patients
(Hampers et al., 1966; Hutchings et al., 1966; Cerletty and
Engbring, 1967). Sherwin et al. (1976) demonstrated an exaggerated
blood glucose rise following glucagon administration and
proposed an increased peripheral sensitivity to glucagon in
uraemia which is correctable by dialysis. Furthermore normal
liver glycogen content was found in uraemic rats (Bo'ucot et al.,
I960), and uraemic patients (Dzurick and Brixova, 1968). Glucose
fluxes across the liver in uraemiahave not yet been studied to
define more precisely the hepatic glucose uptake and output in
uraemia. An absolute increase in hepatic g1uconeogenesis or
an inability of the liver to decrease glucose production in
response to insulin could also explain the glucose intolerance
in uraemia. Neither of these possibilities have been explored.
E. Cellular glucose metabolism
A primary alteration in peripheral tissue glucose metabolism
secondary to the metabolic changes of renal failure has been
proposed as the cause of glucose intolerance and insulin
antagonism (Westervelt, 1969; Davidson et al., 1969; Cohen and
Horowitz, 1968). Westervelt (1969) suggested impaired
phosphorylation of glucose. This view is consistent with that
of Cohen and Horowitz (1968). Renner and Heinz (1972) have
shown that glucose utilisation via the Krebs cycle is diminished
and is increased via the pentose phosphate shunt. Uncoupling
of oxidative phosphorylation occurs and the synthesis of Acetyl
COA is decreased. This is consistent with work of Galloway and
Morgan (1964) who found elevated pyruvate levels in their uraemic
patients and suggested a metabolic block in pyruvate utilisation.
However, Ganda et al. (1976) reported normal plasma pyruvate
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concentration in their patients. Metcoff et al. (1978), using
the circulating neutrophil as a cell model, demonstrated that the
decrease in blood glucose levels post-dialysis was associated
with significant increases in the activities of the regulatory
glycolytic enzymes: G1ucose-6-phosphate dehydrogenase
(G-6-PD), phosphofructokinase (PFK) and Pyruvatekinase (PK).
The effect of uraemia on the activities of the enzymes of the
glycolytic, hexosemonophosphate, and glycogen cycle pathways has not
received much attention and data reported (Dzurick et al., 1969;
Boucot et al., 1960; Mannan et al., 1975; Maier et al., 1973)
has been conflicting and difficult to interpret as the enzyme
activities and/or intermediate metabolites were studied in
different tissues under different conditions.
Effect of haemodialysis on glucose intolerance of uraemia
It is generally accepted that haemodialysis improves glucose
tolerance in patients with uraemia (Hampers et al., 1966; 1970;
Lowrie et al., 1970; Spitz et al., 1970). However, Reaven and
his colleagues have pointed out that th i s apparent.improvement was due to
non-specific methods used for glucose determination (Swenson et
al., 1973). They found no improvement on oral glucose tolerance
tests using a specific glucose-oxidase method. They pointed out
that the use of non-specific methods that do not discriminate
between glucose and other reducing substances overestimates the
apparent improvement in glucose tolerance that follows dialysis.
Davidson et al. (1976) reported similar observations. They also
considered the glucose intolerance in uraemia to be modest. On
the other hand, there are studies which have used specific
methods for measuring blood glucose which demonstrated glucose
intolerance in uraemic patients (Westervelt and Schreiner, 1962;
Cerletty et al. , 1967; Horton et al., 1968; Orskov and
Chris tensen, 1971)-
The insulin response to a glucose load rises significantly with
chronic dialysis (Alfrey et al., 1967; Hampers et al., 1966;
1970; Spitz et al., 1970), and it may even be supranormal (Lowrie
et al., 1970; Lindall et al., 1971). This rise is particularly
striking in the first ten minutes of an intravenous glucose
tolerance test and correlates, in some studies, with improvement
in glucose disappearance rate (Hampers et al., 1966; Lowrie et
al., 1970). Haemodialysis also decreases the high fasting
the
plasma insulin concentration and shortens/insu1in degradation rate
(Hampers et al., 1970; Ganda et al., 1976).
The mechanism by which haemodialysis alters glucose and
insulin metabolism is not known. The increased insulin response
to glucose stimuli after adequate dialysis suggests the removal of
a dialysable inhibitor of insulin release. It has also been
suggested that dialysis removes inhibitors of glucose uptake
(Dzurik et al., 1973). Davidson et al. (1969), however, found
no difference in the effects of pre and post dialysis serum on
insulin stimulated glucose uptake by rate hemidiaphragm. Dialysis
may improve glucose metabolism by the removal of inhibitors of
key enzymes in the glycolytic pathways (Metcoff et al., 1978).
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Summary and Conclusions
Carbohydrate intolerance with hyperinsu1inism is a well
established feature of chronic renal failure. This impairment is
the result of renal failure or some effect of it, arid is not simply
the consequence of malnutrition or simple electrolyte imbalance.
Peripheral insulin resistance, the mechanism of which is not known,
and decreased degradation rate of circulating insulin - primarily
due to loss of renal tissue - would appear to be the principle
pathogenetic factors. There is little evidence which implicates
a primary defect in pancreatic insulin release as a cause of the
glucose intolerance, but there is the possibility that uraemia
inhibits the normal compensatory response of P-cells to hyper-
glycaemia. The complexity of the dynamics of normal insulin
release from /^-cell coupled with the profound disturbances in
cellular metabolism in uraemia, makes the state of insulin secretion
in uraemia difficult to assess. Haemodialysis, according to most
authorities, improves glucose tolerance in uraemic patients but does
not norma 1ise it.
Although the glucose intolerance of uraemia and its associated
hyperinsu1inism does not have obvious clinical manifestations,
the defective energy production which may result from such
abnormalities in glucose metabolism may have a direct or indirect
effect on cellular energy metabolism. It is not known what
influences these alterations have on other aspects of metabolism
such as protein, lipids and other hormones.
Understanding of these interrelationships is of obvious
the
importance and they may be implicated in/growth failure and tendency
to catabolism characteristic of renal failure; this dissertation is
primarily concerned with this aspect of the problem.
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3.2. LIPID METABOLISM IN URAEMIA
Lactescence of the serum from patients with renal disease was
noted over one hundred and sixty years ago (Blackall, 1813; Bostock,
1827). However, these early observations were on 'dropsical'
patients likely to have the nephrotic syndrome which is classica1ly
associated with hypercholestero1aemia. Chauffard et al. (1911) and
Ashe and Bruger (1933) described elevated serum cholesterol levels
in patients with chronic renal failure which returned to normal or
below normal levels as the uraemia progressed. This fall was
considered to be due to cachexia (Ashe and Bruger, 1933).
Although increased blood lipid levels have been observed in
experimental renal failure for many years (Johnson et al. , 1951),
only recently the lipid abnormalities in adult patients with
chronic renal failure, both treated conservatively or by regular
haemodia 1ysis, have been described (Bagdade et al., 1968; Arora
et al., 1973; Gutman et al., 1973; I be 1s et al., 1975;
Daubresse et al., 1976). Hypertrig1yceridaemia is the prominent
feature and plasma cholesterol concentrations are usually found
to be normal though occasionally increased (Kaye et al., 1973;
Persson, 1973; I be 1s et al., 1975). There are considerable
interstudy variations in the reports published due primarily to
differences in the degree of renal impairment, mode of therapy,
dialysis schedules and dietary information in the patients studied.
A wide variation in control values were also used in assessing
the degree of plasma lipid abnormalities in these patients. It
is, therefore, difficult to compare these studies or
discriminate between them.
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Recently, two studies on plasma lipid levels in children on
regular haemodialysis for chronic renal failure have been published
(Pennisi et al., 1976; Broyer et al., 1976). The findings in
both studies were similar to those reported in adults with hyper-
triglyceridaemia as the main feature and raised plasma cholesterol
in some but not all of the patients.
Lipoproteins and triglycerides
Elevated plasma triglycerides are present in the majority of
uraemic patients, whether they are managed conservatively or on
regular haemodialysis and appear to persist in most patients after
a successful renal transplantation (Ibels et al., 1975; Bagdade
et al., 1976). Roodvoets et al. (1967) first demonstrated that
the raised triglyceride level in uraemia was associated with an
increase in the plasma pre-beta lipoproteins and this was confirmed
by others (Bagdade et al., 1968; Ibels et al., 1975; Kaye et al.,
1973; Cattran et al., 1976). It is now well established that the
hypertriglyceridaemia of uraemia is due to an increase in the plasma
concentration of triglyceride - rich, very low density lipoprotein
(VLDL). This corresponds to Type IV according to Fredrickson1s
classification (Fredrickson et al., 1967). Fredrickson and his
colleagues considered that this type of lipoprotein pattern, which
may be either primary or secondary, is characteristic of endogenous
hyper 1ipidaemia, and is typically carbohydrate induceable and
accompanied by glucose intolerance. This phenotype may occur
as a result of increased hepatic triglyceride synthesis, diminished
removal of triglyceride from plasma or a combination of both. However,
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recent analysis of plasma lipoprotein fractions in undialysed and
dialysed uraemic patients (Bagdade et al., 1976, 1977; Norbeck
et al., 1976) revealed more extensive abnormalities in the composition
of the three major lipoprotein classes (VLDL, LDL, HDL): The
triglyceride and cholesterol concentrations in VLDL were increased,
whilst their normal ratio for this lipoprotein class was maintained.
In LDL, the concentration of triglycerides was increased, whilst
that of cholesterol was low. The LDL was, therefore, more
trig1yceride-rich than normal indicating a disturbed triglyceride
metabolism. The cholesterol content of HDL was extremely low
but HDL triglyceride was only slightly raised.
Mechanism of hypertriglyceridaemia of uraemia
The exact mechanism responsible for the elevated plasma
triglyceride concentration is not known. However, two possible
mechanisms were proposed:
1. Increased hepatic triglyceride synthesis
2, Decreased plasma triglyceride clearance.
Bagdade et al. (1968) and Bagdade (1970) suggested that the
increased plasma triglyceride concentration was the result of both
increased TG production by the liver and impaired removal from
plasma - a combination they termed 'mixed lipaemia1. They
considered the increased hepatic TG synthesis to be the consequence
of the hyperinsulinaemia found in these patients. This was based
on the indirect evidence of a positive correlation between plasma
TG concentration and plasma insulin level. Since hyperinsulinaemia
is known to be associated with increased hepatic TG synthesis in non-
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uraemic subjects (Reaven et al., 1967; Bierman and Port, 1968;
Eaton and Nye, 1973; Olefskey et al., 197*0, and since a decrease
in the levels of both plasma insulin and TG concentration was noted
following intensive dialysis, a causal relationship was suggested.
Although this remains a viable possibility, there is as yet no
direct evidence that elevated insulin levels alone increase hepatic
triglyceride production.
Studies on the kinetics of triglyceride metabolism in uraemie
patients produced conflicting results. Cramp et al. (1976) studied
TG synthesis rate in uraemic adults and reported raised plasma TG
concentration, a diminution in the fractional turnover rate and an
increase in the total turnover rate. They suggested hepatic over¬
production of triglycerides. However, Cattran et al. (1976) found
the TG turnover rates to be less than the values predicted for
comparable plasma TG concentration in non-uraemic subjects and
implied a defect in the plasma TG removal system.
The first step in the removal of triglyceride from plasma and
its deposition in adipose tissue is hydrolysis. This is catalysed
by the enzyme lipoprotein lipase (LPL). Post heparin lipolytic
activity 'PHLA1, which is an indirect measure of tissue lipoprotein
lipase and hence TG removal capacity, is reduced in uraemia (Bagdade
et al., 1968; Gutman et al., 1973; Daubresse et al., 1976). The
decrease in PHLA has been interpreted by various authors as an indic¬
ation of a defect of plasma TG clearance system. This plasma
lipolytic activity reflects more accurately the release of LPL from
a number of different tissue sources into plasma after heparin
administration (Krauss et al., 197*0 and hence may not reflect
quantitatively adipose tissue LPL which is believed to be the
principal mediator of TG removal (Robinson, 1965)- Moreover,
PHLA does not differentiate between absolute deficiency of tissue
LPL, resistance to heparin action, or the presence of an inhibitor
of LPL in uraemia. However, Persson (1973) reported a low level
of LPL in fat cells of uraemic patients and considered this as an
important factor causing hypertriglyceridaemia in uraemic patients.
More recently, Murase et al. (1975) demonstrated an inhibitory
effect of plasma from uraemic patients on LPL activity in vitro
and suggested the presence of circulating inhibitor of LPL which
is not dialysable. In support of the hypothesis of a reduced
plasma TG clearance, Ibels et al. (1976) demonstrated a decreased
clearance of infused TG emulsion 'Intralipid' in uraemic patients.
It has also been suggested (Bagdade, 1975) that the peripheral
insulin resistance known to occur in uraemia may be a factor in the
lowering of LPL activity, thus reducing TG removal, since insulin
is probably required for normal LPL activity (Elkeles, 1973).
LPL activity is also reduced in malnutrition, thyroid deficiency
and corticosteroid excess. These three factors, particularly
malnutrition, occur in uraemia.
Influence of haemodia 1ysis on the hypertrig1yceridaemia
Haemodialysis may affect plasma TG levels in a number of ways:
glucose and acetate can cross the dialysing membrane and contribute
to increased hepatic TG synthesis. However, glucose-enriched and
glucose free dialysate seems to have no appreciable effect on plasma
TG concentration (Hubner et a 1 . , 1971; Daubresse et al., 1976).
Systemic heparanisation is another important factor because
heparin activates tissue LPL in normals, but no difference in
plasma TG was found after systemic or regional heparinisation in
uraemic patients (Daubresse et al. , 1976). Moreover, if the
presence of hypertriglyceridaemic factor is postulated,
haemodialysis does not seem to remove it as high plasma TG levels
are as evident in the dialysed as they are in the undialysed
patients or even higher. However, Bagdade (1970) reported a
decrease in plasma creatinine, insulin and triglycerides in one
patient after intensive haemodialysis. Similar observations were
reported by Gutman et al. (1973). It may be that the amelioration
of the uraemic state by more intensive dialysis improves lipid
metabolism as it does improve other metabolic disorders, particularly
carbohydrate metabolism (Hampers et al., 1973).
Plasma cholesterol
Disturbance in cholesterol metabolism is classically seen in
association with the nephrotic syndrome. In non-nephrotic patients
with chronic renal failure plasma cholesterol concentration is
usually found to be within normal range. However, increased plasma
cholesterol levels have been reported (Cohen and Lindall, 1969;
Kaye et al., 1973; Persson, 1973). Broyer et al. (1976) found
38% of children on haemodia 1ys i s to have high plasma cholesterol
levels. As stated above, the predominant electrophoretic lipo¬
protein pattern is type IV but occasionally types Ma and lib with
increases in both plasma TG and cholesterol concentrations are found.
The concentration of the normally cholesterol-rich LDL was reported
to be normal but with increased TG content (Bagdade et al., 1976;
Norbeck et al., 1976). Ibels et al. (1975) found an increase of LDL
their patients, but with normal cholesterol concentration. The VLDL
cholesterol content is increased (Bagdade et al., 1976; Norbeck et
al., 1976), but HDL cholesterol content is very low (Norbeck et
al., 1976; Bagdade et al., 1977).
Role of diet
The concentration of plasma triglycerides in normal individuals
is readily increased by diets which are rich in carbohydrates. The
magnitude of this increase and its duration are governed by factors
such as the amount and the type of carbohydrates, age, sex, presence
of obesity and genetic predisposition (Fredrickson et al., 1967)•
The causal mechanisms have not been established although published
reports suggest that increased formation of triglycerides in the
liver is of greater importance than diminished removal from the
plasma (Reaven et al., 1965; Nestel , 1966). Insulin is thought
to play a major role since the insulin response to the ingestion of
carbohydrates appears to be significantly correlated with the
degree of hypertriglyceridaemia (Farquhar et al., 1966; Reaven
et al., 1967). Since circulating plasma free fatty acids are a
major source of plasma TG, excessive synthesis of FFA from
carbohydrates has also been considered as a possible causal factor.
There is no support for this, however, apart from occasional
findings of raised plasma FFA in some hypertriglyceridaemic
states. The consumption of saturated and polyunsaturated fat is
also known to influence the plasma triglyceride concentration
(Ahrens et al . , 1957)•
Although it is a potential cause of the endogenous hyper-
triglyceridaemia of chronic renal failure, carbohydrate intake has
been found to correlate with plasma triglyceride levels in uraemic
patients (Bagdade et al., 1968; Ibels et al., 1976; Cattran et
al., 1976). This lack of correlation does not exclude entirely
the possibility that the increased carbohydrate intake often
prescribed for patients with renal failure may be important.
Both Pennisi et al. (1976) and Broyer et al. (1976) demonstrated
a positive correlation between the percentage calories derived from
carbohydrates and plasma TG levels. They also reported a positive
relationship between carbohydrate intake either related to body
weight (Pennisi et al., 1976) or to recommended daily allowance
(RDA) (Broyer et al., 1976) and plasma TG concentrations but this
relationship must be viewed with caution. Expression of nutrient
intake in relation to body weight when the population studied by
them included young children and young adults is complicated by
the fact that in relation to body weight, young children have a
considerably higher intake (Widdowson, 19^7) and if age is not
taken into account, erroneous conclusions may be reached. It is,
therefore, more appropriate to refer food intakes to surface area
or to RDA. However, Broyer et al. (1976) in calculating the RDA
for carbohydrates assumed that carbohydrates provide 60%
of calories in the normal diet, a
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figure much higher than is accepted in the UK (40-45%). More
recently, Sanfelippo et al. (1977) reported significant reductions in plasma
TG levels after feeding their uraemic patients diets low in
carbohydrate and high in polyunsaturated fat. Unfortunately, it
is not known from their study which of the two variables in the
diet altered the TG levels. The lowering of plasma TG was
associated with a decrease in TG production rate and plasma insulin
response. They suggested a defect in plasma TG clearance as the
prime cause of the raised TG levels because the patients had higher
plasma TG levels than did normal subjects at any given TG
production rate. However, amelioration of hypertriglyceridaemia
could have been obtained by a decrease in TG production rate with
low carbohydrate diets.
Clinical significance of plasma lipid abnormalities in uraemia
Epidemiological studies have clearly defined the relationship
of cardiovascular disease and hyper 1ipidaemia (Kannel et al., 1971;
Carlson and BBttinger, 1972); raised levels of VLDL (Carlson et al.,
1975) and low levels of HDL (Miller and Miller, 1975; Carlson and
Ericsson, 1975) are associated with ischaemic heart disease.
An increased incidence of atherosclerosis and premature
cardiovascular disease in adult patients on regular haemodia 1ysis
has been reported recently (Lindner et al., 1974; Lowrie et al.,
1973; Brunner et al., 1972). The occurrence in chronic renal
failure of the three lipoprotein abnormalities,
1) increased VLDL, 2) increased LDL, and 3) decreased HDL,
may be a major contributing factor in the rapid development of
atherosclerotic vascular disease in these patients. Many children
with chronic renal failure are now being treated by regular
haemodialysis in preparation for renal transplantation and are
often encouraged to take carbohydrate and fat supplements in their
diet in an attempt to improve statural growth. An evaluation
of plasma lipid profile, particularly in relation to diet, is




Free fatty acids(FFA)are an important metabolic fuel supplied
by the blood to peripheral tissues. They can be used for energy
production by many different cells in the body, (and probably are
the major source of fuel for cardiac and striated muscle (Fritz,1961) ) or
can be stored in adipose tissue as triglyceride until needed.
it had been realized long ago that most stored energy is in the
form of fat. This maximises efficiency, adipose tissue having very
little intracellular water and thus having the most calories available
per gram of tissue. Triglycerides are hydrolysed to glycerol and
FFA. Glycerol is primarily converted to glucose in the liver
(gluconeogenesis) and accounts for only a small fraction of the
energy requirement; FFA become the major energy source being oxidised
to CO2 and water. Important metabolites of FFA oxidation in the
liver are ketone bodies, which become a substitute energy substrate
during starvation (Cahill et al., 1966).
The pool size of plasma FFA is very small, but because of the
very rapid turnover large quantities of FFA can be transported in the
course of a day from one part of the body to another bound to
plasma albumin (Issekutz et al., 1967). The caloric value of the
FFA flux is, therefore, very large amounting to two thirds or more
of the total caloric expenditure of an average man (Dole and
Rizzack, 1961).
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Hormones play an important role in the regulation of FFA
release from adipose tissue (Siddle and Hales, 1975). Growth
hormone, glucagon, TSH, thyroxine and catecholamines stimulate
the triglyceride lipase activity in adipose tissue and increase
FFA mobilisation; insulin and some prostaglandins inhibit the
lipase activity and decrease FFA mobilisation. The sympathetic
nervous system also plays an important role but quantitative
information is lacking at the present time.
Insulin is a potent anti1ipolytic hormone (Butcher et al.,
1966; Siddle and Hales, 1975), and it is generally accepted that
it exerts its anti1ipolytic effect by lowering intracellular cyclic
AMP levels. Insulin also antagonises the lipolytic effects of
other hormones such as glucagon, catecholamines and ACTH (Butcher
et al., 1966). The interrelationships between cyclic AMP, hormones
and lipolysis are very complex, but insulin appears to play a
dominant role in the control of fat mobilisation. Being an anabolic
hormone, it enhances lipogenesis by promoting glucose uptake by
adipose tissue and stimulating re-esterification of FFA to
triglycerides. A decrease in insulin levels has a permissive
effect on fat mobilisation and liberation of FFA in excess as energy
substrate in time of need, e.g. starvation (Cahill et al. , 1966).
The concentration of FFA in the blood is related to FFA release
into the circulation which in turn is determined by the balance
between triglyceride breakdown during lipolysis and the rate of
re-esterification of fatty acids. The latter process is dependent
on glycerol phosphate derived from glucose. The uptake and oxidation
of FFA by tissues is a function of their concentration in the
plasma (Issekutz et al., 1967). The amount of glycerol released
is a measure of that formed by hydrolysis of triglycerides, and
since glycerol utilization by adipose tissue is negligible,
lypolysis is usually measured by the amount released into the
circulation (Steinberg and Vaughan, 1965).
Free fatty acid in uraemia
Little information is available regarding fatty acid metabolism
in uraemia. Fasting plasma concentrations have been reported by
various investigators to be within the normal range (Hampers et al.,
1966; Spitz et al., 1970; Daubresse, 1976). Others (Persson, 1973
Ghosh, 1973) found reduced plasma FFA levels in their patients.
Raised levels were reported in patients with acute uraemia and
during haemodialysis (Losowsky and Kenward, 1968; Mydlik et al.,
1976). The increased FFA levels during dialysis are likely to be
due to heparin which stimulates plasma lipolytic activity and,
therefore, do not reflect the effects of uraemia on FFA metabolism
Because of their extreme lability and rapid turnover rate, single
untimed measurements of plasma FFA concentration do not represent
accurately the rate of FFA release from adipose tissue. However,
oral and intravenous glucose produced a fall in plasma FFA
concentration which was of greater magnitude and duration in
uraemic patients than in a group of normal subjects (Roth et al.,
1973; Losowsky and Kenward, 1968). This response suggests that
the effects of hyperglycaemia and insulin on adipose tissue are
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preserved and may even be enhanced in uraemia. Unfortunately,
in spite of the close relationship which has been shown to exist
between glucose and FFA metabolism (Randle et al., 1963) and
the major contribution of FFA to the bodys total energy expenditure,
studies of the kinetics of this important metabolic fuel have not
been undertaken in uraemia.
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3.3. NITROGEN METABOLISM IN URAEMIA.
Patients with chronic renal failure develop a number of
manifestations of abnormal protein metabolism. These include
reduction in body protein mass, particularly muscle' protein,
negative nitrogen balance and disturbances in amino acid metabolism.
Because uraemic patients are often subnourished as a result of
prolonged anorexia or deliberate dietary protein restriction, it proved
difficult to ascertain whether the abnormalities in nitrogen metabolism
are attributable to uraemia per se, to malnutrition, or to an inter¬
action between uraemia and malnutrition. In fact, the general
malnutrition in uraemia depends on several factors which are not
easily separated and appear partly as a result of poor dietary intake,
gastrointestinal disturbances, and increased demands of energy and
perhaps also of nitrogen, besides various derangements of inter¬
mediate metabolism.
NITROGEN BALANCE IN URAEMIA
Many investigators have reported a persistently negative
nitrogen balance in patients with advanced chronic renal failure
(Hyne et al., 1972; Kopple and Swenseid, 197*0, but it is still
i
uncertain whether insufficient intake of energy and nitrogen, poor
absorption, or interference with protein synthesis or degradation
is the prime cause.
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Major factors which influence nitrogen retention
(a) Nitrogen intake
There is no concensus of opinion on the minimal protein intake
required by uraemic patients and the optimal protein and energy
requirements have not yet been determined with any degree of accuracy.
Even in normal individuals the ideal protein requirements are
debatable. Estimates of minimal nitrogen requirement for maintenance
of nitrogen balance in uraemic adults have varied from 3.1 ~ 5.6 grams
per day (Shaw et al., 1965; Ford et al . , 1969). It is doubtful
whether these figures differ significantly from 3-1 ~ 4.2 grams
minimal nitrogen requirement for normal individuals (Bricker et al.,
1949; Rose and Wixon, 1955). Giordano (1963) and Giovanetti (1964)
demonstrated that uraemic patients could re-utilise urea for protein
synthesis if essential amino acids constituted the bulk of their
dietary protein, suggesting that the nitrogen requirements of uraemic
patients may be reduced. Using high quality protein diets Giordano
et al. (1967) and Berlyne and Hocken (1968) observed that uraemics
may be able to maintain a nitrogen balance on lower protein intakes
than normal subjects can. However, results obtained by Kopple et al .
(1968) and Ford et al. (1969) failed to support this conclusion
although the enlarged nitrogen pool in uraemia, mainly coming from
urea and non-essential amino acids can provide supplementary nitrogen
for protein synthesis under reduced protein intake. Such recycling
of nitrogen may be insufficient for anabolic purposes (Walser, 1974;
Richards, 1975) and data obtained from experimental animals (Young
et al., 1973) suggest that protein requirements may be higher in
uraemia than normal despite probable reuti1isation of non amino
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nitrogen, so that a low protein intake will cause more marked
reduction in protein synthesis and increase body protein depletion.
The provision of ketoacid analagous of most essential amino acids
have been shown to produce more efficient nitrogen utilisation and
maintain nitrogen balance even if the protein intake is low (Walser
et a 1., 1973)• But the improvement in protein anabolism so realised
seems still insufficient for body economy; a considerable amount of
analogue compounds are not utilised for synthetic purposes but
undergo degradation in the body, so that benefits for limited periods
only have been achieved. In order to attain nitrogen equilibrium,
the diet must supply, in addition to essential amino acids, sufficient
nitrogen for the in vivo synthesis of non-essential amino acids.
Such a requirement will further reduce nitrogen available for
anabolism if dietary protein is restricted.
(b) Energy requirements for maximal protein utilisation
A crucial factor influencing the efficiency of utilisation of
the intake nitrogen is the non protein energy content of the diet.
It is generally recognised that tissue protein synthesis can proceed
effectively only if there is an adequate intake of energy (Munro,
1964). The protein energy relationship was emphasised by Calloway
and Spector (1954) who showed that in normal individuals a limiting
energy level could be defined beyond which increasing the energy
intake is of no advantage. They found that an intake of 3 grams
nitrogen daily resulted in maximum nitrogen retention with
approximately 900 calories, and that no further nitrogen retention
occurred on increasing the energy. In uraemic patients, on the
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other hand, nitrogen retention continues to improve beyond what is
expected with additional increments to the energy intake (Hyne et
al., 1972). This suggests that the uraemic patient is somehow more
dependent on the level of calorie intake than a normal subject and
that there is an additional demand for energy over and above that
required in normal individuals. The reason for this is not clear
but it may be the necessity for greater utilisation of endogenous
non protein nitrogen which depends on the availability of ATP.
(c) The effect of metabolic rate
Alteration in energy expenditure adds another dimension to the
interrelationships between nitrogen intake and energy intake and
nitrogen balance. It is well known that an increase in metabolic
rate in hypermetabo1ic states such as infection, trauma or burns is
associated with negative nitrogen balance. However, the provision
of energy sufficient to cover energy expended, along with a normal
nitrogen intake, fails to establish positive nitrogen balance as
shown by Coleman and Dubois (1915) more than 60 years ago in patients
with typhoid fever. Soroff et al. (1961) demonstrated the effect
of metabolic rate on protein efficiency and nitrogen balance in a
study of a group of hypermetabolic burn patients receiving energy
sufficient to satisfy metabolic demands (100 - 120% of BMR measured
by indirect calorimetry) and a constant intake of normally adequate
dietary nitrogen. They found nitrogen balance became more and
more negative as the metabolic rate increased and, in order to
achieve nitrogen equilibrium, nitrogen intake had to be increased
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to approximately double the quantity normally required at any level
of energy intake. This observation suggests that the normal
relationship between energy and nitrogen intake as described by
Calloway and Spector (195^0 is altered in hypermetabo1ic states.
It is evident that not only are the energy demands increased in
these patients but also nitrogen requirements, both in absolute
terms and in relation to energy intake, the increase in metabolic
rate is the underlying cause.
Basal energy expenditure of malnourished animals (McCance and
Mount, 1960) and children (Ablett and McCance, 1969) is low and
rises to normal after recovery. Although the cause of the low BMR
has not yet been elucidated, it seems to be an adaptation to low
energy and protein intake. Ashworth (1968) has shown that young
Jamaican adults on low-calorie intakes for long periods of time adapt
and maintain energy balance and body composition by developing a lower
maintenance energy requirement and a lower rate of energy
expenditure for physical activity.
The relationship between metabolic rate and growth (as assessed
by body weight ) is interesting. Montgomery (1962) noted that the
weight of malnourished children did not increase unless the calorie
intake consistently exceeded the basal metabolic rate, and that the
greater the weight deficit the higher was the BMR during recovery and
the higher the calorie requirements for weight gain.
Inadequate food intake is common in uraemic children and may be
a factor in their poor growth. This may be that uraemia increases
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basal calorie requirements either by decreasing the efficiency
of food utilisation, or by increasing basal energy expenditure
making the requirements for energy and nitrogen balance much
higher than normal and thereby limiting growth. No observations
on the basal energy expenditure of children with chronic renal
failure have yet been reported and the influence of the BMR,
if any, is not known.
IMPACT OF URAEMIA ON NUTRITIONAL STATUS
Poor dietary intake is common in patients with uraemia and there
are striking similarities in many indices of nutrition between chronic
renal failure and protein-energy malnutrition syndrome (PEM) (Chantler
and Holliday, 1973)- However, in uraemia, factors other than
deficient food intake may act directly to influence the nutritional
status. Thus nutritional state assessment alone will not provide
information regarding the cause of the disorder and this is obviously
needed before appropriate action can be taken to restore the balance.
Assessment of nutritional state
Nitrogen balance measurements, discussed above, do not provide a
reliable index of the nutritional state since (a) nitrogen require¬
ments may vary with the degree of protein depletion (Allison, 1951),
(b) overall balance may not reflect balance in critical organs or
tissues (Shear, 1970). Furthermore, they are difficult to perform
with any accuracy particularly in patients on dialysis because of
nitrogen losses in the large volumes of dialysate.
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Body composition
Gross body composition reflects previous nutrition. In
nutritional deficiency the composition will change but will revert
to normal with treatment. Measurements of whole body composition
in adult uraemic patients both on and off dialysis (Comty, 1968;
Coles, 1972) showed changes similar to those reported in subjects
with protein-energy malnutrition (Waterlow and Alleyne, 1971)-
In both conditions there is a reduction in body fat, fat-free solids
and lean body mass; body water is increased relative to body weight
due to an excess of intracellular fluid. Wilson et a 1 (1971) studied one
uraemic child on dialysis and reported increased extracellular fluid
and decreased cell mass. These changes in body composition may be
entirely due to malnutrition (Coles, 1972) but recent experimental
evidence (Adelman, 1977) suggests that uraemia, independent of
nutrient intake, may affect body composition. This author found
total body water and extracellular fluids to be increased and total
body solids decreased in uraemic rats compared with pair-fed controls.
Precise indices of protein deficiency are lacking. Serum
albumin concentration, a crude index of protein malnutrition is
depressed in some uraemic patients even in the absence of heavy
proteinuria and was considered to represent dietary protein
deficiency (Coles, 1972). Serum transferrin concentration is a
more sensitive index of protein-energy malnutrition (McFarlane et
al., 1969). Subnormal levels of transferrin have been found in
uraemic patients with apparently adequate food intake and normal
plasma albumin concentration, and were equally low in dialysed and
non-dialysed patients (Young and Parson, 1970; Ooi et al., 1972).
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Thus, despite improvement in dietary intake that usually follows
regular dialysis, subclinical protein-energy malnutrition may
pers i s t.
Plasma concentrationsof complement proteins are sensitive
indicators of nutritional state. Several components of the system
including were found to be decreased in uraemic patients and
reverted to normal with essential amino acid supplementation
(Heidland and Kult, 1975). Young et al. (1975) have shown that
the plasma levels of and that of transferrin were dependent on
the availability of essential amino acids in the diet and emphasised
their value in the assessment of dietary intake in chronic renal
fai1ure.
A more subtle but striking similarity between chronic renal
failure and protein-energy malnutrition syndrome is the plasma amino-
gram. The abnormalities in the plasma amino acid profile in uraemia
(vide infra) is at least partly due to protein deficiency, as similar
changes are also seen in patients with Kwashiorkor as well as in
normal subjects maintained on low protein diet (Whitehead and Dean,
1964; Swendseid et al., 1968).
PLASMA AMINO ACIDS IN URAEMIA
Many plasma amino acid levels are altered in chronic renal failure
eyen after treatment by haemodialysis (Gulyassy et al., 1970; Young
and Parson, 1970; Kopple and Swendseid, 1975). However, there are
many discrepancies in these reports which may relate to differences
in dietary intakes, degree of renal impairment, dialysis procedures,
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or methods of plasma amino acid analysis. Abnormalities for which
there is some consensus are decreased levels of essential amino acids
particularly the branched-chain amino acids valine, leucine and iso-
leucine; tyrosine and lysine are usually decreased, and cystine is
increased. Plasma levels of non- essential amino acids are usually
normal or increased, particularly glycine and citrulline. One and
3~methy1histidine, normally present in trace amounts in plasma, are
increased. The ratios in plasma of essential/non-essential amino
acids, valine/glycine, tyrosine/phenylalanine, are characteristically
reduced. Alterations in the concentration of phenylalanine and
histidine (considered as an essential amino acid in uraemia) vary
from study to study.
Pathogenesis of plasma amino acid abnormalities
The mechanisms underlying the plasma amino acid abnormalities
are not well understood. Published reports indicate a multi¬
factorial cause and the following possibilities are considered
important.
(1) Nutritional factors
Alterations in plasma amino acid concentrations in children
suffering from protein-energy malnutrition or individuals on low
protein diets are well documented (Arroyave et al., 1962; Swendseid
et al., 1968). In these conditions the essential amino acids
particularly the branched-chain amino acids ,valine, leucine and
isoleucine are reduced and the non-essential amino acids are normal
or increased. The plasma valine concentration is particularly
sensitive to low protein intake, while glycine is usually increased
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and, therefore, a reduced valine/glycine ratio is characteristic
of protein malnutrition. As anorexia is a common feature of
chronic renal failure and often leads to reduced spontaneous food
intake (Holliday, 1972), the observed similarities between plasma amino
i n
acid profiles in uraemia and/PEM lead to the assumption that
malnutrition underlies the plasma amino acid abnormalities in
uraemia. However, while the disordered aminogram in protein energy
malnutrition reverts to normal on feeding,the abnormalities in
uraemic patients seem to persist after apparently adequate protein
and energy intake attending regular haemodia 1ysis. In an elegant
study, Kopple and Swendseid (1975) attempted to separate the
effects of uraemia per se from that of protein malnutrition on
plasma amino acid pattern in uraemic patients and concluded that
both uraemia and protein intake seem to affect plasma amino acid
levels; some concentrations of amino acids are abnormal independent
of protein intake, other amino acids differ from normal only as a
result of low protein intake. They also demonstrated that the
response of many amino acids to protein restriction is abnormal in
uraemic patients compared to normal subjects. Uraemia per se,
therefore, directly affects protein and amino acid metabolism.
Specific enzyme defects, such as the impairment of the activity
of the enzyme phenylalanine hydroxylase with reduced tyrosine
formation and decreased tyrosine/phenylalanine ratio has been
demonstrated in uraemia (Young and Parson, 1970). Other less
specific metabolic defects may involve reduced efficiency of protein
and energy utilisation for anabolic purposes as the requirements
of both seem to be increased in uraemia.
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The amino acid abnormalities may be related to the disordered
carbohydrate and fat metabolism, already discussed, and/or changes
in the hormonal milieu in uraemia. Such interrelationships have
not been explored.
(2) Dialysis losses
Haemodia 1ysis does not directly produce substantial losses of
albumin or globulin, but large losses of free and conjugated amino
acids occur (Rubini and Gordon, 1968; Kopple et al., 1973)•
However, the quantities lost in each dialysis, estimated by Kopple
et al. (1973) to be approximately 6-8 grams of free amino acids and
grams of bound amino acids, are most 1y of non-essential amino
acids and largely derived from the intracellular pool as there
is little or no depression of plasma amino acids at the end of
dialysis (Rubini and Gordon, 1968). The amino acid losses are
easily replenished by eating during dialysis and greatly minimised
by the use of glucose containing dialysate (Kopple et al., 1973).
Thus, providing the diet is adequate, the losses during dialysis
would not affect the plasma amino acid profile. If, on the other
hand, the intake is poor, these losses would undoubtedly exacerbate
protein deficiency and lead to disrupted protein metabolism.
(3) Intestinal absorption
Transport of amino acids from the gut into the circulation after
a protein meal could influence the concentration of plasma amino
acids. However, in the post absorptive state, the intestine does
not appear to play a major role in the regulation of plasma amino
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acid composition (Frame, 1958).
Few studies on intestinal absorption in uraemia have been
carried out. Gulyassy et al. (1970) reported reduced absorption
of tryptophan in uraemic patients and Kassler et al. (1973) found
a decrease in arginine absorption in uraemic rats. The extent,
however, of the impairment of amino acid absorption from the gut in
uraemia is uncertain and the few observations reported do not provide
evidence that alterations in intestinal transport could account for
the plasma amino acid abnormalities.
(4) Altered renal metabolism
The kidney is involved in the metabolism of a number of amino
acids. It is, for example, a major contributor to plasma serine
levels in normal individuals. In renal failure, the absence of this
function probably accounts for the reduced serine to glycine ratio
which is found almost universally.
In normal subjects a linear relationship exists between tyrosine/
phenylalanine ratio (T/P) and glomerular filtration rate (Kopple et
al. , 1972), and a direct relationship between plasma tyrosine levels
and the degree of renal impairment has been demonstrated (Giordano
et al., 1970). Since there is evidence that renal phenylalanine
hydroxylase (the enzyme converting phenylalanine to tyrosine) is
reduced in uraemia independent of dietary intake (Wang et al., 1975),
a decreased formation of tyrosine by the kidneys may contribute to
the altered T/P ratio in chronic renal failure.
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(5) Impaired amino acid metabolism
The changes in plasma amino acids may represent a change in amino
acid utilization for protein synthesis or energy production, changes
in release or uptake by cells, or a combination of these factors.
Skeletal muscle, by virtue of its mass, contains the largest
free amino acid pool in the body which is available for protein
synthesis, and it is also the tissue which Is mainly broken down
in conditions of catabolism. Bergstrom et al. (1975) have shown in
samples of skeletal muscles from uraemic patients significant
increases in the intracellular concentrations of the majority of
amino acids except for threonine, valine and tyrosine. These findings
suggest either a block in amino acid incorporation into protein, a
defect in transport across cell membrane, or increased breakdown in
cellular protein. These observations are important because intra¬
cellular amino acid concentrations reflect more closely the metabolic
state of the patient. Moreover, it has been suggested that imbalances
in the intracellular concentrations of the branched-chain amino acids
could lead to a decrease in the synthesis rate of cellular protein
(Buse and Reid, 1975; Fulks et al., 1975).
(6) Endocrine influences
Changes in balances between protein synthesis and degradation can
be influenced by a number of hormones:
(a) I n s u1 in: Insulin is the most important hormone controlling energy
homeostasis and it is the principal and perhaps the only hormone
regulating both muscle proteolysis and amino acid availability for
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protein synthesis; it increases the rate of incorporation of amino
acids into protein (Cahill, 1971), decreases that of protein
degradation in muscle (Fulks et al., 1975), and decreases the rate
of gluconeogenesis (Exton, 1972). In uraemia, several factors
prevail which could antagonise these important actions on protein
and amino acid metabolism. However, studies of insulin actions
in uraemia have so far been almost entirely confined to
carbohydrate and fat metabolism.
Old data reported by Mirsky in 1938 showed that administration
of insulin to nephrectomised dogs decreased the rate of protein
catabolism of muscle and in turn increased the utilisation of
exogenous amino acids by skeletal muscle of the uraemic dogs. More
recently, Arnold et al. (1977) reported a relative decrease in amino
acid uptake by skeletal muscle of uraemic rats in response to
insulin administration. Whether the insulin resistance, known to
occur in uraemic patients, is as important in nitrogen metabolism
as it is in carbohydrate metabolism is not clear.
(b) Other hormones: Changes in circulating levels of glucagon,
growth hormone, glucocorticoids and other hormones occur in uraemia.
Their possible effects on protein metabolism as related to growth
are considered in Chapter 4.
EFFECT OF URAEMIA ON BODY PROTEIN ECONOMY
In normal man subjected to starvation or suffering from
protein-energy malnutrition, nitrogen excretion declines in an
exponential manner as adaptive processes proceed to conserve body
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protein (Cahill and Aoki, 1970; Waterlow and Alleyne, 1971)-
In contrast, during disease or trauma, with negative calorie balance,
the body is much less efficient in preserving its protein (Duke et
al., 1970) and significant protein losses during disease were first
shown by nitrogen balance studies at the turn of the century by
Coleman and Dubois (1915). Changes in nitrogen balance are usually
reflections of changes in muscle protein and these in turn correlate with
growth in the case of children (Waterlow and Alleyne, 1971).
Protein depletion, particularly muscle protein (Coles, 1972),
reduces soluble cell protein content in muscle (Delaporte et al., 1976),
negative nitrogen balance and retardation of growth are common
findings in uraemia. Moreover, the low-protein diet for treatment
of chronic renal failure is often followed by marked muscle cell
protein depletion (Campanacci et al., 1970)# and some uraemic patients
remain in negative nitrogen balance despite an adequate energy and
protein intake (Richards, 1975). These observations along with the
possibility, discussed above, of increased energy demands for anabolism
suggest an impairment in the efficiency of energy utilisation to
preserve body protein.
Protein synthesis and degradation
The protein constitution of the body is in a constant state of
change with tissue proteins continuously being broken down and
resynthesised and a balance is obtained between synthesis and
degradation.
The reduced cell mass in uraemia may be a result of failure to
sustain an adequate balance between protein synthesis and degradation
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(i.e. a relative decrease in synthesis or an increase in degradation,
or both). Although no specific catabolic effect of uraemia has been
identified, studies in uraemic patients and experimental animals
have shown profound abnormalities in protein turn over (Coles, 1970;
Shear, 1969; Bianchi et al., 1972; Abittol and Holliday, 1976).
However, the possible superimposed effects of malnutrition makes
the interpretation of data,particular1y those in the clinical studies,
difficult and the conclusions reached are rather inconclusive. Coles
et al. (1970) found impaired synthesis and degradation of I -1abe1 led
serum albumin as well as a shift of albumin from the extravascular
to the intravascular space. However, these abnormalities are found
in any state of malnutrition (James and Hay, 1968). Studies by
Shear (1969) in uraemic rats, using single injection of lA^-leucine,
have shown that net protein synthesis, while increased in lung and
heart, was decreased in skeletal muscle. His findings suggested
that the source of amino acids for increased protein synthesis in
the liver was skeletal muscle. However, similar results were found
in rats fed low protein diet (Waterlow and Stephens, 1968).
Abittol and Holliday (1976) studied protein synthesis and degradation
in uraemic rats and pair-fed controls thereby eliminating the
nutritional influences; they found both synthesis and degradation
to be reduced in uraemic rats in comparison with pair-fed controls,
but the degree of catabolism was more growth limiting in uraemic rats
than controls. Bianchi and his group (1972) studied albumin turn
over in uraemic patients on low protein diets and demonstrated a
marked reduction of the total albumin pool and proportionately
reduced catabolic rates. The synthesis rate was also reduced but
equal to the catabolic rate. They concluded that a new equilibrium
state in protein turn over had been reset at a level significantly
lower than normal. They claim that the abnormalities were not due
to the dietary treatment per se as the changes were independent of
the duration of the diet (1 month - 5 years). Studying albumin
catabolism in the early phases of the development of the uraemic
syndrome and during the uraemic state in a group of patients on
dialysis therapy, the same group (Mariani et al., 197*0 reported
a highly increased catabolic rate in the acute phases of uraemia
or relapses of it. They made the point that increase in
catabolism in uraemia is only transient but is not followed by
subsequent compensatory increases in synthesis rate
to restore the previous metabolic state as is the
case with recovery from non-uraemic catabolic illnesses. These
findings, if confirmed, suggest a failure of adaptive increases
in synthesis rate to counteract catabolic episodes, such as acute
infections and may be relevant to the persistence of protein
depletion in chronic renal failure. Indirect evidence of
increased muscle catabolism is provided by the finding of increased
alanine release from muscle in uraemia (Garber, 1978). Since
alanine is the most important gluconeogenic substrate and since
substrate supply is the main drive for gluconeogenesis (Exton,
1972), hepatic glucose production may be increased in uraemia.
More recently, Holliday et al. (1977) showed that after starvation
muscle protein synthesis decreased and degradation rate increased
more in moderately uraemic than control rats. This suggests that
the catabolic response to nutritional stress is more exaggerated
in uraemia.
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A fundamentally important question is what factor(s) render(s)
the uraemic organism less efficiently adaptive to calorie deficiency
and consequently insufficiently anabolic.
In the absence of disease, the organism adapts to calorie
deprivation by rapid mobilisation of endogenous fat for energy
production so as to minimise amino acid degradation and preserve
body protein (Cahill and Aoki, 1970). A number of hormones,
particularly insulin, are involved in the control of these adaptive
metabolic processes. It may be that in uraemia the protein wasting
is caused by a relative lack of substrates other than amino acids
to support energy production in muscle. Such a derangement may
in turn be related to abnormalities in hormone metabolism arising
from non-nutritional causes but as a result of renal failure.
Although many hormonal changes have been described in uraemia
(discussed in some detail in Chapter A), their relationship
to eaergy substrates and, therefore, their relevance to body
protein economy have not been assessed. The present study is
concerned, in part, with such an assessment.
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CHAPTER k.
HORMONAL CHANGES IN URAEMIA WITH PARTICULAR REFERENCE
TO GROWTH REGULATING HORMONES.
Despite intensive investigation of the biochemical and metabolic
disturbances that accompany renal failure, study of the associated
hormonal changes has received only intermittent attention. However,
during the past ten years or so, there has been growing interest in the
changes which may occur in the function of various endocrine glands in
uraemia. This is partly due to advances made in immuno assay techniques
and also to the recognition of the role of the kidney in the metabolism
of many hormones.
Renal failure may affect hormonal balance in many ways:
(1) by increasing or reducing hormone synthesis, (2) by altering
hormone binding to plasma proteins or tissue receptors, or
(3) by altering hormone metabolism or renal clearance. These effects
may be (a) directly due to uraemia per se or reduced functioning renal
mass, (b) indirect as a response to specific metabolic disturbances,
or (c) related to protein energy malnutrition so commonly associated
with the uraemic state. In interpreting published reports of hormonal
changes in renal failure particular account has to be taken of
population differences, especially in regard to degree of renal
insufficiency, nutritional status and treatment differences; and also
of possible interference of uraemia in vitro function tests. Certain
hormones are now known to be essential for normal growth. Among them
are the pituitary growth hormone (GH) , insulin, thyroid hormone and
the gonadotrophic and sex hormones. Little is known about the
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endocrine status of uraemic children, in particular the hormonal changes
which may relate to their poor growth. Evidence, already discussed,
suggests that the uraemic patient is insufficiently anabolic and
since failure of growth may be equated with poor anabolism, this review
will be restricted to those hormones known to have anabolic or
catabolic .functions.
GROWTH HORMONE (GH)
The importance of pituitary growth hormone in the regulation of
growth is generally accepted and the subject extensively reviewed
(Korner, 1965; Raiti and Blizzard, 1970).
Metabolic actions of GH
Early work established that growth hormone is an anabolic hormone
with potent stimulatory action on nitrogen retention. This
subsequently proved to be a reflection of its ability to stimulate
synthesis of tissue proteins by enhancing amino acid incorporation
and, when there is a decrease in the level of substrate amino acids,
it also promotes amino acid uptake by cells (Kostyo and Rillema, 1971;
Turner et al., 1976). In addition to having this anabolic property,
GH has also been found to inhibit glucose utilization and uptake
(Daughaday and Kipnis, 1966), and to possess the ability to promote
mobilization of fat from storage depots causing FFA release from
adipose tissue and enhancing the FFA uptake into muscle (Rabinowitz
et al., 1965). The first action is abolished by administration
of glucose or food.
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GH levels fluctuate enormously during the course of the day.
Hunter and Rigal (1966) studied this diurnal variation in children
aged 9~15 years and showed very low GH levels in the first two hours
after meals, but levels rose to much higher later. Values were
consistently high during the night. The authors inferred that GH
was secreted at those times when the mobilization of fat and the
conservation of amino acids was most necessary, and consequently allows
for continuity of growth during short term fasting conditions.
Growth hormone in uraemia
Recognition of abnormal GH metabolism in uraemia resulted from
the search for a cause of carbohydrate intolerance of uraemia. Samaan
et al. (1966, 1970) were the first to demonstrate elevated fasting GH
levels and a paradoxical rise in GH following glucose infusion in non-
dialysed and dialysed uraemic patients. Subsequently, high GH levels
in uraemia have been observed by others (Horton et al., 1968; Wright
et al., 1968; Spitz et al., 1970; Orskov and Christensen, 1971).
An exaggerated rise in GH levels following insulin has also been seen
in uraemic patients despite a diminished hypoglycaemic response
(Kokot and Kuska, 1972). To date, there are no reports of GH
measurements in children with renal failure.
The cause of the elevated GH levels in uraemia is not known.
It has been variously attributed to impaired degradation (Cameron
et al., 1972) or increased secretion (Taylor et al., 1972). The
techniques used have involved the administration of labelled or
unlabel led human growth hormone and the measurements of either
metabolic clearance rate (MCR) or plasma half disappearance time (ti)
It has been suggested that the metabolic clearance rate of GH is
reduced in renal disease (Cameron et al., 1972). However, since the
plasma ti of labelled GH was not prolonged in nephrectomised rats
until significant uraemia developed, Rabkin et al. (1972) proposed
that the kidney itself is not important in GH degradation and ascribed
the prolonged tj of GH to secondary metabolic effects of uraemia.
Somatostatin (growth hormone release-inhibiting factor) inhibits GH
secretion by direct action on the anterior pituitary. Using intra¬
venous exogenous somatostatin the t? of endogenous GH can be
calculated and Pimstone et al. (1975) found the disappearance rate of
endogenous GH in patients with chronic renal failure to be within
normal limits. Their data suggest that high levels of plasma GH
found in these patients are caused by hypersecretion rather than
impaired clearance.If there is hypersecretion in uraemia, the stimulus
for this is unknown. It may relate to protein-energy malnutrition
(Heard and Stewart, 1971; Pimstone et al., 1967). Wright et al.
(1968) found an inverse correlation between serum GH and serum albumin
in 41 non-dialysed uraemic patients and suggested that the high GH
levels are a reflection of protein malnutrition, a consequence of
renal failure. However, Samaan and Freeman (1970) could not confirm
this correlation and Davidson et al. (1976) failed to find any
relationship between dietary protein intake and GH levels in adult
uraemic patients undergoing maintenance haemodia 1ysis. The range of
serum albumin and different therapeutic setting make comparison of the
reported data difficult. Furthermore, serum albumin may not be a
useful index of nutritional status in uraemic patients. Lunn et al.
(1973) have shown that, in children with protein-energy malnutrition
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(PEM), plasma GH may not increase until plasma albumin concentration
falls to a very low level. Obviously, more sensitive indices of
protein malnutrition in uraemia, such as plasma transferrin
concentration, will have to be used to establish whether or not
protein malnutrition is an underlying cause of the GH abnormality
in uraemic patients.
The importance of associated changes in carbohydrate, fat and
protein metabolites in uraemia in the pathogenesis of high GH levels
is not known, and the stimulus for and the metabolic effects of the
increased GH concentration in uraemia remain obscure.
SOMATOMEDIN (SM)
Despite intensive study of the structure and function of growth
hormone, the mechanism of growth hormone stimulation is still not well
understood. Because of the ineffectiveness of GH in stimulating
anabolic processes in cartilage from hypophysectomized rats in vitro
and the effectiveness of normal serum, but not hypophysectomized rat
serum, in restoring these anabolic processes,Salmon and Daughady
(1957) originally proposed what is now termed the somatomedin
hypothesis. This states that GH does not stimulate growth of tissues
directly but leads to the generation of secondary hormonal factors
collectively called somatomedin (SM) , which stimulate growth of both
extraskeleta 1 and skeletal tissues (Daughaday et al., 1972). Van Wyk
et a 1(197^) characterized SM as a serum factor that (1) stimulates
the growth of at least one tissue, (2) is under GH control,
(3) has insulin like action and (A) promotes sulphur uptake by cartilage.
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Recently, several somatomedins have been purified (Uthne, 1973;
Van Wyk et al., 197*0 and the factor stimulating the uptake of
sulphate into chicken embryonic cartilage has been designated
somatomedin A (Uthne, 1973)- Hall and Fillipsson (1975) demonstrated
a significant correlation between somatomedin A in serum and growth
rate in healthy children. Abnormal somatomedin levels are seen in
some growth disorders, e.g. they are high in acromegaly and low in
pituitary dwarfism, and growth response and serum somatomedin have
been shown to be closely correlated in GH treated hypopituitary
children (Hall and Olin, 1972).
Serum levels of somatomedin and growth rate may not, however,
always parallel the level of growth hormone. Low somatomedin with
associated growth failure despite elevated GH was first noted in
children with Laron type dwarfism and their growth failure in this
disorder has been attributed to defective somatomedin generation
secondary to a more generalized lack of responsiveness to GH
(Daughaday et al., 1975)•
Nutritional status may be another factor that influences the
relation between somatomedin and GH. Decreased SM and poor growth
despite normal or elevated GH levels have been reported in children
with Kwashiorkor-type malnutrition, and when the children were
referred, SM.levels increased to normal (Grant, 1973). A similar
relationship was demonstrated in fasted rats which were subsequently
refed (Phillips and Young, 1975).
Growth failure in children with chronic renal insufficiency
may be due, in part, to somatomedin deficiency. Saenger et al.
(197^) have reported low SM levels by bioassay in uraemic children.
These levels rose to normal in those patients who had substantial
improvement in creatinine clearance and growth rate following
transplantation. More recently, Schwalbe et al. (1977) found a
significant correlation between SM levels and linear growth rate
in a group of children with various degrees of renal insufficiency.
Whether the reported reduced levels of plasma SM activity in uraemia
is a direct result of uraemia per se or secondary to protein-energy
malnutrition so commonly associated with uraemia is not known.
Although the liver has been suggested as an important site for
SM formation and perhaps also the kidney, virtually nothing is
known of the mechanism involved in its formation nor of the factors
controlling its homeostatic regulation. It is not known whether there
is a feed-back mechanism between SM and GH or not. Whether the
depressed SM levels are important aetiologically in the growth failure
of children with uraemia, or simply a marker of undernutrition is also
unknown.
Serum SM activity is at present quantified by bioassays in vitro
using the incorporation of radioactive sulphate. Inorganic sulphate
concentration may be raised in chronic renal failure and may,
therefore, influence the uptake of radio labelled sulphate. Saenger
et al. (197^) found that the SM activity of uraemic sera with very
high inorganic sulphate concentrations may be underestimated by
about 30%. Phillips et al. (1978) confirmed the interference of
serum inorganic sulphate in the estimation of bioassayable SM activity
in uraemic subjects and further noted an increase in SM activity after
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haemodialysis, possibly due to removal of SM inhibitors. Audhya and
Gibson (197^0, however, found no evidence for changed SM activity in
the presence of raised sulphate with serum dilutions less than k0%.
Sufficient quantities of the purified SM are not yet available
to study the in vivo effects of SM administration and, therefore,
caution must be observed in drawing conclusions concerning the
physiologic significance of these substances in vivo.
INSULIN
The effects of chronic renal failure on insulin metabolism and
its possible relationship to the observed derangements in the metabolism
of carbohydrates, lipids and proteins have already been discussed.
Insulin is a very important anabolic hormone; it has synergistic
action with GH in promoting protein synthesis and growth (Manchester
and Young,1961), and its effect on cellular growth has been emphasised
with the concept that GH is responsible for growth by increasing cell
number and insulin by increasing cell size (Cheek et al., 1970).
The relationship between insulin and growth is, however, complex
because both growth hormone and increased nutrition may result in
increased insulin secretion (Curry et al., 1973; Wagner and Scow,1957),
and insulin is required for a full anabolic effect of GH (Milman et
al., 1951). Inadequate insulin therapy of diabetic children is
associated with retardation of growth (Birkbeck, 1972) despite higher
than normal GH levels (Hansen and Johansen, 1970). Protein-energy
malnutrition is also associated with decreased levels of insulin and
impairment of growth despite high GH concentration. Increased food
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intake with adequate insulin secretion, on the other hand, may increase
growth in the absence of GH; children with craniopharyngioma may
become hyperphagic and obese after removal of the tumour,with
hyperinsulinaemia and normal or increased growth rate despite low
GH levels. When hyperglycaemia is accompanied by increased insulin
secretion, increased growth may occur as in infants of diabetic mothers
who have hyperplasia of islet tissue, hyperinsulinaemia and increased
birth weight and length (Molsted-Pedersen and Jorgensen, 1972).
Although somatomedin shares certain features with insulin, this
relationship between insulin and somatomedin is not clear. Because
both SM and insulin levels are low in malnourished children while GH
is raised (Grant, 1973), it was suggested that insulin may play a
permissive role in SM production by the liver but there is no
experimental evidence that insulin is involved in SM generation.
Recently, Phillips and Young (1976) demonstrated a significant
association between insulin deficiency and reduced SM activity and
between SM and growth in streptozotocin-induced diabetes in rats.
However, the low SM levels may not be causally related to reduced
insulin concentration but relate to protein depletion in the diabetic
state.
As pointed out in Chapter 3, glucose intolerance is often seen
in uraemia but circulating insulin levels are usually high as the
degradation rate is abnormal, and tissue resistance to the action of
insulin is well established. There is also evidence that specific
binding of insulin is markedly reduced (Soman and Felig, 1977).
Whether the uraemic effect on insulin metabolism and its peripheral
action is important in the pathogenesis of growth failure in uraemic
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children is not known. Indeed, it is not yet elucidated that the
abnormalities in carbohydrate and insulin metabolism, documented in
adult patients, occur in children with chronic renal failure. The
state of insulin secretion and its relationship to other growth
determinants remain to be investigated in these children.
GLUCAGON
Glucagon and catabolism
The important catabolic effects of glucagon are those related to
its actions on the liver and adipose tissue (Unger, 1971). In the
liver, it stimulates glycogen breakdown and gluconeogenesis (Park and
Exton, 1972). In adipose tissue, it stimulates lipolysis. Further,
Marliss et al. (1970) reported that infusion of glucagon in physiological
amounts in man caused a marked depression of some plasma amino acid
levels and enhanced net urea excretion. This suggested that glucagon
increased protein catabolism, perhaps to fuel gluconeogenesis.
Although many factors influence the secretion of glucagon, glucose
and amino acids are the most important in the physiologic regulation
of pancreatic glucagon secretion (Unger, 1971)-
The opposing effects of insulin and glucagon and the various
interactions between them in the fed and fasted state lead to the
concept that they function as an opposing pair, with insulin acting
as an anabolic hormone and glucagon as a catabolic hormone (Unger,1971).
Unger and his co-workers proposed that the insulin to glucagon molar
ratio, rather than the absolute values of either insulin or glucagon,
is the major determinant of fuel homeostasis in normal man; an
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increase in the ratio would favour anabolism and a decrease favour
catabolism. The implication of this is that glucagon plays an
important role of nutrient homeostasis by mobilizing stored energy
substrates when exogenous sources are lacking or when there is an
increased demand for metabolic fuel.
In recent years, an important role for glucagon in the regulation
of normal blood glucose concentration and in the pathogenesis of
diabetes this has been postulated (Unger et al., 1970). However,
more recent work (Felig et al., 1976) has detracted from these ideas
and laid emphasis on the primary role of insulin-deficiency in the
diabetogenic actions of glucagon.
Glucagon in uraemia
Glucagon was inevitably investigated as a possible mediator of
glucose intolerance in uraemia. Bilbrey et al. (197^) have shown
that pancreatic glucagon concentration in patients with chronic
renal failure is almost invariably elevated and is correlated directly
with plasma creatinine levels. They also demonstrated a normal rise
of glucagon after a protein meal but the levels remained inappropriately
high during hyperglycaemia induced by glucose infusion. Since
haemodia 1ysis improved glucose tolerance in some of their patients
without altering the high plasma glucagon levels, the authors
concluded that the hyperglucagonaemia was not responsible for the
glucose intolerance of uraemia. Sherwin et al. (1976) confirmed the
finding of Bilbery et al. and further noted that the hyperglycaemic
effect of exogenous glucagon is increased in undialysed uraemic
patients and that dialysis normalizes the glycaemic response to
glucagon. On the basis of these findings, they suggested an'
increased tissue sensitivity to glucagon in uraemia which is
correctable by dialysis accounting, therefore, for improved
glucose tolerance despite persistent hyperg1ucagonaemia.
Several investigators have indicated that immunoreactive
glucagon (IRG) may exist in several forms in the plasma of normal
and diabetic subjects (Weir et al., 1975). Kuku et al. (1976)
demonstrated similar heterogeneity of plasma glucagon in patients
with chronic renal failure. They showed that the hyperglucagon-
aemia in these patients is largely due to an increase of fraction
(B) of approximately 9100 mol. weight, which is consistent with
proglucagon, although fraction (C) (mol. wt.3500), corresponding to
the biologically active glucagon, is also considerably elevated.
The cause of elevated plasma glucagon concentration in chronic
renal failure is not known. The observation that a rapid rise of
plasma glucagon levels can be produced by urethral ligation in dogs,
but not by infusions of urea or creatinine (Bilbery et al., 197*0,
and that plasma glucagon concentration falls to normal levels in
patients following successful renal transplantation (Bilbery et
al., 1975), lead this group of investigators to believe that hyper-
glucagonaemia of uraemia is the result of decreased glucagon
catabolism as a result of a reduced functioning renal mass. Although
the kidney plays a role in pancreatic glucagon catabolism (Lefebvre
et al . , 197*0, the liver is the major site of its degradation
(Assan, 1972). Furthermore, it is difficult to separate the effects
of uraemia per se and those of reduction in renal tissue in both
Bilbery's clinical and animal studies; the dogs undergoing bilateral
ureteral ligation did not, for example, develop sustained hyper-
glucagonaemia till prior to death from uraemia. Moreover, the
infusion of urea or creatinine may not be equated wi.th uraemia as
other uraemic 'toxins' or deranged metabolism may be responsible for
the hyperglucagonaemia. The fall of plasma glucagon levels following
successful transplantation may equally be due to amelioration of
uraemic state. Increased secretion, at least of the 3500 mol.
weight fraction (active glucagon) is likely since the elevated levels
in patients with chronic renal failure is suppressable to normal
by glucose infusion (Kuku et al., 1976). In addition, high
concentrations of glucagon have frequently been observed in severely
catabolic non-uraemic patients (Unger, 1971; Lindsey et al., 197^),
and in this respect hyperg1ucagonaemia of uraemia may be related to
derangements in metabolism and other hormonal changes associated with
chronic renal failure. Whatever the cause , the significance of
the elevated levels of this catabolic hormone on protein




Since the observations made by Ingle more than 25 years ago
(Ingle, 1951), it has been generally accepted that Cortisol is
necessary for a catabolic response to occur, but its role is only
'permissive' and that Cortisol itself has no true regulatory role
in catabolism. However, more detailed studies of metabolism in
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the past ten years have delineated the functions and target tissue
of glucocorticoids more precisely. Whereas the effects of these
compounds on hepatic g1uconeogenesis dominated the literature for
many years, it is now clear that Cortisol exerts a direct effect on
a wide variety of peripheral tissues including muscle, adipose tissue,
lymphoid tissue and bone (Leung and Munk, 1975). The nature of the
response induced by Cortisol, however, varies in different tissues.
One fairly general effect is inhibition of glucose uptake by cells
with simultaneous insulin resistance which may underlie some of the
catabolic effects of this hormone (Munk, 1971)-
Administration of glucocorticoids results in a marked increase
in the free amino acid pool in muscle and in the release of amino
acids particularly alanine, the main gluconeogenic amino acid, into
the circulation (Wise et al., 1973)* The activity of key gluco¬
neogenic enzymes is increased with resultant increase in hepatic
glucose production. The release of non-esterified fatty acids
from adipose tissue is increased primarily as a result of a decrease
in re-esterificat ion and also a depression in the activity of lipogenic
enzymes (Diamant and Shafrir, 1975).
Catabolic states such as trauma, burns and infection are
associated with increased adrenocortical secretion (Beisel, 1975),
and strong correlations suggesting a causal relationship between plasma
Cortisol levels and various energy substrates have been found during
burn injury (Batstone et al., 1976). It is evident from the work
of Batstone et al. (1976) and Alberti et al. (1975) that Cortisol
together with other catabolic hormones play a major role in fuel
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mobilization when energy requirements are increased or when the
utilization of glucose as energy substrate is defective.
Cortisol and growth
It is now wel1 recognised that inhibition of growth is a
prominent problem in children treated chronically even with relatively
low doses of corticosteroids. Falliers et al. (1963) have shown that
as little as 6 mg of prednisone per square meter per day,
corresponding to only 2-3 times average daily secretion of hydro¬
cortisone, results in suppression of somatic growth in children.
Moreover, cessation of corticosteroid administration or the cure of
spontaneous Cushing's syndrome in children after a period of growth
suppression may be followed by a period of accelerated growth rate
'catch up growth1 (Prader et al., 1963; Loeb, 1976).
Although the growth-suppressive effects of the corticosteroids
are clear, the mechanism(s) of this inhibition is not. One potential
mechanism that was considered is an inhibition of growth hormone
secretion (Frantz and Rabkin, 1964). However, most of the data in
this respect comes from studies on adults and more importantly the
argument against this mechanism is the fact that GH administration
does not overcome the growth inhibiting effect of corticosteroids
(Morris et al., 1968). Interference either with somatomedin
generation by the liver or with somatomedin action on growing
cartilage has recently been postulated as a possible mechanism
(Phillips et al., 1974). The results have not been conclusive
and certainly this is an issue that needs further examination.
Loeb (1976) considered the inhibitory effects of glucocorticoids
on nuclear DNA synthesis and cellular replication as the basis of
corticosteroid-induced growth suppression. This direct cellular
effect may be mediated through changes in the hormone receptor
complex binding to nuclear chromatin and messenger RNA synthesis
(Baxter, 1977).
Adreno-cortical function in uraemia
Little is known about the function of the adrenal cortex in
association with chronic renal failure. Fanconi (195^) suggested,
without evidence, that adrenal hypertrophy in renal disease with
excess circulating corticoids might cause growth retardation.
Adrenal hypertrophy involving mainly the zona fasciulata and zona
glomerulosa has been found in uraemic rats (Morrison, 1962) and in
patients with renal failure (Nibira, 1971). Whether the adrenal
hypertrophy is associated with increased corticosteroid production
response is not known. Plasma Cortisol levels in uraemic adult
patients are in the upper limits of normal or raised (Snodgrass et
al. , 19 70; Bacon et al., 1973; Bindeballe et al., 1973; Pichler
et al., 1972). There are no values reported for children on dialysi
but Betts et al. (1975) found plasma Cortisol levels to be within
normal range in 11 non-dialysed children with various degrees of
renal insufficiency who also exhibited a normal diurnal rhythm.
However, only five normal controls were included in this study.
Several diurnal patterns of Cortisol secretion have been reported;
whereas some investigators (Varghese et al., 1969; Snodgrass et
al., 1970) found the diurnal rhythm to be abnormal, others
(Lindsay et al . , 19 69; Betts et al., 1975) reported a normal rhythm
These discrepancies may be due to different methods used to measure
plasma Cortisol or to heterogeneity of patients studied with the
effects of uraemia and dialysis not separated. The Cortisol
responses to ACTH stimulation and dexomethasone suppression are
normal (Pichler et al., 1972; Lindsay et al., 1969; Barbour and
Sevier, 197*0, but the plasma Cortisol half-life is consistently
prolonged.
Effect of dia 1ysis
Englert et al . (1958) described a fall in conjugated, but not
free, 17~OHCS levels after a single dialysis. Subsequent studies
(Asbach et al., 1973; Bjndeballe et al., 1973; Pichler et al.,
1972) demonstrated specific oscillatory patterns of plasma Cortisol
levels in response to haemodialysis. Although the patterns reported
were variable, some studies suggested early removal of Cortisol into
the dialysate, followed by a rise in plasma Cortisol above normal
limits. This increase is ACTH-induced as a consequence of an
increase in the negative component of the feed-back mechanism
(Hrubesch et al., 1973). The overshoot of feed-back regulation
may be due to stress but the exact mechanism is not clear.
Cortisol dialysance is small amounting to only 1-3% of normal
daily production (Mishkin et al., 1972), but the metabolic clearance
rate increases by 30% during dialysis (Deck et a 1.,1968). There is
also evidence, though not conclusive, that in most dialysed patients
the amount and rate of Cortisol secretion exceed expected normal
values (Mishkin et al., 1972).
The evidence from published data suggests an increase in the
level of circulating Cortisol in uraemic patients. Since Cortisol
causes a pronounced reduction in nitrogen retention and suppresses
growth even in relatively low doses, it seems probable that such
levels of Cortisol if sustained may adversely affect growth in
uraemic children. Such a possibility has not been evaluated.
THYROID HORMONES
Effects of thyroid hormones on growth and development
The importance of thyroid hormone in normal postnatal growth is
well established, and abundant evidence shows that this hormone is
the essential stimulus to skeletal maturation throughout childhood,
although at puberty, and after, the thyroid role in bone maturation
is taken over by the sex hormones. The decreased rate of growth in
hypothyroidism is reflected in other measurements of growth;
hydroxyproline excretion, which is an index of body growth, is
decreased in hypothyroid children and increased after therapy
(Graystone and Cheek, 1968); hypothyroid children show a far less
positive nitrogen balance than normal for their age or size which
could be corrected by thyroid hormone treatment. Cell population
studies in children with acquired hypothyroidism (Cheek, 1968)
indicate that the reduced body size associated with hypothyroidism
results from a decreased cell population.
Although it has been suggested that growth retardation in
hypothyroidism may result from a secondary growth hormone deficiency,
the evidence from animal studies indicates that thyroid hormone
deficiency is the primary cause (Greenberg et al., 197^).
Thyroid hormone excess can also influence growth; linear
growth and bone maturation are enhanced in hyperthyroid children
(Hung et al. , 1962). However, if present in great excess, thyroid
hormone can be toxic and impairment of ultimate growth despite
accelerated bone maturation has been demonstrated in rats (Best
and Duncan, 1969)•
The process of sexual maturation is also influenced by the
thyroid status; hypothyroidism in childhood generally delays
puberty (Ahuja et al., 1969), but occasionally precocious puberty
may occur.
Thyroid hormones in uraemia
Patients with chronic renal failure are generally considered
to be euthyroid. However, a variety of disturbances in thyroid
function indicating both hyperthyroidism (Bailey et al., 1967) and
hypothyroidism (Ramirez et al., 1973; silverberg et al., 1973;
Carter et al., 197^) have been described in these patients. Extra
thyroidal factors associated with uraemia and its treatment make
the interpretation of thyroid function tests difficult.
Alterations in the binding of thyroid hormones to their
respective binding protein either as a result of reduction in the
plasma concentration of the binding proteins or displacement by a
variety of phenols and indols retained in large quantities in the
serum of uraemic patients (Bailey et al., 1967) will influence the
total and free plasma thyroid hormone levels. Reduced iodide
clearance and raised plasma levels of inorganic iodides in uraemia
may affect the thyroid uptake of 1^ (Koutras et al., 1972).
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Furthermore, since the kidney plays an important role in the metabolism
of thyroxine and its conversion to the more biologically active tri¬
iodothyronine (Burke etal,1972) it is possible that impairment of
this mechanism occurs in renal disease (Carter et al., 1974) • In
addition, although the losses of thyroid hormones across haemodialysis
membranes are negligible (Silverberg et al . , 1973)> post-dialysis levels
of free thyroxine are significantly higher than pre-dialysis levels
because heparin administration decreases the binding of thyroxine
to protein (Schatz et al., 1969), but there is a progressive fall
in serum thyroxine and free thyroxine index associated with long term
haemodialysis (Dandona et al., 1977). Changes in the plasma thyroid
hormone levels may, therefore reflect failing renal function or
haemodialysis treatment rather than thyroid gland dysfunction.
Laboratory indices which suggest hyperthyroidism can often be explained
by non-specific extrathyroidal factors but it is more difficult to
exclude mild hypothyroidism. Reductions in the serum levels of
total T^, free and , and decreased resin uptake have been
demonstrated in both dialysed and non-dialysed uraemic patients
(Silverberg et al., 1973; Joasoo et al., 1974; Carter et al., 1974;
Dandona et al. , 1977). The reasons for the low levels of thyroid
hormones remain controversial. The thyroxine binding globulin
capacity was found to be normal by many investigators (Ramirez
et al., 1973; Joasoo et al., 1974; Neuhaus et al., 1975); therefore,
the low levels of T^ and T^ are unlikely to be due to a decreased
concentration of carrier protein. According to Lim et al. (1975)
and Carter et al. (1974) a defect in the peripheral conversion of
"^4 to 'n these patients may explain the low serum levels of
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T^, but this is an unlikely explanation when circulating levels are
decreased as well. It is possible, however, that thyroxine
monodeiodonation may be altered to produce a metabolical1y inactive
form of triiodothyronine (rT^) which does not cross-react in
radioimmunoassay (Burr et al., 1975). The preferential conversion
of to rT^ rather than to in uraemia is suggested by the finding
of high rT^ levels in uraemic patients (Chopra et al., 1975).
If hypothyroidism exists in uraemic patients the impairment may
be due to reduced TSH output by the pituitary (Silverberg et al.,
1973; Czernichow et al., 1976), or to decreased TSH-responsiveness
of the thyroid gland (Ramirez et al., 1973). The plasma TSH response
to synthetic thyrotrophin-re leasing hormone (TRH) is usually found to
be blunted (Hasegawa et al., 1975; Czernichow et al., 1976; Dandona
et al., 1977). The reason for this abnormal response is not clear;
it may be due to decreased sensitivity of the pituitary to TRH or to
an abnormal thyrotroph cell function the nature of which is unknown,
but raised GH levels have been implicated (Czernichow et al., 1976).
However, the TSH response to TRH stimulation is not uniformly
subnormal in the different patients studied; a normal or even
exaggerated response has been demonstrated in some patients
(Ramirez et al., 1973).
Thyroid response to TSH stimulation has been variously described
as normal (Ramirez et al., 1973) or diminished (Dandona et al., 1977),
but the pituitary-thyroid axis seems to be intact.
In summary, the thyroid status in uraemic patients remains
controversial. The evidence from data reported suggest increased
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incidence of relatively low levels of circulating thyroid hormones
particularly T^. Regardless of the mechanisms involved, the
metabolic significance and particularly the effect upon growth and
development in uraemic children of such suboptimal levels of
circulating thyroid hormones require to be assessed.
SEX HORMONES
Understanding of the role played by the sex hormones, i.e.
androgens, oestrogens and gonadotrophins in growth, particularly at
puberty, has advanced considerably in the past decade and is well
reviewed (Root, 1973)•
Anabolic actions and effects upon linear growth
(a) Androgens:
The relationship of androgens to muscular development in the male
is well recognised and it is assumed that it is largely due to protein-
anabolic action on skeletal muscle (Kochakian et a 1., 1956).
Androgens stimulate protein-synthesis and produce an increase in
the amino acid pool and nitrogen retention (Haak, 1966). Although
increased nitrogen retention is not synonymous with accelerated
growth, it is certain that advancement in growth cannot occur without
it. Many animal and clinical studies have shown clearly that
androgens stimulate both linear growth and skeletal maturation.
However, osteogenesis and sexual maturation are the main target
system for androgens and, therefore, skeletal maturation proceedsmore
rapidly than linear growth under the influence of androgens.
Congenital adrenal hyperplasia with over production of adrenal
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androgens produces increased growth rates, accelerated epiphyseal
maturation, early puberty and reduced ultimate stature. Similar
effects are produced in normal children and in children with
'constitutional short stature1 when given androgens (Geller, 1968).
With androgen deficiency, as in male hypogonadism, the period of growth
is greatly extended with marked delay in the onset of puberty and
epiphyseal fusion.
(b) Oestrogens:
Unlike androgens, oestrogens have only a modest anabolic effect.
They have a specific growth promoting effect on certain tissues such
as the breast and the female genitalia. Their action on bone is
similar to that of androgens in accelerating skeletal maturation
and hastening epiphyseal closure - with eventual inhibition of
linear growth. Although it has been suggested that oestrogens may
interfere directly with cartilage growth and peripheral somatomedin
action (Herbai, 1970), this has not been substantiated (Phillips et
al., 1975). More definite suppressive effects of oestrogens on
plasma somatomedin levels both in experimental animals and in man
have recently been demonstrated (Phillips et al., 1975;
Wiedemann, 1976).
In contrast to oestrogen, the possible influence of androgens on
somatomedin metabolism has received no attention, and the inter¬
relationships between gonadal steroids, growth hormone and somato¬
medin during periods of growth and sexual maturation remain to be
further clarified.
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Hormonal control of the onset of puberty
In the normal child there are important and poorly understood
central nervous factors which become operative at the age of puberty.
The common pathway for central nervous system effects is the hypo¬
thalamus and particularly luteinizing hormone releasing factor which
is a hypothalamic factor promoting the secretion of FSH and LH. These
gonadotrophins act on the gonads and lead to maturation and the
secretion of sex steroids. This mechanism is not operative during
childhood mainly because of the very sensitive nature of the feed-back
mechanism during this period, in which very small amounts of gonadal
steroids and perhaps adrenal secretionssuppress hypothalamic
activities. An intact hypothalamic pituitary-gonadal axis, as
well as normally functioning gonads, is important in the process of
sexual maturation.
Nutritional status of the individual and the attainment of a
certain percentage of their ideal body weight are considered to be
important factors in the initiation and the progress of sexual
development and clearly, the adolescent growth spurt takes place against
the background of genetic, nutritional and environmental factors,
but this dramatic increase in growth velocity is best explained by
the hormonal changes that accompany the physical manifestations of
puberty.
As pointed out above, both androgens and oestrogens accelerate
linear growth and in terms of the adolescent growth spurt the all
important steroids are the gonadal steroids; testosterone from the
testes and oestrogens from the ovary (Root, 1973). The growth spurt
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is preceeded by gradual rises, in the male of testosterone and in the
female of oestrogens. Whether oestrogen acts directly or whether
it is mediated through other factors remains to be determined.
The role of pituitary growth hormone during puberty remains
speculative. However, quantitative and qualitative changes in the
secretion of GH occur at puberty, and there is evidence that both
gonadal steroids and GH are required for pubertal growth spurt,
though GH has only a permissive effect (Zachmann and Prader, 1970).
This has to be on a background of normal thyroid, insulin and
Cortisol secretions.
Sex hormones in uraemia
Considerably more information is available regarding sex hormone
function in adult uraemic males than in uraemic females, and
surprisingly, in view of the delayed pubertal onset, there are no
reported observations on uraemic children with the exception of reports of
delay in the onset of puberty.
Frequently observed clinical abnormalities in male patients
include gynaecomastia, testicular atrophy, azoospermia, impotence and
decreased libido. Amenorrhoea, infertility and decreased libido
are common findings in female patients.
Low testosterone levels are found in adult males (Chen, 1970;Guevara
et al., 1969; Holdsworth et al., 1977) and may be related to some
of the clinical findings mentioned above. Testosterone insufficiency
may also be partly responsible for the muscle atrophy and anaemia
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associated with uraemia (Gupta and Bundschu, 1972). Since the plasma
testosterone binding affinity is either normal or increased (Chen,
1970; Gupta and Bundchu, 1972; Hagen, 1976), the low plasma
testosterone levels cannot be due to defective protein binding.
Abnormal levels of the gonadotrophic hormones (FSH and LH) are
seen. Elevated FSH and LH levels with raised FSH:LH in both males
and females have been reported (Hagen et al., 1976; Olgaard et al.,
1975; Holdsworth et al., 1977). On the other hand,others have found
elevated LH levels but normal FSH values (Stewart-Bently et al., 197^;
Disti 11 er et al., 1975) .
Studies of hypotha1 amic-pituitary-testicular inter-relationships
suggest a primary testicular defect: (a) FSH and LH responses to
luetenizing hormone releasing hormone (LHRH) are normal,
(b) the responses of FSH and LH to clomiphene stimulation are
usually normal, (c) blunted testosterone response to exogenous
gonadotrophin and (d) the suppression of LH by testosterone
propionate is usually normal. However, some patients have either
high LH levels with normal testosterone, or normal LH levels with low
testosterone. Both combinations indicate a derangement in normal
feed-back mechanisms, or a primary hypothalamic-pituitary abnormality
(Sawin et al., 1973; Guevara et al., 1969)- In a more recent
study Holdsworth et al. (1977) have shown that the feed-back mechanism
is intact and the pituitary function, as assessed by stimulation and
suppression tests, is normal. They confirmed a primary testicular
failure as the major cause of reduced testosterone levels.
Furthermore, they demonstrated that both reduced metabolic clearance
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rate and increased production of LH contribute to the raised
plasma LH levels.
PROLACTIN
Raised prolactin levels are commonly associated with gonadal
dysfunction. In women infertility and menstrual irregularity occur
(Bohnet et al., 1976) and in men impotence, loss of libido and
galactorrhoea are common clinical findings (Thorner et al., 1977)•
However, the relevance of hyperprolactinaemia to pubertal delay
in children is not yet established (Thorner, 1978 - personal
communicat ion).
Prolactin in uraemia
Hyperprolactinaemia occurs in a high percentage of both male and
female patients with chronic renal failure (Hagen et al., 1976;
Nagel et al., 1973; Olgaard et al., 1975). Its relationship to the
gonadal dysfunction in these patients is not known and no correlation
was found between plasma prolactin and gynaecomastia in dialysed adult
male patients (Nagel et al., 1973; Hagen et al., 1976).
The cause of hyperprolactinaemia of uraemia is not known.
It may be a result of hypothalamic-pituitary abnormality, be secondary
to stress, or simply related to reduced renal clearance. Irrespective
of the cause of the elevated prolactin levels in uraemia, the
elucidation of its possible role in the delay of sexual maturation
and consequently growth is obviously important as hyperprolactinaemia






THE MEASUREMENT OF GROWTH
(1) Stature and weight:
After removal of shoes and outer clothing, height was measured
by a wall stadiometer (Harpenden) using the technique described by
Marshal 1 (1966). Body weight was measured by standard beam scales.
Observed heights were plotted against both chronological age and bone
age using Tanner's growth charts for normal children (Tanner and
Whitehouse, 1976). To calculate the significance in deviations of
height from the norm at different ages, height was expressed as standard
deviation scores (Tanner et al., 1971) according to the formula:
HSDS = X-x/SD; where X — present height; "x » mean height for age;
SD = standard deviation in height for age. Mean height and standard
deviation for age in normal children were obtained from standard
tables (Tanner et al., 1966).
(2) Growth velocity (GV) (cm/year):
Growth performance over the period of observation (one year) was
calculated and expressed: (a) as standard deviation score for bone age
(Tanner et al., 1971). The standard deviation score (GVSDS) was
calculated as follows: GVSDS = observed GV - mean GV for age/standard
deviation in GV for age in normal children. Growth velocities and
standard deviations in normal children were obtained from standard
tables for normal British children (Tanner et al., 1966). (b) The
stage of puberty was taken into account when assessing growth
performance (Marshalland Tanner, 1970): The children were classified
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according to their puberty rating as being either (i) Prepubertal;
(ii) at a stage of sexual development compatible with the accelerating
phase of the adolescent growth spurt; (iii) advanced in puberty and
probably in the deccelerating phase of growth after -peak height
velocity. Using these three categories of puberty rating growth
performance was then classified into the following three grades,
based on the method described by Marshal's group (Wass et a 1.,1977):
Grade (I) Very poor: Well below (growth velocity 2cm/year)
3rd centile, taking puberty into account.
Grade (II) Poor : Below 3rd centile (but growth velocity
^ 2cm/year), taking puberty into account.
Grade (III) Satisfactory: Within normal limits, i.e. on 3rd centile
or above, taking puberty into account.
These grades were used with the sexes combined for further analysis.
The chronological and bone ages used in the calculations of height
velocity were those at the middle of the period of observation.
(3) Skeletal maturation (bone age):
Bone maturation was assessed from hand and wrist X-rays by an
independent observer according to the method of Greulich and Pyle (1959)-
(4) Puberty status:
Sexual development was estimated by the method of Tanner (1962) .
ASSESSMENT OF BONE DISEASE
Renal osteodystrophy was assessed from hand X-rays by an independent




(1) Moderate erosions present
(2) Severe erosions present
THE ASSESSMENT OF NUTRITIONAL STATUS
Nutrition may be defined as the process by which the organism
utilises food (McLaren, 1976). Nutritional status is, therefore, the
state resulting from the balance between the nutrient intake and the
nutrient expenditure. A survey of nutrient intake is thus an integral
part of nutritional assessment.
There are many other methods available for assessing nutritional
status: anthropometric measurements, biochemical tests and biophysical
tests. Although most of these methods are adequate for the detection
of gross states of deficiency, they are not so satisfactory in the
detection of borderline or incipient deficiencies.
For the purpose of this study nutritional status was assessed
by (1) survey of nutrient intake and (2) biochemical indices.
(1) Determination of dietary intake:
The methods available for the determination of food intake have
been described by Marr (1971) and Davidson, Passmore and Brock (1972).
They are as follows:
(I) Estimation from consumption of groups
(ii) Estimation by recall, either from the immediate past
(e.g. 2k hours) or as the usual intake (customary diet)
(iii) Measurements as eaten.
109
The latter method is generally accepted as the most accurate of
the techniques available. The precise weighing method which demands
close supervision of the subjects by the observer was considered
impractical for long term dietary survey, and the weighed record
was chosen for the purpose of this study.
The parents or older children were required to weigh and measure
accurately all items Of food and fluids taken on three successive
days (including one dialysis day in the case of the children on
regular haemodialysis) each month, usually a Friday, Saturday or
Sunday. A food intake form was provided on which was recorded the
time and day of food intake and description and quantity of food
and fluids taken. The completed forms were checked with the
parents by a dietician before analysis.
Calculation of intakes
The intakes were coded and computerized. The food tables used
in the computer programme were those of McCance and Widdowson (1969)
supplemented by data from manufacturers. The fatty acid content of
the diet was calculated from tables compiled and adapted for use by
the Unit for Metabolic Medicine, Guy's Hospital, London. The means
of the 3 days intakes of the various nutrients were expressed as a
percentage of recommended intakes (Rl) for healthy children (Department of
Health and Social Security, 1969) for the height-age of the child.
As there is no recommended value for the carbohydrates and fat
separate from the recommended total energy, it was assumed that the
percentage of energy derived from carbohydrate and fat in the normal
diet were k6% and kl% respectively (Francis, 1976).
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Evaluation of the method
This was kindly carried out by Miss H. Brown (Unit for Metabolic
Medicine, Guy's Hospital, London) by the use of duplicate analysis
method: Identical portions of each food taken by .the child and
recorded In the dietary sheet were pooled, homogenised and dried at
105° for 48-72 hours to constant weight. The dried food was ground,
mixed thoroughly, and analysed. Nitrogen was estimated by the
Macro Kjeldahl method (Markham, I960). Protein was calculated as
N x 6.25. Gross energy contents (GE) were measured with the
ballistic bomb calorimeter (Miller and Payne, 1959) and converted
into metabolizab1e energy (ME) from the following equation:
ME/g - (GE/g x 0.95) - (N% x 0.075)
Highly significant correlations were found when the values for
protein and total energy obtained by analysis were compared to those









Calculated 9 7589 2642 51,7 20.1
Analysed 9 7364 2495 48.2 15.3
Correl.coeff. (r) +0.9350 +0.9527
Significance < 0.001 < 0.001
Table I: Comparisons between calculated and analytical
values for energy and protein in one day's diet.
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(2) Biochemical measurements:
In the last ten years or so there has been a continuing
interest in biochemical indices of nutritional status. The search
has been directed towards finding an index which aids the
identification of undernutrition in situations where anthropometric
measurements may be unreliable.
Various plasma proteins have been suggested as indices of
protein-energy malnutrition in children. These include the plasma
concentrations of albumin, pre-albumin, amino acids, transferrin
and complement proteins. In this study plasma albumin, amino acids,
transferrin and complement were used as nutritional markers.
Plasma transferrin and concentrations were found to be sensitive
indicators of nutritional status of adult patients with chronic





Radioimmunoassay (RIA) - Basic Principals:
RIA is a general method by which the concentration of a wide
variety of substances, including peptide and non-peptide hormones
can be determined. The procedure is based on the original
observation of Benson and Yalow (1960) that low concentrations
of antibodies to the antigenic hormone insulin could be detected by
their ability to bind radiolabelled insulin. It was found that
unknown concentrations of the hormone could be determined by measuring
their inhibitory effect on the binding of labelled hormone and
antibody. The principal of the assay, which underlies all
competitive binding assays, involves competition between labelled
and unlabel led substances for a limited number of combining sites
on a specific receptor. The binding agent could be a plasma protein,
an enzyme, or a tissue receptor site. In RIA the binding agent is
antibody and the marker molecule is a radio isotope. A fixed
quantity of radiolabelled antigen is added to the unknown amount of
antigen in the sample and to this mixture a fixed quantity of anti¬
body is added. The antibody binds both radio1abe11ed and unlabel led
antigen without distinguishing between the two forms with the result
that the amount of radio1abe11ed antigen bound by the antibody
bears an inverse relationship to the original concentration of
unlabel led antigen in the sample. The separation procedure is
designed to separate the bound from the unbound antigen, after
which the radioactivity of either fraction can be determined.
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The requirement is for complete and rapid separation of the
bound antigen from the free. At the time of separation, the assay
has reached, or is approaching, equilibrium. Systems which
rapidly remove one or both of the reactants, or the product,
are preferred because they leave little time for a readjustment
of the equi1ibriurn.
Many separation techniques are available. They involve the
use of (a) differential migration of bound and free fractions,
e.g. chromatoectropheresis, (b) precipitation of bound fraction
by either an inorganic salt or organic solvents, (c) solid phase
e.g. sephadex, (d) absorption, e.g. coated charcoal, and
(e) double antibody. In this method a second antibody is used
to precipitate the antibody-antigen complex. The second antibody
is induced in an animal against the gamma globulin (mainly IgG) of
the animal used to raise the first antibody for the assay
(e.g. rabbit anti-guinea pig IgG). The method relies upon the
antigenic sites on the IgG of the first antibody being distinct
from those involved in its antibody activity.
The assay is a comparative one and, as a rule, unknown and
standard solutions of the antigen are assayed simultaneously.
The measurements of radioactivity obtained from the standard
solutions are used to construct a standard curve and the unknown
amount of the antigen in the samples can then be determined by
interpolation.
THE MEASUREMENT OF INSULIN (IMMUNOREACTIVE INSULIN - IRI)
Numerous modifications of RIA of insulin have been devised.
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A]] are based on the original principle described by Benson and
Yalow (1960), the competition between standard or unknown
quantities of insulin and known amounts of radiolabel1ed insulin
for a known amount of insulin antibody. The differences exist
in the methods of separation of the free from the antibody-bound
insulin. The double antibody method involves the use of a second
antibody against the guinea pig gamma globulin which results in the
precipitation of the soluble insulin-anti-insulin complex. This
can then be separated by filtration (Hales and Randle, 1963), or
centrifugation (Morgan and Lazarow, 1963)- The main advantage of
the centrifugation technique is that a single tube can be used for
incubation of the reactants, isolation of the precipitate and final
measurement of radioactivity. The latter method (Morgan and
Lazarow, 1963) was used in the measurement of plasma insulin
concentration in this study.
Reagents:
(1) Phosphate buffer: This contained: 5-708 g disodium
hydrogen orthophosphate, 1.33^ g potassium dihydrogen orthophosphate,
3.572 g sodium EDTA, and 9.00 g sodium chloride. This was made up
to one litre with deionized water and the pH of the buffer was
adjusted to 7.^. One hundred mg of sodium azide as a preservative
was added to each litre of the buffer.
(2) 0.5% Bovine serum albumin (BSA): 9-00 g BSA was added to
each litre of phosphate buffer. This solution was used as a dilutent
for all the material used in the assay. Henceforth, the term
phosphate buffer will imply phosphate buffer containing 0.5% BSA.
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(3) 1nsulin standards: The standard human insulin was supplied
by the Medical Research Council, Mill Hill, London, Code No. 66/304,
in a freeze-dried form (3 u/ampoule). This was diluted in phosphate
buffer to give a concentration of 30 ,000 ^iU/ml . • One ml quantities
of this solution were stored at -20°C. For use the stock solution
was diluted in 10 ml phosphate buffer to give a standard solution
of 272 jjU/ml , which was subsequently serially diluted to give
standards of 136, 68, 34, 17, 8.5, 4.25/iU/ml .
(4) Anti-insulin serum: This was purchased ready prepared
from Wellcome Reagents Ltd., Beckenham, Kent, Code No. RD 09/10,
and supplied in vials containing 0.5 ml of a 1:1000 dilution of
guinea pig serum freeze-dried and contained 0.1% sodium azide
as preservative. This was diluted in phosphate buffer to give a
dilution of 1:60,000. The anti-serum was prepared freshly for
each assay.
125(5) J 1 abel1ed insulin: This was purchased from the
Radiochemical Centre, Amersham, Buckinghamshire, Code No.IM 38
0.1 jjg of insulin with an approximate specific activity of 5 >iC
supplied in a volume of 5 ml phosphate buffer, pH 7.4. On receipt
1 ml was diluted to a total volume of 10 ml with phosphate buffer
and 1 ml aliquots of this was stored at -20°C. For use this 1 ml
aliquot was made up to 15 ml with phosphate buffer, i.e. a final
di1ution of 150 fold.
125To estimate radiation damage, 0.1 ml of the I labelled
insulin used with each assay was precipitated with 2 ml of 10%
trichloroacetic acid (TCA), centrifuged at 2000 rpm for 20 minutes,
the supernatant decanted off and the precipitate counted for
radioactivity. Less than 90% precipitation indicated radiation
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damage or denaturation.
(6) Normal guinea pig serum (NGPS): Purchased from the Wellcome
Research Laboratories, Code No. VD 11. This was stored at 4°C.
For use 0.1 ml of the NGPS was added to 39•9 ml phosphate buffer.
The solution was stored at k°C for no longer than five days.
(7) Rabbit anti-guinea-pig serum (RAGPS): This was prepared
in our laboratory by the injection into New Zealand White rabbits
of 2 ml of 50% (V/V) NGPS, 1 ml intraperitoneally and 1 ml
subcutaneous 1y to the cervical lymph nodes at the base of the neck,
initially injections were given every ten days. After four such
injections, the rabbits were bled from an ear vein and the sera
separated.
The serum was titrated by setting up a series of sero standards
and adding increasing quantities of RAGPS. An amount (20%) in
excess of that required to produce maximal precipitation was used
in the assay.
When the rabbits had a high enough titre, injection and bleeding
were carried out on alternate weeks. The serum was pooled,
titrated and stored at -20°C.
Assay procedure:
The assay was carried out in polystyrene rubes (Luckhams Ltd.,
Burgess Hill, Sussex, Type LP3).
Stage I: The setting of a competition reaction between
standard or plasma insulin and labelled insulin and a known amount of
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anti insulin serum. All samples and standards were assayed in
duplicates. The volumes of the reagents indicated were added
to the tubes in the order shown by means of an automatic sample
processor (LKB Ultralab System 2071):
0.6 ml phosphate buffer
0.1 ml standard insulin solution or plasma sample
0.1 ml labelled insulin
0.1 ml anti-insulin serum.
The contents of the tubes were thoroughly mixed and then incubated
for 72 hours at k°C.
Stage 2: The separation of the free from the antibody-bound
insulin. To each tube was added:
0.1 ml normal guinea pig serum
0.1 ml rabbit anti-guinea-pig serum (or sufficient to
ensure complete precipitation).
The tubes were mixed on vortex and incubated for 24hours at k°C.
All the tubes were then centrifuged for 30 minutes at 2000 rpm
at A°C. The supernatants were carefully decanted and the tubes
allowed to drain in an inverted position for ten minutes and then
counted in a gamma counter (LKB 80000). The efficiency of the
counter assuming 10,000 cpm was - 2.5%.
Calculation of results
The individual counts obtained from the standard solutions were
plotted against the corresponding insulin concentration to construct
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FIG. 1 Typical standard curve for the insulin radioimmunoassay.
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a standard curve (figure 1). The means of the duplicate,
counts for the unknown samples (providing they agreed within - 2%)were
used to read off their insulin concentration values from this
curve.
Intra-assay variation
Ten aliquots of a single plasma sample were assayed in a
single assay. The mean value was 26.2 mU/1 and the standard
deviation was 1.2 mU/1 (coefficient of variation of 4.6%).
Inter-assay variation
A single plasma sample was assayed on eight occasions. The
mean concentration was 24.6 mll/1 and the standard deviation was
2.4 mU/1 (coefficient of variation, 3.1%).
THE MEASUREMENT OF GROWTH HORMONE (HGH)
The radioimmunological method for insulin assay introduced
by Berson and Yalow (i960) was applied to HGH by Hunter and Greenwood
(1962). The principal of the method is the same as for insulin
outlined above.
The various methods available for R1A of HGH differ mainly
in the technique used to separate free from antibody-bound hormone.
A number of methods for separation have been published. The
double-antibody precipitation method (using a second antibody to
precipitate the antibody-bound hormone) was used in this study and
was based on the method described by Hartog et al. (1964).
119
Reagents
(1) Pi 1uent Buffer:
0.05 M phosphate buffer, pH 7.4, containing sodium EDTA,
0.5% bovine serum albumin, sodium chloride and sodium azide, were
prepared as described in the insulin assay above. 100 ^1 of carrier
NGPS was added for every 100 ml of buffer used.
(2) 1125 label led HGH:
This was kindly supplied by Professor Barbara Clayton,
Institute of Child Health, London University. HGH was labelled
1 25
with radioiodine I , using the method of Hunter and Greenwood
(1962), and had specific activity of 150 - 200 yC/yg. 200 ^1
of HGH was diluted in 15.8 ml of phosphate buffer, which generally
gave 10,000 counts per tube per five minutes, were prepared just
before the assay was started.
(3) HGH Standard:
HGH MRC standard A supplied by the Medical Research Council
was used. Each ample contained 0.1 mg whichwas found to contain
0.114 i.u. of HGH by immunoassay against WHO international reference
preparation (IRP). Each ample was diluted in 100 ml of phosphate
buffer to give a concentration of 1140 ^iu/ml . 1 ml quantities
of this solution were stored at -20°C. For use, the stock
solution was diluted in 10 ml phosphate buffer to give a
standard solution of 114 jju/ml , which was subsequently serially
diluted to give standard solutions of 76, 57, 38, 28.5, 14.25,
7.125 ^Ju/ml .
(4) Anti-HGH Serum:
Guinea pig antiserum to HGH was kindly supplied by the Department
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of Endocrinology, Royal Postgraduate Medical School, Hammersmith
Hospital, London. Each batch of anti-HGH serum received was
tested by setting up a series of standard curves with various
dilutions of the anti-HGH serum. The aim was to obtain about
60% binding of the 1-125 labelled HGH in the absence of non-labelled
HGH. There was a certain degree of variation from batch to batch
but the final dilution of the anti-HGH serum to be used in the
assay was between I:1A0,000 and 1:150,000.
(5) Rabbit anti-guinea-pig serum (RAGPS):




The setting of a composition reaction between standard or plasma
HGH and labelled HGH and a known amount of anti-HGH serum.
All samples and standards were assayed in duplicates. The
volumes of the reagents indicated, were added to the assay tubes
(polystyrene, Luckhams Ltd.) in the order shown by means of an
automatic sample Processor (LKB Ultralab System 2071).
Incubation mixture:
0.6 ml phosphate buffer + NGPS
0.1 ml I 125 HGH
0.1 ml anti HGH serum.
The mixture was thoroughly mixed and incubated for 72 hours at 4°C.
121
Stage 2
The separation of free and antibody-bound HGH.
The tray containing the assay tube was immersed in melting ice.
To each tube was added 0.1 ml of rabbit anti-guinea-pig serum
by means of Hamilton microlitre pipette. The contents of the
Tubes were thoroughly mixed and then incubated for 24 hours at 4°C.
Thereafter all the tubes were centrifuged for 30 minutes at 2000
r.p.m. at 4°C. The supernatants were carefully poured off and the
tubes allowed to drain in an inverted position for ten minutes.
The radioactivity in the precipitates was counted in a gamma
scintillation counter (LKB 80000). The efficiency of the counter
assuming 10,000 cpm was - 2.5%.
The individual counts obtained from the standard solutions
were plotted against the corresponding HGH concentrations to
construct a standard curve (figure 2). The means of the duplicate
counts for the unknown samples (providing they agreedwithin 2%) were
used to read off their values from this curve.
Intra-Assay Variation
In order to assess intra-assay variation, ten aliquots of a
single plasma sample were assayed in a single assay; the mean value
was 12.4 ml)/! and the coefficient of variation was 8.2%.
Inter-Assay Variation
To study inter-assay variation, a quality control plasma
sample was assayed on ten occasions. The mean concentration was
6.1 mU/1 and the coefficient of variation was 12.5%.
20 40 60 80 100 115
Growth hormone (mU/l)
FIG.2 Typical standard curve for the growth
hormone radioimmunoassay.
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THE MEASUREMENT OF CORTISOL
Plasma Cortisol concentration was measured by a competitive
protein binding assay (CPB) using a kit (Cortipac) purchased from
the Radiochemical Centre, Amersham, Buckinghamshire, Code No. SC6.
Outline of method
After dilution with distilled water the plasma samples were
heated to denature the endogenous Cortisol binding protein
1transcortin1 and release the Cortisol. An aliquot of the diluted
denatured plasma sample was mixed with a solution which contains
selenium-75 labelled Cortisol bound to transcortin and absorbent
granules (Sephadex). Cortisol from the plasma sample and the
radioactive Cortisol compete for binding sites on the transcortin.
The free fraction was simultaneously distributed between the granules
and the supernatant fluid. At equilibrium, the granules were
allowed to settle and the radioactivity of the supernatant was
counted. The measured radioactivity was inversely proportional
to the concentration of Cortisol in the unknown plasma samples.
A series of Cortisol standards in human serum was treated in an
identical manner to the unknown serum samples to produce a standard
curve from which values for the unknowns may be interpolated.
Reagents
Each 'Cortipac1 kit contained:
(l) 25 test vials; each contained the same weight of
absorbent granules and the same volume of buffered transcortin-
75 75Cortisol (SC ) solution (not more than 0.2 ^Ci Se per vial).
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(2) 4 vials lyophilised human reference serum containing
2.5, 7.4, 13 and 45 ug/100 ml of Cortisol. These were reconstituted
just before use by the gentle addition of 500 ul of distilled water
to each of the standard serum vials; left to dissolve at room
temperature for ten minutes; inverted gently for a few minutes
to wash any particles from the cap and left for a further short
period for complete solution. The vials were swivelled gently
to obtain a homogenous solution.
(3) 25 glass tubes for the heat denaturation stage
(see procedure).
Assay procedure
All contents of the kit were stored at 4°C. They were brought
to room temperature just before use. Standard solutions and the
unknown plasma samples were assayed in duplicate:
(1) 100 ul aliquot of the serum standard or unknown plasma
samples was pipetted into the glass denaturation tubes provided
with the kit. 200 jjI of distilled water was added to each tube
and vortex mixed. The tubes in a rack were then placed in a water
bath at 70°C for ten minutes.
(2) After allowing the tubes to cool to room temperature,
200 ul of the denatured sample was pipetted into an individual assay
vial and the contents mixed continuously at ambient temperature for
45 minutes. A blood cell suspension mixer was used for the purpose.
(3) At the end of the mixing period, the vials were inverted
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a few times to wash any granules off the cap and sides and then
the granules left to settle for five minutes.
[b) 500 jjI aliquots of the supernatant solutions were then
transferred into counting tubes. These were counted in a gamma
counter (LKB 80000) set for counting selenium-75, for 100 seconds.
(5) Counts obtained from the standard solutions were plotted
against their corresponding Cortisol concentrations to construct a
standard curve from which Cortisol values for the unknowns were
interpolated.
THE MEASUREMENT OF THYROID HORMONES
THYROXINE (lb)
Serum thyroxine concentration was measured by radioimmunoassay
using a commercial kit (TA RIA (PEG) Kit, Code No. IM 92), purchased
from the Radiochemical Centre, Amersham, Buckinghamshire.
Princip1e: The method depends on the competition between Jb
125in the serum and I labelled TA for binding with Jb specific
antibody. The antibody bound hormone was separated by precipitation
with polyethylene glycol (PEG). The radioactivity in the precipitate
125
was measured by gamma scintillation counter. The I labelled TA
bound to antibody was inversely related to the concentration of
unlabelled T4 present in the serum.
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By measuring the proportion of I labelled T4 bound in the
presence of reference standard sera containing known amounts of Tb
a standard curve was constructed and the concentration of Jb present
125
in the unknown samples was determined by interpolation.
Thyroxine binding proteins (TBG) in the serum may interfere
with the serum assay. The degree of interference depends on the
concentration of TBG in each serum sample. In this kit, a
combination of an appropriate buffer and a TBG blocking agent
(Thiomersalate) in the reaction medium has been used to minimise
this interference.
Reagents: All reagents required for the assay were provided
ready-made in the kit:
1 25
1 Vial containing up to 6 uci I labelled thyroxine.
1 Vial containing anti TA serum freeze-dried.
k Vials of reference standards of T4 in human serum
(0, 5, 12 and 22 /jg TA/100 ml freeze dried)
1 bottle containing 55 ml aqueous polyethylene glycol (PEG)
Reconstitution of reagents
1. Standards: The contents of each of the standard serum vials
were gently dissolved, at room temperature, by the addition of 500 ^1
of distilled water to each vial by means of a mi cropipette.
2. Antiserum and labelled thyroxine: 10.5 ml distilled water
was added to each and mixed until dissolved.
3. Aqueous PEG solution: This was supplied ready for use in




Standards and samples were all assayed in duplicate.
Polystyrene tubes provided in the kit were used in the assay.
1. 50 /jl aliquots of the standards and of the unknown samples
were pipetted into appropriately marked tubes, by means of micro-
pipette (using a new pipette tip for each sample).
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2. 200 ^il aliquots of the I thyroxine solution were added
to each tube, followed by 200 ^1 aliquots of the antiserum solution.
3. All tubes were mixed thoroughly on a vortex, and then left
stand for kS minutes at room temperature.
k. At the end of the incubation period, 1 ml of the aqueous PE
solution was added to each tube and mixed thoroughly on vortex.
5. All tubes were centrifuged for 15 minutes at 2000 rpm at
room temperature.
6. The supernatant liquid was decanted and tubes were left
inverted to drain for ten minutes.
7. Radioactivity in each precipitate was then counted on a
gamma scintillation counter.
8. A standard curve was constructed by plotting the counts
obtained from the standard solutions against their corresponding T4
concentration and the means of duplicate counts for the unknown
samples were used to read off their values from the standard curve.
The normal range of plasma Jh with this assay is 70-190 nmol/L.
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TRIIODOTHYRONINE (T3)
T3 was assayed radioimmunologically by T3 radioimmunoassay
kit (T3 RIA Kit, Code No. IM ~]k) , purchased from the Radiochemical
Centre, Amersham, Buckinghamshire .
The principle of the assay is the same as that described above
for the T4 RIA. The main difference were thetechniques used for
separation of the antibody-bound hormone from the free hormone.
In the T3 assay the free T3 was separated by absorption on a solid
matrix and the radioactivity of the antibody-bound T3 remaining
.125
in solution was measured. Thus, by measuring the proportion of I
labelled T3 bound in the presence of reference standard sera containing
known amounts of T3, the concentration of T3 in the unknown samples
can be determined by interpolation.
The possible interference by T3 binding proteins in the serum
both with the antibody T3 reaction and with the separation of free
T3 by absorption on a solid matrix was eliminated in this assay by
the combination of an appropriate buffer and a TBG blocking agent.
Jk interference is minimized by the use of a highly specific T3
antiserum with a low cross reactivity with TA.
Reagents ;
The following freeze dried reagents were provided in the kit:
125 125
1 Vial of I labelled T3 containing not more than 5^ci I
1 Vial of anti-T3 serum, also containing 100 mg sodium
barbitone.
k Vials of reference standards of T3 in serum, containing
0, 0.7, 2 and 5 mg T3/ml.
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1 plastic beaker containing absorbent powder suspension,
which contains 200 mg Na barbitone, for the separation
of antibody-bound and free T3.
Assay Procedure:
The kit components were stored at 4°C and reconstituted just
before use. The standards and test samples were all assayed in
duplicate. Polystyrene tubes were used.
1. Each serum standard was reconstituted by addition of 500 p\
of distilled water by means of a micropipette and gently dissolved.
125
2. Antiserum and I labelled T3 were reconstituted by adding
10.5 ml distilled water to each and swirling until dissolved.
3. 50 y] aliquots of the standards and 50 y\ aliquots of the
samples were pipetted into appropriately marked polystyrene tubes.
125k. 200 y\ aliquots of the 1 labelled T3 solution were added
to all the tubes and mixed on vortex.
5. 220 y\ of the antiserum solution was then added to all
tubes and mixed thoroughly on vortex.
6. The tubes were then incubated in a water bath at 37°C
for one hour.
7. The separation suspension was reconstituted by adding 55 ml
distilled water and stirred by the means of a magnetic bead
introduced into the adsorbent suspension.
8. 1 ml of the suspension was added to each tube.
9 • All tubes were then capped and placed on a rotator for
one hour at room temperature.
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10, After allowing the adsorbent to settle completely to the
bottom of the tubes, 1,0 ml of the supernate of each tube was
pipetted into a counting tube and radio-activity measured by a
gamma counter,,
11o A standard curve was constructed by plotting the means
of the duplicate counts obtained from the standard solutions against
their corresponding concentration. The means of the duplicate
counts for the unknown samples were used to read off their values
from the standard curve. The normal plasma T^ range with this
assay is 1,2 - 3o0 nmol/L,
THYROTROPH IN (TSH)
A radioimmunoassay kit (HTSH-RIA, Diagnostic Kit), purchased
from Abbott Laboratories, Chicago, U,S,A, was used for the determination
of the concentration of thyroid stimulating hormone in serum.
Principle:
This was a competitive radioimmunoassay in which non-radioactive
Human Thyroid Stimulating Hormone (HTSH) in serum competed with a
1 25
constant amount of I labelled HTSH for binding sites on a limited
amount of HTSH antibody. The percentage of radioactive HTSH bound
was inversely proportional to the concentration of HTSH in the serum.
The antibody-bound HTSH (both radioactive and non-radioactive) was
separated by precipitation with polyethylene glycol (PEG) from the
free HTSH, The radio-activity of the precipitate was then
measured by a gamma scintillation counter. The concentration
of HTSH in the serum was determined by comparison with reference
standard solutions containing known amounts of HTSH,
Reagents
All reagents used in the assay were provided ready made in
the kit, and include the following:
1, I vial (5 ml) I HTSH solution, 0,1 M TRIS buffer,
0,3% Bovine Albumin. Activity, 0.1 p ci/ml, 0.2% sodium Azide as
a preservative,
2, I vial (6 ml) HTSH standard, 0,0 p iu/ml HTSH in equine
serum. Preservative: 0,21 sodium azide,
3, 5 vials (1 ml each) HTSH standards, concentrations of HTSH
2,5, 5.0, 10,0, 20,0 and ^+0.0 pi iu/ml in equine serum.
Preservative: 0,2% sodium azide,
k, I vial (15 ml) HTSH Antiserum (Rabbit), 0,1 M TRIS buffer,
0,3% bovine albumin, 0,2% sodium azide,
5, I vial (2,5 ml) TRIS buffer, 0.1 M TRIS hydroxymethyl-
aminomethane, 0,3% bovine albumin, Preservative: 0,2% sodium azide.
6, I bottle (150 ml) Polyethylene Glycol (PEG), 16% solution
in 0,09 M Barbital buffer.
Procedure
All reagents were kept at b°C until just before use when they
were brought to room temperature. Standards and unknowns were all
measured in duplicates and only polystyrene tubes provided with the
Kit were used for the test:
0,1 ml of HTSH of each standard solution and 0,1 ml of the
unknown samples were pipetted into appropriately marked tubes.
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0,3 ml HTSH Antiserum was then added to each tube and mixed by
shaking,, The tubes were covered with parafilm and incubated in
a water bath at 37°C for three hours,, After incubation 0,1 ml
125
I HTSH solution was added to each tube, mixed gently and
reincubated in water bath at 37°C overnight (approximately
18 hours),, After the overnight incubation, 3 ml of
Polyethylene Glycol solution was added to each tube over a period
of less than five minutes and the contents of the tubes mixed
thoroughly on vortex. Tubes were then centrifuged at 1000 r,p,m,
at room temperature for ten minutes. The supernatant solution
was then decanted and the radio-activity in the remaining
precipitate counted on a gamma counter. Two tubes containing
125
aliquots of 0,1 ml of I HTSH solution only were also counted
for the determination of total radio-activity (TC),
Calculation of results
The percent bound for each standard or unknown samples was
calculated as follows:
o/ o j precipitate cpm ,nn4 Bound = r K
_ x 100
mean total count pm
A standard curve was plotted on linear graph paper using the
mean of % Bound values on the Y axis and various concentrations of
HTSH standard on the X axis. Using the six points, the best fit
smooth curve was constructed. The mean % bound for each unknown
sample was used to read off its TSH concentration from the standard
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curve,, This assay gives a normal range for serum TSH
concentration of 0 - 5 mll/L,
T3 UPTAKE TEST
This was carried out by the use of a kit (Thyopac-3) purchased
from The Radiochemical Centre,(Amersham),
Each kit consisted of 12 test vials containing adsorbent granules
suspended in buffer containing 1-125 labelled T3, A vial of standard
reference serum was also provided. The standard serum as a
dessicated pooled human serum, which upon reconstitution has a known
T3 uptake value which has been accurately determined by the
manufacturers.
Test Procedure
1, After allowing the components of the kit to attain room
temperature, the dessicated standard serum was carefully reconstituted
by the addition of 1 ml of distilled water to the standard serum vial
by means of a micro-litre pipette, a homogenous solution was then
obtained by gentle shaking of the vial,
2, The test sera were brought to room temperature and 0,1 ml
of each of the unknown serum and of the reconstituted standard
reference serum was then transferred to a "thypac-test" vial by
means of an automatic pipette (Eppendorf), The standard serum was
examined in duplicate,
3, All the test vials were then attached to a mixer and mixed
at room temperature for 20 minutes.
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At the end of the mixing period, the contents of the vials
were allowed to settle, 1 ml aliquot of the supernatant solution
was transferred from each vial by microlitre pipette to a polystyrene
tube and counted in a gamma scintillation counter,,
Calculation of results
The T3 uptake value of the standard reference serum was known.
The T3 uptake value for each unknown serum was calculated by the
following formula and expressed in terms of the reference standard:
T3 uptake value Countrate of unknown serum ^ T3 uptake value of
of unknown serum Countrate of standard serum standard serum
The normal range for this kit is 32 - 117,
Free thyroxine index (FT!) was calculated from plasma total TA
concentration and T3-uptake value as follows:
Tk
FT I = X 100
T3 uptake
The normal range using T4 RIA (PEG) kit and Thypac~3 kit is 70 - 180,
ASSAYS FOR OTHER HORMONES
(i) G1ucagon
Plasma immunoreactive glucagon was measured by radioimmunoassay
with a pancreatic glucagon specific (C-terminal reacting) antiserum
(Bloom 197^)» These measurements were kindly carried out by
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Dr. S.R. Bloom in the Department of Endocrinology, Royal Postgraduate
Medical School, Hammersmith Hospital, London,
(ii) Sex Hormones
Plasma testosterone was measured by radioimmunoassay after
extraction. An antibody raised by immunisation with a 3-oxime
derivative of testosterone conjugated with serum albumin was used
(Green et a 1., 1977)°
Plasma luteinizing hormone (LH) , follicular stimulating hormone
(FSH) and prolactin (PRL) were measured by specific double antibody
radioimmunoassays, using MRC standards 68/40 for LH and 69/104
for FSH (Mortimer et al,, 1973), and 71/222 for PRL (McNeilly
et al,, 1973)<> These assays were kindly undertaken by Dr. L. Rees,
Department of Endocrinology, St, Bartholomew's Hospital, London.
(iii) Somatomedin
Serum somatomedin activity was estimated by a bioassay using
11 day old embryonic chick pelvic cartilage and radiolabelled sodium
sulphate (S-35) as an index of sulphate incorporation. The method
used was essentially that described by Hall (1970), Four cartilage
leaflets were used for each of five serum dilutions (1, 2.5, 5,
7o5, 10% v/v) and observations were made in duplicate, giving
8 cartilages for each serum concentration. In each experiment,
pooled serum from healthy men, with assigned somatomedin activity
of 1,0 units/ml, was used as a reference standard. Radioactivity
was expressed per mg dry weight of the cartilage. Liquid
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scintillation spectrometry was used to count the radioactivity,
Serum somatomedin potency relative to reference serum and tests
for parallelism and significant regression were computed using
methods described by Finney (1964)0 The assay was kindly carried
out by T, Leaky, The Academic Centre, The London Hospital, London,
Statistical analyses were performed by E, Steven, Computer
Centre, The London Hospital, London,
PLASMA AMINO ACIDS
Amino acids were measured by ion-exchange chromatography on an
automatic amino acid analyser (LKB 3201), A three sodium buffer
step system was used with a constant operating temperature of 60°C,
These measurements were undertaken by my research colleauge, Dr,
R, Counahan, Department of Paediatrics, Guy's Hospital, London,
The coefficients of variation of replicate analyses of amino acid
standard solutions at the beginning and end of the project and of plasma
are shown in Tab 1e I,
PLASMA PROTEINS
(i) Albumin: - by autoanalyser (Technicon, bromocresol dye-binding
method),
(ii) Transferrin: - by single radial immunodiffusion (Hyland plate).
(iii) Complement protein C3: - by radial immunodiffusion into agar
plate containing monospecific antiserum against C3° The results
were expressed as a percentage of reference standard serum










Va1ine ooo 2.3 2.6
Leucine 2.6 1.0 1.5
1 soleucine 2o8 3.9 1.6
Methionine 2 o 1 2,6 -
Phenylalanine 5.5 2,7 0.9
Lysine 2.9 2.7 7.0
His tidine 3.0 7.8 4.5
Glycine 3.5 2.8 5.8
A1anine 3.7 2.8 1.1
Tyrosine 1.2 2.7 4.2
Table I: Coefficients of variation (100 x
standard deviation of mean/mean)
of replicate analysis of amino
acid standard solutions at beginning
and end of project and of plasma.
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PLASMALIPI PS
Plasma triglycerides were measured by a semi automated
fluorimetric method (Levine and Zak, 1964), plasma non-esterified
fat acids (NEFA) by a semi automated fl uori metri c. method (Carruthers
and Young, 1973)» serum glycerol by enzymatic method (Eggstein
and Krautes, 1966 )« Lipoprotein electrophoresis was performed
on agarose gel (Noble, 1968), These measurements were performed
by the Unit for Human Metabolism, Guy's Hospital, London,
METHODS OF OTHER BIOCHEMICAL MEASUREMENTS
Plasma urea: - by autoanalyser (Technicon, diacetylmonoxide
reaction),
Plasma Creatinine: - by autoanalyser (Technicon, method lib,
Jaffe reaction).
Blood glucose: - by autoanalyser (Technicon, Ferricyanide method).
Plasma calcium: - by autoanalyser (Technicon, cresolphthalin
complexone method).
Plasma phosphate: - by autoanalyser (Technicon, phosphomolybdic
acid method).
Plasma bicarbonate: - by autoanalyser (Technicon,
phenolphthalein indicator method).
Plasma alkaline phosphatase: - by autoanalyser (Technicon,
Phenyl sodium phosphate hydrolysis
-pheno1 - method),
These measurements were performed by the Department of Clinical
Chemistry, Guy's Hospital, London,
PART III
STUDIES ON CHILDREN WITH
CHRONIC RENAL FAILURE
TREATED BY REGULAR HAEMODIALYS I S
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CHAPTER 7
PROSPECTIVE OBSERVATIONS ON GROWTH, HORMONAL CHANGES AND
NUTRITIONAL AND METABOLIC STATUS IN CHILDREN ON HAEMODIALYS1S■
STUDY I
This study was designed to monitor longitudinally, growth and
nutrition as well as a series of growth-regulating hormones, measure¬
ments of carbohydrate, lipid and protein metabolism, and other
biochemical and haematological parameters in a group of children with
end stage renal failure treated by regular haemodialysis in order
(a) to establish to what extent the metabolic and hormonal
disturbances reported in uraemic adults are manifested in children
(b) to determine interrelationships that might exist amongst the
nutritional, metabolic and hormonal parameters measured, and
(c) to attempt to identify the influence of various nutritional,
endocrine and metabolic factors upon growth velocity during the
period of observation.
Patients
Sixteen children, nine boys and seven girls aged between 11-17
years who had been on regular haemodia 1ysis in the home for more than
six months (seven months to six and one-naif years) were the subjects
of this study. The primary renal disease and clinical data of the
patients at the beginning of the study are shown in Table I. None
had the nephrotic syndrome, clinical or biochemical evidence of
diabetes mellitus or any other systemic disease apart from
cystinosis in two children.
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Dialysis information
All patients dialyse at home for ten hours overnight on
three nights of each week, thirteen using Meltec multipoint dialysers,
two using Watson-Mar low Kii1 type dialysers and one-using a Travenol
Ultra-Flo dialyser. The surface area of the kidney was varied
according to the child's weight and each dialyser was rebuilt once
a week. The dialysates had a glucose concentration of 200 mg/dl
and calcium concentration of 2.7 meq/1. Access to the circulation
was gained using external Si1icone-PTFE Scribner shunts in four
patients and subcutaneous arterio-venous fistulae in the remainder.
The amount of dialysis received per week was expressed as a product
of the dialyser surface area and the total of dialysis hours per
2
week. This was expressed for each child as m /hours/kg. body
weight, using the child's mean post-dialysis weight during one
month at the middle of the assessment period.
D i et
Free diets were allowed with only sodium and potassium
restriction where necessary. Fluid intake was limited to approximately
300 - 500 ml per day. Each child also took a variable amount of a
highly concentrated energy supplement. This consisted of a milk
shake containing egg, double cream {k cal/ml), milk and a glucose
polymer (caloreen, Milner Scientific and Medical Research Co.,
Liverpool) with an average length of five glucose units which contains
17 kj/g. All of the children took iron, folic acid and vitamin B
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2 M 15.5 12.0 Focal glomerulo-
sclerosis







Fistula 0.77 0.52 1.0
4 M 15.0 14.0 Chronic
glomerulo-
nephritis
Fistula 0.77 0.54 1.5
i
5 M 11.8 11.5 Focal glomerulo-
sclerosis
Fistula 0.77 0.77 1.0
6 F 12.3 11.5 Juvenile nephro-
nopththisis
Fistula 0.77 0.76 2.5
7 M 11 .0 • Ref1ux
nephropathy
Shunt 0.6 0.67 5.5
■
8 M 14.1 10 Obstructive
uropathy
Shunt 0.75 0.46 1.5
9 F 12.3 8.5 Ref1ux
nephropathy
Shunt 0.6 0.80 3.0
. 10 M 14.1 10 Ch ronic
glomerulo-
nephritis
Fistula 0.77 0-71 6.5
11 M 15.1 12.5 Single
dysplastic
kidney
Fistula 0.77 0.58 1.5 , i





13 M 14.0 10.5 Cystinosis Fi stu 1 a 0.77 0.76 1.0
14 M 11.7 10.5 | Cystinosis Fistula 0.77 0.73 2.0
15 F 14.9 14.5 Juvenile nephro-
nophthis is
Shunt 0.77 0.45 0.75
16 F 13.6 8 Focal glomerulo-
sclerosis
Fistula 0.77 0.59 . 3.0
TABLE 1. Clinical data of the patients.
141
Study protocol
Patients were included in the study after successful
establishment of regular haemodialysis for a period of not less
than six months, and each patient was observed for a period of one
year.
All patients were studied at two monthly intervals as outpatients
on a predialysis day approximately 30 - 36 hours postdialysis and
after an overnight fast for more than twelve hours. Anthropometric
measurements were taken at each visit; bone maturation and the degree
of osteodystrophy determined at the start, middle and end of period
of observation. Evaluation of puberty status was undertaken at
the beginning and end of the year of study. In addition, the mean
post-dialysis body weight during one month at the start, middle and
end of the period was calculated.
Fasting venous blood samples were taken at each visit for the
estimations of: urea, creatinine, bicarbonate, potassiurn,calcium,
phosphate, alkaline phosphatase, albumin, haematocrit and
haemoglobin. The means of the values thus obtained throughout the
study were taken for further analysis. On three occasions, corresponding
with the start, middle and end of the period of observation, fasting
venous blood samples were taken while the patients were resting and
in stable state for simultaneous measurements of the following
hormones and metabolic parameters:
(I) Hormones: growth hormone (GH) , insulin (IRI), Cortisol,
thyroxin (TA), triiodothyronine (T3) , thyrotrophin (TSH) and T3
Resin Uptake. As puberty rating was performed at the beginning and
end of the study, plasma sex hormones - testosterone, luteinizing
hormone (LH) , follicular stimulating hormone (FSH) and prolactin
(PRL) concentrations were determined on these two occasions only
and assessed in relation to puberty status. Serum somatomedin
activity (SM) was measured once at the middle of the period.
Thyroid function was further assessed by the evaluation of the
integrity of the hypotha1 amic-pituitary axis by administering
thyrotrophin releasing hormone (TRH) to six patients: each received
200 ^ig of synthetic TRH intravenously with venous blood taken for
TSH estimations prior to administration and at 20 and 60 minutes.
The values obtained were compared to the responses of seven normal
children being investigated for short stature for which no
organic cause was ultimately found.
Luteinizing-Hormone-Releasing Hormone (LH-RH) Stimulation Test:-
The hypothalamic-pituitary-testicular function was further
assessed in five boys - three prepubertal, one in early puberty and
one pubertal - by the determination of the gonadotrophin response
to LH-RH stimulation. 100 pg synthetic LH-RH (Hoechst) was
administered intravenously. Blood samples were collected prior to
the injection and 20 and 60 minutes thereafter for LH and FSH
estimations. Values were compared to age-matched control group
of six boys being investigated for short stature which ultimately
proved to be familial.
The Circadian rhythm of Cortisol secretion was evaluated in
fifteen patients by the determination of early morning and late evenin
plasma Cortisol levels. The blood samples for hormone analysis were
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separated immediately and plasma or serum stored at -20°C
unt i 1 assayed.
(I I) Metabolic Parameters:
Plasma amino acids, transferrin, triglycerides (TG), cholesterol
(CHOL) , nonesterified fatty acids (NEFA), serum glycerol, whole blood
glucose ( G) and plasma lipoprotein electrophoresis were determined.
Aliquots of plasma for amino acids were promptly deproteinized with ]%
picric acid, to which norleucine had been added as an internal standard
and stored at -20°C prior to analysis. Plasma samples for TG, CHOL,
NEFA and lipoprotein electrophoresis were kept at A°C and analytical
procedures carried out within 48 hours. Blood glucose concentrations
were measured on the same day. Aliquots of serum for glycerol
estimations were stored at -20°C until assayed.
Nutrient intakes were assessed monthly and for the purpose of
this study both the mean of the intakes over the whole period of study
and intakes recorded within two weeks of blood sampling at the middle
of the period were used for statistical analysis.
The means of the various hormones and metabolic indices were measured
in each patient over the year and, as growth performance was assessed
in relation to bone age determined at the middle of the period of
observation, the values obtained at that time were both used for
the








Post-Dialysis Weight + + +
Skeletal Maturation + + +
Puberty Rating + +
Nutrient Intakes <
Bone Disease + + +
Hormone Assays :
Growth Hormone + + +
Insulin + + +
Cortiso 1 + + +
Thy roxine + +
Triiodothyronine + + +
T^ Uptake + + +
Thyrotrophin +




LH - RH Stimulation Test +
Prolactin + + +
Somatomedin +
Metabolic Measurements:
T riglycerides + + +
Cholesterol + + +
Fatty Acids + + +
Glycerol + + +
Lipoprotein Electrophoresis +
Biood Glucose + + +
Amino Acids + + +
T ransferrin + + +
c, +3
Routine Biochemistry and Haematology Vv.
TABLE 2. Summary of Study Protocol.
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CONTROLS
Eighteen healthy British children aged 12.3 ~ 1-9 (1 S.D.) years
with normal renal functions were tested as controls. Their clinical
data is presented in Table 3. All were asymptomatic and on an
adequate diet prior to blood sampling but nutrient intakes were not
formally assessed. Nine were being investigated for short stature
for which no organic or socio-economic cause was ultimately found;
eight were fully recovered from minor surgery and tested shortly
before discharge from hospital; one was a laboratory technician.
Fasting plasma amino acids were also measured in a further
thirteen healthy children undergoing dental treatment in hospital,
and plasma amino acid comparisons were, therefore, made with a total
combined control group of 31 children.
Laboratory normal values for plasma sex hormone levels
obtained from a large population of boys and girls in various






















Sex Age Weight He i ght
(yrs) (kg) (cm)
F 10 28.5 124
M 10.5 25.8 123
M 12 28 127
M 14 30.5 138
F 13 22 136
F 12.5 27.5 134
M 14.6 40.5 142
M 12 28.5 132.6
M 14 35.5 150
M 10 30.4 140
M 11.4 38.5 148
F 11.5 35.4 146.8
F 10.1 31 146
M 12.4 31.5 141
M 10.2 29.5 136
F 17 51 156.5
M 13.5 41 153











TABLE 3. Clinical data of control subjects.
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RESULTS
Clinical data of the patients and dialysis information are
shown in Table 1. Table k depicts the mean (- 1 S.D.) of the
predialysis plasma urea, creatinine,potassiurn, bicarbonate, calcium,
phosphate and alkaline phosphatase concentrations for each patient
during the year of study. Mean haemoglobin, packed cell volume and
diastolic blood pressure measurements are also shown.
Haematological and biochemical parameters measured in samples
obtained at the middle of the period with simultaneous measurements
or other metabolic and hormonal variables are presented in Table 5.
It is apparent from Table 4 that all patients maintained
moderately raised plasma urea concentrations and relatively high plasma
creatinine levels. Plasma calcium concentration was slightly increased
in most of the patients while plasma phosphate concentration was
predominantly within normal range with the exception of patients No.
3, 5, 8 and 11 who had moderately elevated levels. Plasma alkaline
phosphatase was variably increased in 12 of the 16 patients. Plasma
potassium concentration was within normal limits except in patient
No. 11 in whom it was increased. There was no evidence of metabolic
acidosis as judged by the plasma total bicarbonate concentration
(<20 mmol/1) except perhaps in patients No. 7, 8 and 11 in mid-period
sampling (Table 5)•
Anaemia was present in all patients but hypertension was not
encountered during the period of the study.
Table 6 shows the correlation coefficients obtained between




HAEMOGLOBIN PCV UREA CREATININE POTASSIUM BI CARBONATE CALCIUM PHOSPHATE PHOSPHATASE BP
g/dl mmol/1 umol/I mmol/1 mmol/1 mmo 1/1 mmo 1 /I u/i mm Hg
(S.D.) (S.D.) (S.D.) (S.D.) (S.D.) (S.D.) (S.D.) (S.D.) (S.D.) (S.D.)




1 6.1 19.1 12.7 595.5 A.3 23.5 2.63 1.36 1AA 72
(0.2A) (0.78) (1.8) (52.2) (0.32) (2.1) (0.05) (0.16) (50.8) (10.9)
2 7.A 22.2 12.3 612.6 A.7 25.6 2.8A 1.08 90.8 82.5
(0.6) (0.6) (2.7) (67.9) (0.5) (1.3) (0.1) (0.29) (22.1) ( 9.5)
3 8.A 25.A 21.8 668.8 A.3 21.6 2.7 1.77 2 A 3 - 7 70
(1.7) (5.A) (A.5) (158.2) (0.5) (1.7) (0.25) (0.36) (106.8) (16.3)
A 8.1 23.6 ' 16.3 765.7 A.9 23 2.73 1.26 1A9.9 70.7
(1.2) (3.6) (3-9) (1AA. 2) (0.A) (1.6) (0.16) (0.12) (AO.5) (15.A)
5 6.6 19. A 21.2 59A 3.9 23.6 2.7 1.78 56.8 86.6
(1.4) (3.7) (7) (1A0.2) (0.A7) (2.1) (0.36) (0.9A) (16.8) ( 9.8)
6 7.A 21.7 10.5 539. A 3.A 2A. T 2.61 1.06 180.5 77.5
(1.2) (3.6) (3.5) (153.7) (0.6) (A.6) (0.05) (0.35) (63) ( 9.5)
7 6.07 17.A 8.7 395.5 A.27 25.5 2.7 A 1.02 209.A 78.7
(0.A2) (2. A) (8.9) (3.6) (1.2) (A.3) (0.08) (0.AA) (68.2) (10.3) j
8 6.9 20.9 17.5 636.A A.9 19.9 2.A6 1.77 8A5.3 65
(0.A) (1.8) (5.1) (35.1) (0.38) (A.5) (0.07) (0.22) (322.5) (5.7)
9 5.6 17 10.3 A69 3.3 2A.8 2.58 1.19 12A.2 78
(0. A) (0.7) (1.9) (50.7) (0.3) (1.7) (0.07) (0.35) '(17.8) (8.3)
10 6.8 20.6 10.8 522.5 A.5 2A.6 2.73 1.22 369.2 65.8
(0.8) (2.6) (A.3) (113) (1.3) (3.9) (0.08) (0.97) (97.5) (1A.9)
11 5.9 18.3 21 .OA 670 5.7 21 2.62 2.07 86.2 87.8
(l.A) (A.A) (6.2) (165) (0.9) (2.7) (0.1) (0.6A) (62.8) (20.7)
12 6.1 17.6 1 A. 3 688.2 3.8 25 2.68 1.28 90.8 76.6
(0-54) (0.98) (7.1) (1A8) (1.5) (3.1) (0.09) (0.26) (12.7) (7.6)
13 6.9 20.6 12.2 A78 A.56 2A. 3 2.7 1.26 203 .5 83.3
(0.33) (0.98) (3.7) (166.9) (0.26) (2.A) (0.05) (0-55) (76.2) (13.6)
1A 5.95 17.3 10.5 5A6.8 3.6 27.7 2.9 1.26 116.3 66.A
(0.2) (0.95) (A.6) (78.8) (0.5) (3.0) (0.1) (0.32) (AA.2) (12)
15 6.01 17.8 17.5 688 A.3 21.1 2.76 0.78 23.3 75
(0.66) (1.7) (7.6) (1A7) (0.7A) (2.7) (0.15) (0.09) (281) (9-1)
16 6.1 18.3 12.06 575.2 3.75 25.6 2.61 0.92 20A.6 86.3
(0.85) (2.6) (A.9) (79.7) (0.25) (1.9) (0.07) (0.17) (60.2) (13.7)
TABLE k. Mean (- 1 S.D.) pre-dialysis biochemical and naematologica1
data of the patients during the year of study.






















































































































































































































TABLE 6: Correlation coefficients (r) obtained between
amount and duration of dialysis and mean
biochemical data.
data during the year of study. The degree of significance, if any,
is indicated. Significant negative correlations were found between
dialysis and plasma urea, creatinine and potassium concentrations, and
significant positive correlation was present between the amount of




Tables 7 and 8 show the mean intakes of total energy, protein, fat
and carbohydrates for each of the patients, expressed both in absolute
amounts and as percentage of the recommended intake (Rl) for normal
children of the same height age (DHSS, 1969) .
The mean intakes for each patient over the year of study (Table 7)
as well as the intakes recorded within two weeks of the blood sampling at
the middle of the period (Table 8) are presented. Both methods of assess¬
ment showed considerable variation in intake from patient to patient, but
relative to body size, of which height age is an approximation, intakes
of the majority of the patients were normal. Only two (numbers 8 and
10) had intakes of total energy less than 80% Rl and three (numbers
8, 10 and 14) had protein intake less than 80% Rl. There were no dietary
records available within two weeks of mid-period sampling for patient
number 6 but her mean intakes during the year of study showed an intake
of 101.4% Rl for total energy and 37% Rl for protein.
(ii) Biochemical indices of nutritional state
The mean (- 1 S.D.) plasma transferrin and albumin concentrations
determined at the start, middle and end of period of study and the plasma
C3 concentrationsmeasured at the middle of the period are shown in
Table 3 and compared to values obtained for normal controls. Individual
data for patients are recorded in Table 1 in appendix (A). Because
comparison between the three sets of data within the group of patients by
means of paired 't1 test (Table 10) revealed no significant differences,























































































































































TABLE 7. Mean (* 1 S.D.) dietary intakes of the patients
during the year of study.




ENERGY PROTEIN CARBOHYDRATE FAT
K Joules/
Day
% RI g/Day % Rl g/Day % Rl g/Day % Rl
1 9520 99 60 103 303 • 101 97 114
2 11698 112 79 125 CMra 101 135 145
3 12127 126 132 228 244 82 156 184
4 12001 102 66 88 265 80 173 166
5 10983 105 77 122 246 102 150 161
6 - - - - - - -
7 14102 134 84 133 378 109 171 184
8 6415 61 46 73 133 56 71 76
9 10964 125 56 106 321 118 128 162
10 4886 47 46 73 136 42 51 55
11 18684 159 128 70 KjJ CO CD 107 268 258
12 15911 181 118 183 396 132 198 251
13 9175 104 55 104 237 87 116 147
14 8010 91 18 34 302 111 76 96
15 10306 107 68 117 297 109 116 136
16 12493 130 64 110 389 130 215 253
TABLE 8. Dietary intakes of the patients







































TABLE9.Mean(-1S.D.)plasmaa bu in,transferrinndconcentrations inpatientsandcontrols.S-star ;M-midd e;E-eofper od ofstudy.RNS-Referencen rmals m.SD-standardeviatio .
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TABLE 10
S vs M S vs E H vs E









TABLE 10: Significance of variation in plasma albumin
and transferrin concentrations determined at
the start (S) , middle (M) and end (E) of
period of study (paired't1 test).
NS « not significant.
well as the mean values over the year of study for further analysis.
The mean and range of plasma transferrin levels in the controls were
similar to that reported in the literature when the plasma transferrin
level was measured by the radial immunodiffusion method (Wardle et al.,
1975*)- Although there were considerable interpatient variations in
plasma transferrin concentration, the mean value in the patients as a group
was not significantly different from mean control value. Only one patient
(number 9) had a level 2 S.D. below the normal mean. Plasma albumin
concentration and protein complement C3 levels were also not significantly
different from those of healthy subjects. in individual patients no
significant relationships were found between transferrin, albumin and
C3, and there was no relation between these plasma proteins and dietary
intakes of either total energy or protein. The relationship between the
nutritional markers albumin, transferrin and C3 and other variables









































TABLE11.Mean(-1SD)PlasmaInsuli ,GrowthHormoneandCorti o concentrationsipatientsa dcon rols. S-start;M-middle;E-enofperiostudy. SD-tandardDeviation.
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METABOLIC HORMONES (insulin, growth hormone and Cortisol).
Table 11 shows the patients mean values (- 1 S.D.) of plasma
insulin, growth hormone and Cortisol levels as determined at the start,
middle and end of the year of study and compared to normal values obtained
from healthy subjects. Statistical analysis by paired 't' test
(Table 12) revealed no significant changes in the metabolic hormone
concentrations during the period of observation in the patients as a group.
Individual data for patients are presented in Table 2 of appendix (A).
TABLE 12
S vs M S vs E M vs E
t P t P t P
Insulin -0.618 NS +1.07 NS +1.92 <0.1
Growth +0.371 NS -1.158 NS -1.48 NS
Hormone
Cortisol + 1.824 <0.1 +1.463 NS +0.256 NS
TABLE 12: Significance of variation in plasma
insulin, growth hormone and Cortisol
levels determined at the start (S),
middle (M) and end (E) of period of
study (paired 1t' test).
NS = not significant.
Mean plasma insulin levels were significantly higher than normal
controls at the first and second sampling and, although they tended to
decrease at the end of period of observation, the levels remained significantly
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elevated (Table 11). Plasma growth hormone concentrations were
significantly raised in patients compared with controls (Table 11)
a
throughout the year with/further increase at the end of the period
coinciding with a decrease in plasma insulin. Individual plasma Cortisol
levels were within the upper range of normal throughout the year,
nevertheless the mean concentration at the start of study was significantly
raised compared with controls (Table 11) and the average value over the
year was significantly increased (Figure 1). Plasma Cortisol levels tended
to decrease at the end of the period as compared with the initial
concentration, but the difference was not statistically significant.
Because of the insignificant changes in the pattern of the three hormones,
the values obtained at the centre of the period of study and the means
of the three samples were considered to represent the basal values and
were used as appropriate for further analysis.
(1) Insulin (IRI)
Mean basal plasma immunoreactive insulin was 20.7 ~ 8.7 mu/1 as
determined at the middle of the period and 18.5 - 5.3 mu/1 when three
samples for a given patient were averaged. These values were
significantly higher than the normal mean of 8.4 - 5.2 mu/1 (p "C 0.001
and p< 0.001 respectively), and do not differ from each other significantly.
The average values did not relate to the mean plasma concentration of
either urea or creatinine, although in dialysed patients these parameters
do not reflect accurately the degree of uraemia. The efficiency of
dialysis is difficult to assess, however, the duration of dialysis and
the amount of dialysis calculated for each subject, as described in
methods, had no apparent influence on plasma insulin concentration.
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Relationship between insulin and other metabolic hormones
There was no correlation between plasma insulin and the
simultaneously measured plasma growth hormone or Cortisol concentrations.
Reports in the literature (Kim et al., 1969) indicated that
parathormone (PTH) enhances insulin secretion and that hyperparathyroidism
in patients with chronic renal failure on chronic haemodialysis is
associated with increased insulin response to glycaemic stimuli
(Lindall et al., 1971). The role of PTH could be related to its well
known role in controlli ng serum calcium as insulin secretion is highly
dependant on calcium ion in the Islets of Langerhan. Unfortunately
plasma PTH concentration was not measured in the patients of the
present study, but comparison of the plasma insulin levels in patients
with signs of secondary hyperparathyroidism, as judged by X-rays, showed
no significant difference. Furthermore, no significant correlation
between plasma insulin and calcium concentration could be demonstrated.
Plasma Insulin and Diet
Plasma insulin concentrations did not relate to dietary intakes
of total energy, carbohydrate, fat and protein recorded closest to the
time of blood sampling and expressed as percentage of recommended intake
for height age.
Plasma Insulin and Nutritional Status
Plasma concentrations of transferrin, albumin and protein complement
C3, measured simultaneously, as indices of nutritional status,
bore no significant relationship to the plasma insulin concentration.
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The relationship between plasma insulin and plasma amino acids
and other metabolic variables will be discussed below.
(2) Plasma Growth Hormone (GH)
/+ \
The mean (- 1 S.D.) basal plasma GH concentration in the control
group was 6.6 - 3-2. Nine of the sixteen patients (56.3%) had basal
plasma GH levels more than 2 S.D. above this value (Tab 1 e 2 .Append ix A). The
mean basal GH concentrations in the patients, determined at the middle of
the period as well as the average over the year of study, were
significantly higher than normal (p < 0.01 and p < 0.001 respectively)
(Table 11). Plasma growth hormone concentrations did not correlate
with the duration of dialysis, the amount of dialysis or
plasma urea or creatinine concentrations. Nor was there any relation¬
ship between plasma GH and plasma insulin or Cortisol concentrations.
Plasma GH and Nutrition
No significant correlation was seen between basal GH levels and
either total energy, protein, carbohydrate or fat intakes recorded within
two weeks of sampling. Similarly, GH did not correlate with the indices
of protein status; plasma albumin, transferrin and C3-
(3) Plasma Cortisol
Figure 1 shows the morning plasma Cortisol levels in the patients
and controls. Although the Cortisol concentrations in the patients
were within the reported normal range for children (Barnes et al ., 1972),
4" 4*
the mean - 1 S.D. was 435-1 ~ 109 nmol/1 for the patients and 355-3







t = 2. 8
p<0. 01
Controls Patients
1. Plasma Cortisol concentration
in patients and controls.
Horizontal lines represent the
mean + 1 SD.
Fig. 2. Morning and evening plasma Cortisol
levels in patients.
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significant (t =. 2.043, p < 0.05). Figure 2 shows in fifteen of
the sixteen patients a well marked diurnal variation of plasma Cortisol
suggesting an intact hypotha1 amic-pituitary-adrenal axis.
There was a tendency towards higher Cortisol levels when basal
insulin concentrations were elevated. Those patients with plasma
insulin levels exceeding 20 mu/1 (> 2 S.D. above the mean for controls)
had significantly (p< 0.02) higher plasma Cortisol concentrations
(Figure 3). There was no demonstrable relationship between plasma
Cortisol levels and GH concentrations, the nutritional status of the
patients, the amount of dialysis or thadegree of uraemia as assessed
by plasma urea and creatinine concentrations.
Serum Somatomedin (SM)
Results for the patients1 serum somatomedin activity are shown
in Table 13. In view of the possible increase in inorganic sulphate
concentration in uraemic sera which may interfere with the bioassay
giving falsely low serum somatomedin activity (Phillips et a]., 1978)
and because no allowance for increased sulphate concentration in
the patients of the present study was made, the results were not
compared to values obtained from normal controls.
Assuming that sulphate inhibition was the same in all the patients,
correlations were tested between serum somatomedin activity and plasma
growth hormone, albumin, transferrin and C3 concentrations, and
between serum SM and dietary intake of energy and protein. A
significant correlation was found only between SM and plasma transferrin
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Fig.3 Relationship between plasma
Cortisol and insulin levels.
Values are the means with
their standard errors.
Fig. 4. Relationship between plasma transferrin
























TABLE 13: Serum somatomedin activity
i n the pat i en ts .
Thyroid Function Tests
All the patients were clinically euthyroid by physical examination
and none had either exophthalmos or a goitre at the time of study.
Table 14 shows the mean values (- 1 S.D.) of plasma thyroxine (T^),
triiodothyronine (T^) , thyrotrophin (TSH), T^ resin uptake (T^RU) and free
thyroxine index (FTI) levels as determined at the start, middle and end
of period of study. The differences in the three measurements were not
statistically significant (paired t-test). Individual patients data


















































TABLE14:Mean(-S.D.)plasmathyroidhormonelevel inthepatientsdetermin datst rt(S), middle(M)aneE)ofp riofstudy. excludingthetwocystin ticpati ts.
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The range and mean plasma values for T^, T^, TSH, T^RU and FTI
in patients, measured in mid-period sampling, and in controls are
shown in Table 15.
All patients had plasma T^ concentrations within normal range for
the assay; however, five patients (numbers 1, 3, 10, 15, 16) were below
the mean-1 S.D. of the control group and the mean plasma T^ in the patients
as a group was significantly lower than in the normal controls (Table 15).
None of the five patients with plasma T^ concentrations at the lower end
of normal had abnormal FTI.
Although in the majority of patients T^ levels were within the
normal range for the assay,with the exception of patient number 11 whose
T^ was below the lower limit of normal, seven (numbers 1, 2, 5, 8, 9,
11, 12) had levels below the mean - 1 S.D. for the controls and the mean
plasma T^ concentrations were significantly lower in the patients than
in the controls (Table 15). Thirteen of the sixteen patients had TSH
levels below the upper limit of normal for the assay. One patient
(number 7) had slightly increased TSH and two patients (numbers 13, 1^),
who were both cystinotic, had a considerably elevated plasma TSH
concentration. Excluding these two patients the mean plasma TSH
concentration was similar in patients and controls (Table 15). The two
patients with cystinosis and elevated plasma TSH had normal plasma
values for T^ and T^. None of the patients who had low normal T^
or T^ had elevated plasma TSH.
Plasma T^RU and FTI were within normal range. In comparison to
controls, mean T^RU was not statistically different but mean FTI was
















































TABLE15:Thyroidfuncti ntestsipatient(m d-p r odsampling)com ared tocontrols.Valuesrmean-1SD.Thabsol tr ngisal included. "Thesignificanceofthediffere cebe w enpatientsandcon rols wastestedbystud ntt-t st. ""Excludingthewocystinotichildren.
Q 20 60
Time (min)
Fl G. 5 TSH response to TRH stimulation in 6 of the patients.
Open circles represent the two boys with cystinosis.
Shaded area indicates the normal range.
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Analysis of thyroid hormone in relation to the other metabolic
hormones, duration and amount of dialysis, plasma urea and creatinine
concentrations and nutritional status of the patients as indicated by
food intake, plasma albumin, transferrin and C3 concentrations
revealed no significant relationships.
TRH ~ Stimulation Test
After TRH injection, plasma TSH concentration rose rapidly in
the seven normal children reaching a peak by 20 minutes. Of the six
patients tested, the two patients who had cystinosis (numbers 13, 1*0
showed an excessive TSH response and the other four patients had blunted
increases in plasma TSH with delayed peak in two of them, (Figure 5).
The basal TSH level was markedly elevated in the two cystinotic patients
and within normal range for both the control group and the non-
cystinotic patients.
SEX HORMONES
LH, FSH and testosterone
*
At the time of sampling, the patients were assigned to puberty
stages (P 1 - prepubertal; P 1-5 = pubertal) as described in methods.
Estimations of plasma LH, FSH and testosterone levels determined at the
start and end of the period of study were pooled according to sex and
puberty status and compared to a range of reference values obtained
from normal children of the same sex and stage of sexual development
(Figure 6). Plasma LH was elevated in both prepubertal and pubertal
boys, while plasma FSH was within normal range in the prepubertal boys and




























































































FIG.6 Plasma sex hormone levels in Prepubertal (Pre.) and
Pubertal (Pub.) boys and girls determined at the start
and end of period of growth observation. Stippled
areas represent the normal ranges. PRL = Prolactin.
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Plasma testosterone levels were normal in the prepubertal boys and
decreased in five of the eight estimates (60.2%) in the pubertal boys.
In the girls, plasma LH was elevated in the prepubertal and in most
of the pubertal girls, while normal plasma FSH levels were found in
both groups; plasma testosterone concentration was within normal
range in the prepubertal and variable in the pubertal girls, with
increases in five and subnormal levels in two of the ten estimates.
There was a significant positive correlation between plasma LH and
testosterone levels in the boys (r - 0.79^, p <0.001) but not in the
girls (r - 0.161, p> 0.05). Similarly, plasma FSH correlated
significantly with plasma testosterone in the boys (r = 0.886, p<0,00l)
and not in the girls (r = 0.365, p > 0.05). In the girls, mean plasma
LH and FSH levels over the period of study correlated positively with mid-
period chronological age (r - 0.706, p< 0.05; r = 0.632, p> 0.05
respectively). Higher correlation coefficients were obtained when
plasma LH and FSH levels were related to mid-period bone age (r =• 0.809,
and r = 0.895 respectively). Although plasma gonadotrophin tended to
increase with age in the boys, the relationship was not statistically
significant (r - 0.38, p> 0.05). Correlations between sex hormone
levels and growth are presented below in the section entitled
"Hormones and growth".
PROLACTIN
Thorner et al. (1977) have shown that in normal boys there was no
significant difference in plasma prolactin levels at any stage of
pubertal development. Thus, plasma prolactin estimates were grouped
according to puberty status in the girls but not in the boys. These
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are shown in Figure 6. Raised levels were found in nine of the seventeen
estimates in the boys (53%) and in three of ten estimates in the
pubertal girls. In the prepubertal girls, plasma prolactin levels were
normal. The elevated levels were not manifested by- ga1 actorrhoea in
any of the patients.
LH/FSH - RH Stimulation Test
The individual gonadotrophin responses to the intravenous
injection of 100 ug of synthetic luteinizing hormone releasing hormone
in four prepubertal or early pubertal boys (Stage 1 - 2) are shown in
Table 16 and compared to mean responses in six normal boys of comparable
age and sexual development. The results in a male patient in advanced
puberty (Stage 4) are also shown. The mean basal LH level was
significantly elevated in the patients compared to controls (p < 0.001).
Mean plasma LH level at 20 minutes following LH-RH injection was similar
in patients and controls. However, the mean rise above basal level
was greater in the control group than in the patients (8.1 - 7.2 u/1 and
4.4 - 2.64 u/1 respectively) but the difference was not statistically
significant. Mean LH level and increment at 60 minutes were
significantly higher in the patients compared to controls (p < 0.02;
p0.05 respectively). The patient in advanced puberty (number 10)
showed augmented LH responses at 20 and 60 minutes. In general, LH
responses to LH-RH were normal but delayed in the boys in pre- and
early puberty and excessive in the pubertal boy.
Mean basal plasma FSH level was significantly higher in the
patients compared to controls (p 0.001) but the mean response to































































































































































































































TABLE17:Mean(-S.D.)plasmatriglycerides(TG), cholesterol(CHOL),non-esterifiedfat yacids(NEFA), serumglycerolandblooglucose(BG)concentrations inpatientsandcon rols. S=start;HmiddleEenofper ostudy.
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group. Patient number 10 had elevated basal FSH level but the response
was normal, though delayed for his puberty status.
BLOOD GLUCOSE (BG)
Mean - S.D. fasting blood glucose concentrations in the patients
measured at the start, middle and end of study are shown in Table 17.
Values in individual patients are presented in Table 4 of Appendix (A).
In comparison to control subjects, the three sets of basal blood glucose
levels in patients were significantly increased (Table 17). Paired
analysis of the data (Table 18) showed no significant difference between
the three sets of mean values. The middle of the period values were,
therefore, used, as appropriate, for further analysis.
TABLE 18
S vs M S vs E M vs E
t P t P t P
TG -1.5475 NS 0.8709 NS 3.4177 <0.01
CHOL -0.5679 NS 0.8537 NS 2.5961 <0.05
NEFA -2.1877 <0.07 -0.1734 NS 2.3276 <0.05
GLYCEROL 0.5831 NS -0.1803 NS 1.1042 NS
BG 0.3223 NS -0.948 NS -1.27 NS
TABLE 18: Significance of variation in plasma
• triglycerides (TG), cholesterol (CHOL) ,
non-esterified fatty acids (NEFA) and
serum glycerol and blood glucose (BG)
concentrations determined at start (S),
middle (M) and end (E) of period of
study (paired t-test).
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Blood Glucose and metabolic hormones
Table 19 shows the correlation coefficients between fasting blood
glucose and the simultaneously measured plasma insulin, growth hormone
and Cortisol levels. There was a positive correlation between blood
glucose and plasma Cortisol significant at 5% level and although there
was a tendency for patients with high blood glucose to have raised plasma
insulin levels, this linear relationship was not significant. Blood
glucose concentration did not relate to plasma growth hormone level.
TABLE 19
1 nsu1 in Growth hormone Cortisol
v p v p v p
TG +0.57 <0.02 -0.138 NS +0.161 NS
CHOL +0.038 NS -0.324 NS -0.397 NS
NEFA -0.198 NS +0.610 c0.02 -0.231 NS
GLYCEROL -0.212 NS +0.275 NS -0.288 NS
BG +0.306 NS -0.024 NS +0.556 <0.05
TABLE 19: Relationships between plasma insulin,
growth hormone and Cortisol levels and
plasma lipid and blood glucose
concentrations (mid-period samples).
TG - triglycerides; CHOL = cholesterol;
NEFA = non-esterified fatty acids;
BG = blood glucose.
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Blood glucose and haemodia 1ysis
Relationships^between basal blood glucose and the duration and
amount of dialysis, plasma urea and creatinine concentrations were tested.
No significant correlation between blood glucose and -these various
parameters was found.
Blood glucose and diet
the
Neither/intake of total energy, protein, carbohydrate and fat
(recorded nearest to sampling )at the middle of the period nor the average intake
over the year had any demonstrable influence on blood glucose levels.
PLASMA LIPIDS
Table 17 shows patients mean - S.D. plasma triglycerides (TG),
cholesterol (CHOL) and non-esterified fatty acids (NEFA) concentrations
and serum glycerol levels measured at the start, middle and end of the
period of observation and compared to mean values of the control group.
Individual patient's values are presented in Table 5 of Appendix (A).
There were consistent increases in both plasma TG and cholesterol
concentrations in patients compared with controls. The differences
were statistically significant (Table 17). No relationship was found
between plasma lipid levels and age or sex of the patients or their body
mass index (weight/height , Keys et al., 1972), or the duration or amount
of dialysis. No patient had detectable chylomicrons or a broad beta-
band on lipoprotein electrophoresis. Type IV hyper1ipoproteinaemia
was the predominant finding occurring in ten of the children. Four had
type II b and two had normal patterns, (Table 5 of Appendix (A) ). The
plasma NEFA levels were significantly decreased at the beginning and end
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of the study and although lower than controls in samples obtained at
middle of the period, the difference was not significant. However, the
mean of the 3 measurements was significantly lower than controls
(p / 0.05 ). In the 2nd and 3rd samplings, serum-glycerol
concentrations were significantly decreased in the patients compared
with controls (Table 17). and the mean of the 3 estimates was
significantly lower in the patients (t =■ 3-05, p< 0.005).
Plasma Lipid Changes
I£
When tested by 't1 test for paired variation (Table 18),the mid-period TG
concentrations were found to be significantly higher than end period
values (t = 3-^1 ; p < 0.01) and although increased in comparison to the
values obtained at the start of study, the difference was not
statistically significant.
Choles terol
The mean plasma cholesterol concentration at the end of the period of
study was significantly lower than mid-period value, but similar to that
obtained at the start of the study (Table 18).
NEFA
Plasma NEFA levels increased in mid-period in comparison to the
initial values, but the difference was only of border line significance
(t = 2.1877, P = < 0.07). There was,however, a significant decrease
in the end period compared with mid-period levels ( t = -2.3276,
p 0.05) (Table 18).
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Serum Glycerol
No significant changes were seen in serum glycerol concentrations.
Plasma Lipids - metabolic hormones interrelationships
Table 19 shows the interrelationships between plasma lipid levels and
the simultaneously measured plasma insulin, growth hormone and Cortisol
concentrations. There was a linear relationship between plasma insulin
levels and TG concentrations. This correlation was significant
(r = 0.57; p< 0.02) in mid-period samples (Figure 7)» and was further
demonstrated when the mean plasma insulin concentration over the year of
study was related to the mean plasma TG over the same period (r = 0.4917;
p< 0.05). The close time-relationship between changes in the
concentration of plasma insulin and TG is shown in Figure 8. It is
apparent that the relative changes in plasma TG and insulin concentration
are closely related. There was no significant relationship between
plasma TG and the other metabolic hormones. While plasma cholesterol
and serum glycerol concentrations did not relate to any of the metabolic
hormones, plasma non-esterified fatty acids bore an inverse relationship
to plasma insulin concentrations at the start and the end of period samplings
which was of border line significance (r = -0.504, p 0.1;
r =-0.413, pCTO.1 respectively) and positively correlated with plasma
growth hormone at the middle of the period (r = +0.610, pc 0.01)
(Figure 9)•
Effect of diet
The relationship between plasma TG and cholesterol concentrations,
determined at the middle of the period, and dietary intakes of total
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Fig. 7. Relationship between plasma triglyceride (TG) concentration














































FIG.8 Relative changes in plasma tri¬
glyceride (TG) and insulin (1RI)
concentrations. S = start;
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Fig. 10. Relationship between plasma triglyceride
concentration and carbohydrate intake ( % of
total energy intake ).
176
time of samplings, is shown in Table 20. There was a tendency for
those children with lower intakes of total energy, fats and protein to
have higher TG levels. There was significant positive correlation
between plasma TG and the percentage of calories derived from
carbohydrates (r - 0.55, p< 0.05) (Figure 10). No correlation
between plasma cholesterol concentration and food intakes could be
shown. A strikingly similar relationship between food intake and plasma
lipids were obtained when the mean intake over the year of study was
related to the mean plasma TG and cholesterol concentrations over the
same period (Table 21).
PLASMA AMINO ACIDS
The mean (- 1 S.D.) of the fasting plasma amino acid concentrations
in the patients determined at the three time points and compared with
control values are shown in Table 22.
There were consistently significant reductions in concentrations
of valine, leucine, isoleucine, lysine, tyrosine and histidine.
Glycine and alanine were significantly elevated, while the remainder
were within normal limits. The ratio of tyrosine to phenylalanine was
consistently reduced, mainly due to the reduction in tyrosine
concentration. The valine/glycine ratio was also low because of the
reduced valine concentration and raised glycine concentration.
Plasma amino acid changes
Comparison by paired analysis of plasma amino acid concentrations
at the start, middle and end of period of observation (Table 23) shows







































S 142 7 28.6 ( 9) 4.17 <0. 001
VALINE M 147.6 31.7 (16) 197 32 (3D 5.62 <0.001
E 170.8 35.3 (15) 2.43 <0.02
S 79.2 17.6 ( 9) 4.56 -<0.001
LEUCINE M 68.6 12.5 (16) 100 16 (3D 7.15 <0.001
E 77.8 17-1 (15) 4.22 <0.001
S 40.3 10.3 ( 9) 3.86 < 0.001
ISOLEUCINE M 41.9 12.8 (16) 55 10 (3D 3.50 <0.002
E 44.2 9.8 (15) 3.48 < 0.002
S 13.2 4.9 ( 9) 2.53 < 0.05
METHIONINE M 13.6 4.0 (14) 18 7 (25) 2.51 <0.02






















1 S 175 26.8 ( 9) 1.7 NS
LYSINE M 154.6 23 (15) 156 31 (28) 0.11 NS
E 164 35.7 (13) 0.69 NS
S 79.3 16 ( 9) 1.14 NS
HISTIDINE M 70.3 10.6 (16) 86 13 (28) 4.33 < 0.001
E 72.6 11.9 (14) 3.34 < 0.002
S 456 90 ( 9) 6.61 < 0.001
GLYCINE M 405 113 (16) 251 44 (3D 5.24 <0.001
E 403 117 (15) 4.87 <0.001
S 447 158.5 ( 9) 3.16 < 0.005
ALANINE M 380 149.4 (16) 276 69 (30) 2.62 <0.02
E 380.2 169.3 (15) 2.29 < 0.05
S 20.3 6.9 ( 9) 9.68 < 0.001
TYROSINE M 23 5.8 (16) 43 Q (28) 11.06 <0.001
E 20.9 4.7 (15) 12.9 <0.001
TABLE 22: Plasma amino acid concentrations in
patients at start (S), middle (M)

















































TABLE23:Significanceofvariationinplasmaminoc dconcentr tio estimatedastart(S),middle(ManeE)ofp riof study.Pairt-test.
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the period compared with the middle of the period (t =■ 3.364, p < 0.005),
although the levels remained significantly lower than normal. The other
branched chain amino acids, leucine and isoleucine showed a similar trend
but the changes in their concentrations did not reach statistical
significance. There was also significant reduction in plasma methionine
concentration at the end of period compared with mid-period values
(t = 2.422, p< 0.05), No significant changes in other amino acids were
noted although both plasma glycine and alanine concentrations tended to
the
decrease at the middle and end of/period in comparison with their
intiia 1 1 eve Is.
Figure 11 shows the relative changes in plasma branched chain amino
acids, valine, leucine and isoleucine and the non-essential amino acids,
alanine and glycine during the period of study. The decline in plasma
level of both alanine and glycine was followed by a reciprocal increase
in valine, leucine and isoleucine concentrations. As all patients
were sampled at the middle of the period and since there were no
statistically significant changes in amino acid concentrations during
the period of study with the exception of valine and methionine, the
values obtained at this time were used for further analysis.
Amino acids and residual renal mass and degree of uraemia
Two patients were surgically anephric (numbers 7, 9) and analysis
of their results showed no difference when compared with the remainder.
No plasma amino acid concentration correlated with the duration or the
amount of dialysis. There was no correlation between plasma creatinine



















FIG. 11 Relative changes in plasma branched-chain amino
acids and alanine and glycine levels during the
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FIG. 12 Relationship between plasma albumin and
plasma valine.
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inversely, both with the plasma glycine (r — -0.6031; p< 0,05) and
plasma alanine concentrations (r =. -0.6060; p <C0.05).
Effect of diet and nutritional state
Table 2k shows the relationship between some plasma amino acids and
the dietary intakes assessed closest to the time of mid-period sampling.
There was an inverse linear relationship between glycine and total
energy, fat and protein. The valine/glycine ratio showed a similar,
though not as close a relationship, and the plasma valine was not
influenced by the diet at all. However, there was a direct linear
correlation between plasma valine concentration and plasma albumin,
significant at the 5% level (Figure 12). Other amino acids did not
correlate with plasma albumin and there was no relationship between
amino acid concentrations and plasma transferrin and C3 concentrations.
Amino acids and the metabolic hormones
Figure 13 illustrates the relative changes in mean plasma insulin,
GH and Cortisol levels and mean plasma valine, leucine and the gluco¬
neogenic amino acid alanine during the year of study.
At the start of study, plasma insulin concentration was inversely
related to both plasma valine and leucine concentrations, (r — -0.A2
and r — -0.50 respectively). However, these relationships did not
reach conventional level of significance (p < 0.1). Similarly the
decline in plasma insulin concentration towards the end of the period
of study was associated with an increase in plasma valine and a
decrease in plasma alanine levels, but this was not statistically
significant and there was no significant correlation between insulin
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:IG. 13 Relative changes in mean plasma plasma insulin (IRI),
growth hormone (GH), Cortisol levels and the plasma
amino acicbvaline, leucine and alanine during the





















































FIG. 14 Relationship between plasma growth hormone
(GH) and (a) Plasma Valine and (b) Plasma
Leucine concentrations. Values are the
means with their standard errors.
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Mean plasma GH levels tended to rise as plasma valine began to
increase and plasma alanine to decrease. These relationships were
not statistically significant. However, when analysed cross-sectiona11y
by grouping the mean plasma valine values according to mean plasma GH
concentrations, patients with higher GH levels were found to have
significantly higher valine concentrations (t =. 2.919; p <C 0.02)
(Figure 14). A similar relationship was found between GH and plasma
leucine (Figure 14), but no other amino acids correlated significantly
with GH.
The direction of change in plasma branched chain amino acids was
opposite to that of plasma Cortisol whereas plasma alanine changes were
in the same direction as those of plasma Cortisol. Regression analysis
of plasma Cortisol and the amino acids at the three time points revealed
no significant correlation.
GROWTH AND DEVELOPMENT
Figures 15 and 16 show the observed heights of the boys and girls
respectively for the beginning and end of period of observation. They
have been plotted against (a) chronological age and (b) bone age and
are numbered as in Table 1.
The mid-period chronological and bone ages,the height, the height
standard deviation score (HSDS) for mid-period chronological and bone
ages and the puberty ratings at the beginning and end of the period are
given in Table 25. The observed height velocity (cm/year), the growth
velocity standard deviation score (GVSDS) for mid-period bone age and
growth rating, as described in the method, are detailed in Table 26.
7 8 9 10 11 12 13 14 13 16 17 18
Fl G. 13 (a) Height at the beginning and end of
study plotted against chronological
age of boys.
8 9 10 11 12 13 14 15 16 17 18 19
FlG. 15 (b) Height at the beginning and end of study

















9 10 11 12 13 14 15 16 17 18 19
. 16 (a) Height plotted against chronological
age of girls.
FIG. 16 (b) Height at the beginning and end of study
plotted against bone age of girls.
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(M) (M) S M E CA BA G P G 1 '
2 16 12.5 143.6 144.1 146.5 -4.31 -0.81 1 1 1 1
15.5 14.5 160.1 162.5 164.8 -1.3 -1.09 3 3 4 4 1
5 12.3 11.5 141.7 142.5 142.6 \£>01 -0.31 1 1 1 1
7 11.5 8 130 131.8 133.8 -1.97 +0.98 1 1 1 i !
8 14.8 10 136.6 137.9 140 -4.66 +0.16 1 1 2 1 !
10 14.6 10 136.2 138.5 141.8 -4.06 +0.26 3 3 4 4 i
11 15.6 13 146 147.5 148.9 -3.56 -0.71 3 2 3 3
13 14.5 11 127.4 130.6 131.3 -5.26 -1 .79 1 1 1 1
14 12.2 10.5 128.7 130 131.5 -2.61 -1.49 2 1 2 1
G Genital Development 1 (Prepubertal) - 5 (Adult)








HEIGHT (cm) HSDS PUBERTY RATING
S M E CA BA
S E
B P M 1 B P M
1 17.2 15 149.6 150.1 151 -2 -1.97 5 4 1 5 5 1
3 12.4 13 150.4 153.3 156 -0.05 -0.58 2 3 0 5 5 1
6 12.8 12 141.3 141.7 143 -2.51 -1.3 3 1 0 3 2 0
9 12.8 8.5 125.9 127.5 129.3 -4.2 -0.05 1 1 0 2 1 0
12 11-3 11 127.1 128 129. 1 -2.88 -2.3 1 1 0 1 1 0
15 15.4 14.5 139.8 141.1 141.6 -3.5 -3-36 5 4 1 5 5 1
16 14.1 3 139.1 140.3 142 -3.35 2.66 2 2 0 3 2 0
3 Breast Change 1 (Prepubertal) - 5 (Adult)
P Pubic Hair 1 (Prepubertal) - 5 (Adult)
M Menarche 0 Absent 1 occurred
TABLE 25: Observed stature and puberty change over the period of study. Puberty rating according, to
Tanner (1962) and the patients ordered from high to low rating.
S » start; M = middle and E = end of period of study. Chronological and bone ages are trios,
of the child at the mid-period. HSDS = Height Standard Deviation Score.





1 1 .4 +0.78 ■ 3
2 2.9 -1 .41 2
3 5.6 +0.25 3
4 b. 7 -0.75 3
5 0.9 -3.07 1
6 1.7 -2.70 1
7 3.8 -2.15 3
8 3 A -2.15 2
9 3 A -1 .79 2
10 5.6 +0.60 3
11 2.9 -1.64 2
12 2.0 -2.56 1
13 3.9 -1.00 3
1b 2.8 -2.55 2
15 1.8 +0.26 3
16 2.9 -2.57 2
TABLE 26: Observed growth velocities, growth
velocity standard deviation score
(GVSDS) for mid-period bone age and
growth rating according to puberty
status .
Figures 17 and 18 show the growth velocities of the boys and girls
respectively during the period plotted against their mid-period
chronological and bone ages.
FIG. 17 Growth velocity plotted against chronological
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. 18 Growth velocity plotted against chronological
age (a) and bone age (A) of the girls.
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Puberty Status
At the beginning of the period of observation five boys (numbers
2, 5, 7, 8, 13) were prepubertal, one of whom (number 8) entered puberty
during the period of assessment, and four showed various degrees of sexual
development (Table 25). On the other hand only two girls (numbers 9, 12)
were prepubertal, one of whom entered puberty during the period of
study. The remaining five girls showed various stages of sexual
development.
Skeletal maturation
Ten children had a delay of bone age greater than one year and in
seven of these the delay was more than three years. On average, the
retardation of bone maturation was less severe in girls than in boys,
but large individual variations occurred. The degree of delay in bone
age was not greater in older children, suggesting that this occurred at
an early age and was not necessarily progressive. Figure 19 demonstrates
the course of skeletal maturation in the boys and the girls during the
period of study.
Stature
Six boys had statures below the third percentile at the beginning
of the observation period (numbers 2, 8, 10, 11, 13, 1*0 and remained
consistently below the third percentile during the year, and three boys
(numbers 7, 5, *0 were on or above the third percentile, one of whom
(number 5) showed a marked fall in height centile at the end of
assessment period. Seven had significantly retarded bone ages so that
when height was plotted against bone age only one remained below the
third percentile. Five girls (numbers 1, 9, 12, 15, 16) had statures
FIG. 19 Correlation of Chronological age with bone age
at the beginning and the end of the period of
study.
Bone age (years)
Fig.20. The relation of height, expressed as
standard deviation score (SDS), to
bone age.
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below the third centile at the beginning of observation and, with the
exception of patient (l) who reached the third centile at the end of
observation, remained below the third centile throughout the year.
While patient (number 3) followed the 50th centile throughout the study,
patient (number 6) who was on third centile at the beginning, had
stature below the third at the end of observation. Three girls had
significantly delayed bone ages. When height was related to bone age
only two girls were below the third centile. it is apparent from
Figures 17, 18 that height gain may continue in older children after it
might have been expected to cease in normal children. These children
may eventually be taller than expected from their current growth
performance though, because of the obvious tendency for statural growth
not to increase at the same rate as the advance of bone age, their
ultimate stature will be reduced.
There was a significant fall in the height centile of the sixteen
children, expressed as standard deviation score for bone age, with
increasing bone age (r =. -0.71; p =-< 0 .005) indicating that the
potential for growth falls with increasing age (Figure 20). This point
was further clarified when the changes in skeletal maturation were
compared with the changes in body height, it was apparent that the
increase in bone age during the period of observation was more than
the increase in height age.
Body weight
Figures 21, 22 show the mean post-dialysis weight during one
month at the start and end of the period of assessment plotted against
J 1
9 10 11 12 13 14 15 16 17 18
Fl G. 21 Mean post-dialysis weight at the beginning
and end of study plotted against age (Boys).
Fl G. 22 Mean post-dialysis weight at the beginning




Fig. 23. Body weight (mean post - dialysisfor one month) for height ratioat the start and end of periodof study (one year).
Fig. 24. (a) Relationship between plasma transferrin
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chronological age. At the beginning of the study, three boys had
weights below the 3rd centile and remained so at the end of the study;
six boys were on or above the 3rd centile, 3 of whom showed a fall in
weight centile at the end of the period of observation (Figure 21).
Four of the girls were above the 3rd centile at the beginning, two of
whom had a marked increase in weight centile at the end of the period.
Three girls were below the 3rd centile and remained so throughout the study,
though one patient (number 12 ) was just below the 3rd centile at
the end of the assessment period (Figure 22).
Wt
The weight for height ratio (trr) > calculated for each patient atnt
the start and end of the period of observation, is shown in Figure 23.
The increase in weight for height ratio was statistically significant
(P 0.001 , paired 111 test).
The deficit in weight for age and for height (% expected normal)
calculated at the middle of the period, correlated inversely with
plasma transferrin concentration (Fig.2Aa,b) but not with dietary intake
of energy or protein.
Height Velocities
Figures 17 and 18 show the growth velocities of the boys and the
girls respectively during the period of the study, plotted against their
chronological and bone ages. The height velocities (cm/year) were
calculated and expressed, as described in the methods, both as standard
deviation score for mid-point bone age (GVSDS) and in relation to the
child pubertal status (growth grades) (Table 26). Of the five boys
who were prepubertal at the beginning of the study (numbers 2, 5, 7, 8, 13)
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three had growth rates that were subnormal for prepubertal ch-ildren
and two (numbers 7, 13) had a satisfactory growth rate. Patient
number ]b who was in early puberty at the start of study grew inadequately.
The remaining three boys (numbers 4, 10, 11) were pubertal at the
beginning of the study, two (numbers k, 10) grew satisfactorily and
one (number 11) had inadequate growth. The two prepubertal girls
(numbers 9, 12) had poor growth rate and of the five pubertal girls
(numbers 1, 3, 6 15, 16) three (numbers 1, 3, 15) had adequate growth
and two (numbers 6, 16) showed poor growth for their pubertal status.
On the whole, pubertal children had better growth performance than
prepubertal children, taking puberty status into account.
Bone disease
Bone disease gradings, as described in the methods, at the start,
middle and end of the period of study for each patient are shown in
Table 27. At the start of the study there were eight children
with no definite evidence of subperiosteal erosions (grade 0 ),
two of whom developed moderate to severe erosions (grades
1-2) at the time of the last observation. Six children had initially
grade 2 osteodystrophy four of whom improved over the year and two
remained the same.
Clinical and biochemical factors and linear growth
There was no significant relationship between growth velocity,
expressed as 1SDS1 , and the duration or amount of haemodia 1ysis, the
diastolic blood pressure, the degree of acidosis^ the severity of anaemia,










1 2 1 1
2 2 1 0
3 " 2 1 1
J.
4 " 2 1 0
5 0 0 0
6 0 0 0
7 0 0 0
JL.
8 " 2 2 2
9 0 0 0
10 * 0 1 1
11 0 0 0
12 1 0 0
13 0 0 2
»L
14 " 2 2 2
J.
f\
15 1 1 2
16 0 0 0
TABLE 27: Bone disease (grading)
in the patients as
assessed at the start
(S), middle (M) and end
(E) of period of study.
* Taking dihydrotachystero1 (DHT).
and potassium concentrations (Table 28). Similarly, no significant
differences were found in the various clinical and biochemical
measurements between patients with adequate growth performance





Duration of dialysis +0.209 NS








Alkaline phosphatase +0.003 NS
PCV +0.308 NS
Albumin +0.135 NS
T ransferrin +0.212 NS
Complement +0.118 NS
Diasto1ic BP -0.410 NS
TABLE 28: Relationship between growth velocity, expressed
as standard deviation score (GVSDS), and mean pre-
dialysis biochemical measurements. Relationships
to the duration and amount of dialysis and to
diastolic blood pressure are also included.
Growth and Nutritional Status
The relationship between growth velocity and the mean nutrient
intake over the year of study as well as the intakes recorded at the
middle of the period of growth observation are shown in Table 29.
No statistically significant correlation could be demonstrated.




1 2 1 • 2
r -0.254 -0.10 0.139 -0.009
GVSDS
P NS NS NS NS
TABLE 29: Relationship between growth velocity, expressed as
standard deviation scores (GVSDS), and diet
(as % R.I.)
1 = Intakes recorded at the middle of the
period of growth observation.
2 = Mean intake over the year of study.
concentrations, indices of protein status, did not correlate with
linear growth (Table 28).
Growth and Osteodystrophy
The severity of bone disease had no apparent influence on linear
growth rate : six patients had a moderate to severe bone disease at the
start of study (Table 27), and although the lesion improved in four of
them, this was not associated with improvement of growth. Similarly,
only three out of the eight patients who had no radiological evidence of
osteodystrophy had a satisfactory growth rate (Grade III). Patients,
numbers 1, 3, 4 and 15, had satisfactory growth despite the presence of
bone disease. Renal osteodystrophy had no effect on bone maturation
































There was no significant relationship between growth velocity,
expressed as SDS, and both the means and mid-period values for plasma
growth hormone, insulin, Cortisol and somatomedin concentrations. The
correlation coefficients are shown in Table 30.
Only mid-period values for plasma somatomedin levels were
available for analysis.
(2) Thyroid hormones:
Similarly no significant correlation was found between growth and
either plasma T4 or T3 concentrations (Table 30).
(3) Sex hormones:
The relationships between growth and the mean plasma concentration
of testosterone, gonadotrophins and prolactin in boys and girls are
shown in Tab 1e 31.
TABLE 31
GVSDS Testosterone LH FSH Prolactin
Boys:
r +0.798 +0.797 +0.832 -0.635
P <0.01 <0.01 < 0.001 <0.1
Girls:
r +0.469 +0.875 +0.925 +0.542
P NS < 0.01 <0.005 NS
TABLE 31: Relationship between growth velocity, as standard deviation
for bone age (GVSDS) and mean plasma testosterone,
leutinizing hormone (LH), follicular stimulating hormone (FSH)
and prolactin levels in boys and girls.
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In the boys there was a significant positive correlation between
GVSDS and testosterone, LH and FSH (p < 0.01, 0.01 and < 0.001
respectively). Plasma prolactin levels in eight of the boys related
inversely to growth velocity although this did not reach significance
(r = -0.641*0, p0.1). Patient number 8 was excluded from
analysis as his plasma prolactin level was determined once at the
start of the study and was exceedingly high. In the girls, growth
velocity correlated positively with both plasma LH and FSH concentrations
(p< 0.01 and p<C 0 .005 respectively) but did not relate significantly
to either plasma testosterone or prolactin levels.
In order to identify the effect of puberty on growth performance
the data was pooled and further analysed according to puberty status
of the children (Table 32). Plasma gonadotrophin concentrations
correlated positively with growth velocity in pubertal but not in
prepubertal patients. Plasma testosterone was higher in the pubertal
children with satisfactory growth performance than in those with poor
growth. In the prepubertal patients, on the other hand, both plasma
testosterone and prolactin concentrations tended to be inversely related
to growth velocity but these relationships were not statistically
significant.
Growth and metabolic parameters
There was no significant correlation demonstrable between growth
velocity and the mean of either blood glucose, plasma triglyceride,




GVSDS Tes tos terone LH FSH Prolactin
Pubertal :
Correlation
Coefficient(r) +0.4687 +0.7721 +0.5889 +0.0839
P <0.05 <"0.001 <0.01 NS
Prepubertal :
Correlation
Coefficient(r) -0.4585 +0.2386 +0.2713 - .4974
P NS NS NS < 0.1
TABLE 32: Relationship between growth velocity, expressed as
standard deviation score for bone age (GVSDS), and
plasma testosterone, leutinizing hormone (LH), follicular
stimulating- hormone (FSH) and prolactin levels in
pubertal and prepubertal children. Sex hormone data
was pooled for this analysis.
There was only a slight positive correlation of borderline
significance between GVSDS and the mean plasma valine concentrations
(r - +0.452, p < 0.1) . This relat ionship, however, was found to be
significant when the plasma valine values obtained at the end of the
period of growth observation were plotted against growth velocity
SDS (r = +0.6009; p ^ 0.02) (Figure 25). Likewise, plasma leucine
concentrations at the end of the period correlated significantly and
positively with GVSDS (r = +0.5522; p < 0.05), but the relationship
between the mean plasma leucine values and GVSDS was not significant (p< 0.1).
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Fig. 25.(a) Relationship between growth
velocity (SDS for bone age)
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Fig. 25(b) Relationship between growth velocity (SDS
for bone age) and plasma leucine concentration.
DISCUSSION
The purpose of the study was to find out whether the wide
variety of metabolic and hormonal disturbances known to take place
in adults with renal failure occur in children receiving maintenance
haemodia 1ysis. I also hoped to establish clear associations if not
causal relationships between the nutritional, metabolic and hormonal
changes and to attempt to identify the influences, if any, of such
disturbances on growth and development. The present prospective
study provides data on linear growth rate as well as the biochemical,
nutritional, metabolic and hormonal status of a group of children
with renal failure treated by regular haemodialysis at home.
The biochemical data showed that the patients were stable on
haemodia 1ysis over the period of study and confirm that regular
haemodialysis in the home was technically as successful in children
as it is in adult patients. The significantly negative correlation
found between the amount of dialysis and both plasma urea and
creatinine concentrations might be an indication of the adequacy of
dialysis and gives support to the advocation of
more frequent dialysis for better rehabilitation of these children
(Scharer et al., 1976). However, the adequacy of dialysis was
difficult to assess as plasma urea and creatinine concentrations are
influenced by the patient's protein intake and muscle mass
respectively.
HORMONAL AND METABOLIC CHANGES
The patients in this study were found to manifest a variety of
alterations in hormones and substrates involved in carbohydrate,
protein and lipid metabolism.
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Insulin and Blood Glucose
Peripheral insulin antagonism in chronic renal failure, at least
in respect of glucose utilisation, is well documented in adult patients
(DeFronzo et al., 1978), and the significantly raised fasting blood
glucose in the face of basal hyperinsulinaemia observed in the present
study suggests resistance to the hypog1ycaemic effect of insulin.
As discussed in Chapter 3 carbohydrate intolerance in uraemic adults
is more commonly evident on glucose tolerance testing and fasting
hyperglycaemia is present only occasionally. The elevated basal blood
glucose levels in these children may, therefore, indicate that this
abnormality is more pronounced in uraemic children.
The cause of glucose intolerance in uraemic patients is unknown
(Chapter 3). A net reduction of glucose utilization could result from
impaired peripheral tissue uptake of glucose, augmented hepatic glucose
production, or impaired hepatic glucose uptake. Elevated levels of
growth hormone have been implicated, but no correlation between growth
hormone level and blood glucose concentration could be demonstrated
in the present study or by others (Samaan and Freeman, 1970). A
significant positive correlation was found between plasma Cortisol
and blood glucose. This may reflect the well known antagonistic
action of Cortisol towards insulin both in relation to peripheral
cellular uptake of glucose and hepatic glucose production
(Munk, 1971).
Although insulin resistance in uraemia appears to be primarily
at the periphery (muscle) leading to a decrease in glucose utilization
(De Fronzo, 1978), an increase in hepatic g1uconeogenesis despite
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elevated insulin levels remains a possibility. Dzurik (1973) observed
an increase in glucose formation from lactate in liver slices during
incubation with uraemic sera, and Frohlich et al. (197*0 reported
stimulation of g1uconeogenesis from amino acids in uraemic rats which
was dependent on the presence of the adrenal cortex as adrenalectomy
abolished this effect. More recently, Rubenfeld and Garber (1978)
demonstrated an increase in gluconeogenesis from alanine with relative
impairment of glucose utilization in adult uraemic patients.
The lack of correlation between blood glucose levels and
carbohydrate intake would seem to exclude a direct dietary cause for
the hyperglycaemia. It was not possible to evaluate the effect of
glucose content of the dialysate fluid on the blood glucose levels as
all the children dialysed against fluid containing 200 mg/dl of
glucose. However, this effect seemed unlikely as the fasting blood
glucose levels did not relate to the amount or the duration of dialysis.
Daubresse et al., 1976,found that glucose-enriched and glucose-free
dialysates had no appreciable influence on fasting blood glucose
1evels.
Basal hyperinsulinaemia is a common finding in uraemic adults
(DeFronzo et al., 1978). This study confirms this and extends this
finding to children with chronic renal failure. Decreased degradation
of circulating insulin primarily due to loss of renal tissue and possibly also
due to reduced hepatic degradation would appear to be a contributary cause
of the hyperinsulinism (Chapter 3), but the positive relationship
observed in this study between blood glucose concentrations and plasma
insulin levels, although not statistically significant, would also
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suggest an increased pancreatic insulin secretion in response to
the elevated blood glucose levels. The subject is discussed
further in the next chapter.
Growth Hormone
Elevated levels of plasma GH have been reported in adults with
chronic renal failure (Wright et al., 1968; Orskove and Christensen,
1971). This elevation is due to increased secretion, as shown by the
prompt reduction in plasma GH levels following the administration of
GH release inhibiting factor (somatostatin) (Pimstone et al., 1975).
Like uraemic adults the children in this study had a significantly
raised plasma GH concentration. The stimulus for the increased GH
secretion in uraemia is unknown. Wright et al . (1968) suggested
that protein malnutrition was an important factor determining the
increased GH level in uraemia. However, Davidson et al. (1976)
found no correlation between GH concentration and dietary protein
and I could not demonstrate any correlation between plasma GH
concentration and either plasma albumin or transferrin, used as indices of
nutritional status, or dietary protein. Plasma GH levels are
raised in children suffering from PEM and fall after protein
supplementation (Pimstone et al., 1967). Pimstone et al. (1968)
originally postulated that it could be the low serum amino acid content
which stimulated GH release but this seems unlikely as another
important effect of GH is to promote the uptake of amino acids into
the tissues and this would decrease further, rather than correct,
the serum amino acid concentrations; on the contrary, in normal
individuals it is high serum amino acid concentrations which stimulate
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GH release rather than the reverse (Raiti and Blizzard, 1970). A direct
relationship between basal GH values and fasting plasma NEFA was noted
and, since GH is a lipolytic agent (Raben and Hollenberg, 1959), the
raised levels in chronic renal failure may possibly be an adaptive
phenomenon in an attempt to mobilize endogenous fat for energy
production and minimise amino acid catabolism. Glick et al. (1965)
suggested that GH secretion may be regulated by the need for a non-
carbohydrate source of energy such as fatty acids. Abrupt increases
in plasma GH occur in states characterised by actual or impending
deficiency of glucose within the intracellular environment (Korner,
1965). If one accept that increase of plasma concentration of branched-
chain amino acids towards normal is a reflection of a decrease in amino
acid catabolism, then the positive relationships demonstrated in this
investigation between plasma GH and the branched-chain amino acids,
valine and leucine, might be viewed not as cause and effect relationship
but rather as an indirect evidence of a successful adaptation minimising
branched-chain amino acids oxidation as energy substrates by increasing
the availability of endogenous fat for energy production.
Clearly there is need for more detailed investigation into the
stimulus and role of the raised GH in chronic renal failure particularly
in relation to energy metabolism.
Cortisol
Little is known about the adreno cortical function in
association with chronic renal failure (Chapter A). Contradictory
findings indicating both high (Varghese et al., 1969; Snodgrass et
al., 1970) and normal (Lindsay et al., 1969; Betts et al., 1976)
plasma Cortisol concentrations have been published.
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The difference in methods used for plasma Cortisol measurements
and the difference in the patients studied particularly in regard to
degree of renal insufficiency, nutritional status and type of treatment
(dialysis or non-dialysis) might account for the discrepancies in results
and made direct comparison difficult. Using a more specific competitive
protein binding method for plasma Cortisol determination (Murphy, 1967),
the children in this study had plasma Cortisol values I found that although
within the upper limit of normal, the mean for the group as a whole
was significantly higher than mean control. This is at variance with
the finding of Betts et al, using the same method of assay, of normal
Cortisol levels in a small group of children with varying degrees of
renal failure treated conservatively. However, some of their eleven
patients had minimal renal insufficiency and only five normal
children were tested as controls in their study.
The normal diurnal rhythm of Cortisol was however similar to that
reported by Betts and his colleagues. The two studies are not
strictly comparable since it has been shown that haemodialysis therapy
affects plasma Cortisol levels (Mishkinet al., 1972; Hrubesch et al.,
1973). There is some evidence to suggest that in most dialysis
patients Cortisol secretion is increased (Mishkinet al., 1972) and
that this increase is ACTH-induced. Unfortunately concomitant plasma
ACTH levels were not determined in the present study to make any
comment on this point. The finding of direct relationship between
plasma Cortisol and insulin levels was in accordance with the known
effect of glucocorticoid inhibition of glucose uptake by cells with
simultaneous insulin resistance (Munk, 1971). it has also been
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shown (Batstone et al., 1976; Alberti et al., 1975) that in catabolic
states Cortisol together with other catabolic hormones playsan important
role in fuel mobilisation when energy requirements are increased or when
an
the utilisation of glucose as/energy substrate is defective. It was,
therefore, possible that the raised plasma Cortisol levels were the
consequence of insulin resistance rather than the cause of it.
THYROID FUNCTION
As pointed out in Chapter A, the thyroid status of patients with
chronic renal failure remaire inconclusive as the interpretation of
laboratory findings are particularly difficult due to the complexity
of system studied. It is generally accepted that although uraemic
patients are clinically euthyroid, low levels of circulating thyroid
hormones particularly T3 are common (Lim et al., 1977), and long-term
haemodialysis is associated with further decrease in plasma TA
concentration (Dandona et al., 1977).
In the present study, the mean values for plasma TA, FT1 and T3
were at the lower limits of normal. These findings are in agreement
with data obtained in uraemic adults (Carter et al., 197A; Lim et
al., 1977) and in children with chronic renal failure (Wassner et al.,
1977). The reasons for the depressed levels of thyroid hormones
remain controversial. They could not be due to a decrease in carrier
protein as the thyroxin binding globulin capacity as measured
indirectly by T3 resin uptake was normal. Direct measurement of
thyroxin binding globulin (TBG) was also reported to be normal in
uraemic adults and children (Joasoo et al., 197A; Wassner et al., 1977).
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Basal plasma TSH levels, with the exception of the two patients with
cystinosis, were not increased. This is generally regarded as evidence
against primary hypothyroidism, but hypothalamic-pituitary dysfunction
may be present as suggested by the subnormal TSH response to TRH;
the cause of which is not clear. Blunted TSH secretion after TRH
administration was also reported by Ramirez et al., 1973; Urn et
a 1 -, 1977 and Czernichow et al., 1976. Silverberg et al. (1973)
have also found normal TSH levels with low T4 and free Jb levels in
their patients and proposed an abnormal thyroid-pituitary feedback
mechanism in renal failure. However, this seems unlikely as the TSH
decreases in response to exogenous T3 administration (Czernichow et al.,
1976).
According to Carter et al., (197^) and Lim et al. (1977) the
peripheral generation of T3 from Tb is decreased in uraemic patients.
This may explain the low levels of T3 but does not account for the
low TA. Whether the depressed T4 was due to long-term haemodialysis
as proposed by Dandona et al. (1977). to a possible intra-thyroida 1
abnormality as suggested by a subnormal TA response to exogenous TSH
administration reported by Ramirez et al. (1973), to a subnormal
pituitary response to TRH, or to a combination of these factors, is
not clear.
I have not fully investigated the functional integrity of the
thyroid gland in these children, but the findings indicate that they
are able to maintain a clinically euthyroid state despite a possible
hypothalamic-pituitary dysfunction, and that the subnormal levels of
circulating thyroid hormones seemed to have no demonstrable metabolic
effects particularly in relation to growth.
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The defect in thyroid function in the two patients with cystinosis
appeared different from that present in the other children. The
depressed plasma T^, FT1 and T3 with elevated basal TSH and supranormal
TSH response to TRH stimulation are indicative of compensated primary
hypothyroidism and intact pituitary-thyroid axis. Similar findings
were reported by Chan et al. (1973) and Lucky et al. (1977). The cause
is believed to be due to deposition of cystine crystals in the thyroid
gland. However, clinical hypothyroidism is uncommon in this group of
patients and it is unlikely that the impaired thyroid reserve is the
cause of their growth retardation. Thyroxine treatment in seven growth
retarded cystinotic children with chronic renal failure resulted in
normalisation of basal plasma TSH but had no apparent effect on
growth velocity (Burke, El—Bishti et al., 1978).
SEX HORMONES
Little is known about the hypothalamic - pituitary - gonadal axis
in patients with chronic renal failure. To my knowledge, sex hormone
concentrations and their correlations with the level of sexual development
of children and adolescents on regular haemodialysis have not been
previously studied.
Plasma LH levels were consistently elevated in virtually all
patients in this study and plasma testosterone concentrations were
reduced in most of the pubertal boys, a finding in agreement with previous
studies in adult male patients (Guevera et al., 1969; Lim and Fang,
1975; Holdsworth et al., 1977). This is consistent with impaired
gonadal function with diminished negative feedback at the level of
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the hypotha]amus-pituitary. The positive linear correlation found
between LH and testosterone levels and the reported increased
production rate of LH, in conjunction with low testosterone levels,
in adult male patients (Holdsworth et al., 1977) supports a role for
diminished testosterone feedback in obtaining the elevated LH levels.
However, it has been shown (Apostolakis and Loraine, 1969) that
gonadotrophins have a renal clearance of Q.k - 1.7 ml/min, and thus
the elevated levels may in part reflect impaired plasma clearance of
gonadotrophins.
In few pubertal girls plasma testosterone was increased and was
associated with elevated plasma prolactin levels. Raised plasma
testosterone is typical of the polycystic ovary syndrome and a
proportion of these patients have hyperprolactinaemia (Ginsburg and
Havard, 1976). Solitary ovarian cysts occur more frequently in women
on regular haemodia 1ysis (Thaysen et al., 1975) but I am unaware of
any reports of polycystic ovarian changes.
The number of patients tested with LH/FSH - RH was small for
definitive conclusions to be made in regard to the functional integrity
of the hypotha1amus-pituitary. Nevertheless, the excessive LH response
in the pubertal boy could indicate primary Leydig cell dysfunction
similar to the findings in patients with other types of testicular damage
(de Kretser et al., 1975). On the other hand the blunted initial
response with delayed peaks of LH and FSH in the prepubertal and early
pubertal boys could possibly be due to some degree of pituitary
i nsensitivity in the younger patients.
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The delay in sexual development observed in the patients of
this study could, therefore, be the clinical manifestation of gonadal
impairment and would be expected to be associated with increased
concentration of plasma LH and FSH for the stage of sexual development.
The relationship between statural growth and sex hormone levels is
discussed below in the section "growth and sex hormone status".
The present study confirms that elevated levels of circulating
prolactin occurs in a high percentage of uraemic patients (Nagel et
al., 1973; Hagen et al., 1976; Olgaard et al., 1975) and extends
this observation to children on regular haemod i a 1 ysis . The cause of
hyperprolactinaemia in chronic renal failure is not known. It may
be a result of hypotha1 amic-pituitary abnormality, a non-specific
stress induced response to chronic illness and/or dialysis procedure,
or simply related to reduced renal clearance. However, prolactin
levels were not related to the duration or amount of dialysis and none
of the patients were on drugs which are known to raise the plasma prolactin
level .
It has been suggested that raised prolactin levels may have anti-
gonadotroph i c actions at the gonadal level (Thorner et al., 197^+5
McNatty et al., 197^). In this respect, the impaired gonadal function
in some of the patients in the present study may be related to high
prolactin levels. However, the relevance of hyperprolactinaemia




The nutritional status of patients with chronic renal failure is
difficult to quantitate. No overt clinical signs of protein-energy
malnutrition were present but delayed bone maturation and retardation
of linear growth were common.
Height age rather than body weight was used as reference to
recommended intake because young children normally have much higher
food intakes in relation to body size compared with older children or
adults (Widdowson, 19^7). Although the food intake appeared adequate
that of
in relation to/normal children, it is possible that these children's
energy requirements might have been greatly increased for catch-up
growth to take place as shown to be the case in children recovering from
protein energy malnutrition (Ashworth et al., 1968). The biochemical
indices of nutritional status - albumin, transferrin and protein
the
complement were essentially within/normal ranges though there were
individual patient variations. Serum levels of transferrin have been
described as sensitive indicators of protein deficiency especially when
used in studies of Kwashiorkor and correlated well with the severity of
protein malnutrition (McFarlane et al., 1969). Low serum transferrin
concentrations have been reported in adult patients with chronic renal
failure (Ooi et al., 1972; Young and Parsons, 1975) and in these
patients it appeared to reflect restricted protein intake (Kluthe
et al., 1971; Wardle et al., 1975). In the present study, although
there were individual patient variations, the mean for the group was
similar to that obtained from controls. This would indicate an
adequate protein intake and suggest that measurements of plasma
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transferrin concentration are of no value in the assessment of
nutritional status of uraemic patients when on an adequate protein
intake. However, the value of transferrin for detecting protein-
calorie malnutrition in these patients may be limited in the presence
of iron deficiency anaemia which causes an increase in transferrin
concentration (Mosawe and Rwabwogo - Atenyi, 1973)• On the other
hand, the lack of correlation between transferrin and protein intake
and the presence of significant linear relationship between plasma
transferrin and the deficit in weight for age (Figure 24a) are
interesting and would suggest that the levels were influenced by
protein status of the patients, perhaps as a result of variation in
the degree of protein depletion for metabolic and not for dietary
reasons. An increase in transferrin catabolism in the patients with
the greater body protein depletion would offer an explanation for this
relationship. However, studies of transferrin turnover rates in
uraemic patients are required to test this possibility.
The results of the present study suggest that plasma transferrin
concentrations were not below the normal range until the deficit in
weight for age decreased to less than 80% of the standard value.
GROWTH AND DEVELOPMENT
Retardation of growth is common in children with chronic renal
failure (Chantler and Holliday, 1973). Most reports on haemodialysed
children describe severe growth failure. Poor growth is not, however,
inevitable for some children even with severe renal insufficiency
whether on or off dialysis grow well (Scharer et al., 1976). Growth
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rates of children around the age of puberty with variable degrees of
delay in bone age are particularly difficult to assess. For practical
reasons most of the children enter haemodialysis programme about that
age. The sole use in earlier studies of chronological age in the
assessment of growth is invalid because skeletal maturation is
frequently delayed in uraemic children. It is important that growth
rate should be assessed in relation to bone age because these children
may continue to grow after the age when most normal children have
stopped growing. It is also clear that growth assessment must take
account of pubertal status which is usually delayed in these children.
There is as yet no entirely accurate method of assessing pathological
growth as the reference growth charts used were compiled for assessing
growth in normal children. However, an approximate method frequently
used in such situations is the expression of growth velocity as standard
deviations for the mean of normal children of comparable bone age.
In order to overcome these difficulties, both standard deviation
scores and growth grading, according to puberty status, were used in
this study to assess growth performance of the patients. Analysis
of growth data in the present study showed that growth rates of most
patients were subnormal with variable delay in bone maturation confirming
the findings of others. Puberty was delayed in relation to
chronological age but, whereas younger children were growing below
the third percentile, many adolescent boys and girls were above the
normal rate for their chronological age which was undoubtedly due to
the delay in bone maturation. In general, pubertal children grew well
and prepubertal children did not and no catch-up growth was observed. The
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finding of a significant inverse correlation between growth rate and
age is unfortunate as it indicates loss of growth potential with advancing
bone age. This is similar to the finding of Betts and White (1976)
in children with chronic renal failure treated conservatively. As the
goal of haemodialysis treatment is successful renal transplantation,
satisfactory growth may, therefore, occur in recipients with decreased
bone age at operation. The findings of Grushkin and Fine (1973) and
Hoda et al . (1975) substantiate this concept. It is important, therefore,
that serial determination of bone age should be carried out as an
essential aspect of the clinical management of these children and
renal transplantation carried out at a bone age of 12 years or less to
maximise growth potential.
Various factors have been implicated in the growth failure of
uraemic children of which the two most important are renal
osteodystrophy and protein-energy malnutrition (see Chapter 2).
Although there is no doubt that severe neglected osteodystrophy leads
to renal "dwarfism", some children continue to grow despite radiological
evidence of bone disease appearing during haemodia 1ysis treatment
(3royer et al., 197*0 while others fail to grow inspite of the absence
of osteodystrophy. In this study no significant correlation was
found between linear growth and the degree of bone disease, and there
was no significant difference in the incidence of the bone lesion
between children with satisfactory growth grade and those with poor
growth. There was also a definite trend towards improvement in bone
disease without a comparable improvement in linear growth rate.
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In this study no significant correlation between energy intake and
growth was found. This is in apparent contradiction to other studies
where energy intakes were initially low but growth increased with
improved nutrition (Simmons et al., 1971; Betts et al ., 197^)•
Spontaneous energy intake is often reduced in renal failure but the
children in this study had been encouraged to eat and were receiving
energy supplements during the period of the study and their intakes
seemed adequate. Therefore, although better nutrition may improve
growth, the provision of extra energy does not ensure it. Betts
et al . , (1977) recently reported similar findings. It may be that the
energy requirements of these children are in excess of those
recommended for normal children of the same size as is the case in children
recovering from protein-energy malnutrition; whose energy
requirements for catch-up growth is considerably increased (Ashworth
et al., 1968). Energy expenditure relates to activity, basal
metabolism and growth. While the activity of these children, though
not assessed, was unlikely to be increased, an increase in basal
metabolism could not be excluded (see Chapter 9). A reduction in the
availability of energy for growth was another possibility, and in
this respect the finding that some of the children in this study
became fatter rather than taller following energy supplementation
was interesting and indicated that mcuh of the dietary energy was
being deposited as fat and not available for synthetic processes
other than those necessary for the formation of adipose tissue.
If this is so then it may suggest that fat deficit in the uraemic child
is relatively greater than the deficit of lean tissue, and that
tissue deposited during energy supplementation has a higher fat content
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than it does in a normal child. It may also suggest a defect in
energy utilization for lean tissue anabolism perhaps as a result of
some other metabolic and/or hormonal disturbances.
One of the major problems in understanding growth failure in
these children is how it relates to the hormonal changes described above.
A defect in secretion of the anabolic hormone insulin and growth hormone
seemed to be excluded as the circulating levels of both of these
hormones were increased and no direct relationship was obtained,
between growth and either insulin or growth hormone. This, however,
does not exclude the involvement of these hormones in the pathogenesis
of the growth retardation as their plasma levels may be a reflection
of a more fundamental metabolic disturbance consequent upon renal
failure and culminating in growth failure.
The lack of correlation between growth velocity and serum
somatomedin levels is at variance with data reported by Schwalbe et
al. (1977) in a group of children with chronic renal failure treated
conservatively and using the same bioassay without correction for
plasma sulphate concentration. As it has been shown clearly (Phillips
et al., 1978) that sulphate retention in renal failure seriously
interferes with the bioassay of somatomedin giving falsely low plasma
SM activity, data for serum SM activity in patients with renal failure
must obviously be interpreted with caution. However, the finding in
this study of positively significant correlation between serum
somatomedin activity and plasma transferrin concentration within the
group of patients and assuming that sulphate inhibition is the same
in all the patients is interesting. It has become apparent that
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nutritional status may be a factor that affects the relation between
somatomedin and growth hormone. Decreased somatomedin and poor
growth despite growth hormone levels that were elevated have been
reported in children with protein - malnutrition (Van den Brande et
al., 197^; Grant et al., 1973). Serum somatomedin activity correlated
positively with plasma albumin and transferrin concentrations, and
increased towards normal when the children were refed (Grant et al.,
1973).
Chronic renal failure is associated with changes in metabolism of
protein qualitatively similar to those of protein-energy malnutrition
(Kopple and Swendseid ,1975). Plasma somatomedin levels may thus be
an indicator of the protein status of patients with chronic renal
failure. The finding in the present study of a significant
correlation between plasma somatomedin activity and plasma transferrin
levels is consistent with this hypothesis. However, the nature of the
interaction between growth hormone, nutrition and somatomedin activity
is poorly understood.
Phillips et al. (1976) postulated that the decreased somatomedin
activity in serum may be associated with either a primary decrease in
nutrient supply or a decrease in nutrient utilization for anabolism
despite ample nutrient supply such as in diabetes (Van den Brande,
197^). Since insulin deficiency is a feature of both malnutrition and
diabetes, it was considered (Phillips et al., 1976) that insulin, and
insulin-directed processing of nutrients, are important determinants
of somatomedin activity in serum. Since it is recognized that amino
acids and glucose enhance the sensitivity of cartilage to stimulation
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by somatomedin (Herington et ai., 1972), a decrease in nutrient
supply in chronic renal failure as a result of malnutr'rtion and/or
insulin resistance might conceivably mediate a decreased responsiveness
to the growth promoting actions of somatomedin. There is also an
experimental evidence (Daughday et al., 1975) to suggest that both
insulin and nutrition influence skeletal growth by affecting somatomedin
serum level by modulating its hepatic generation.
Growth and sex hormone status
The positively significant relationships found between growth
velocity and plasma gonadotrophin levels in both boys and girls, and
plasma testosterone concentrations in the boys were obviously a
reflection of the effects of puberty on growth as the correlation
persisted in the pubertal children and not in the prepubertal children.
This indicates that in these children an increase in linear growth rate
did occur in response to an increase in sex steroid levels. However,
the magnitude of this "adolescent growth spurt" was difficult to assess
and one had the impression that although linear growth was accelerated,
most of the children did not reach their normal centile for age because
of the greater loss of prepubertal growth and the delay in the onset
of puberty. The cause(s) of the delay in sexual development was
obscure and probably multifactorial. Nutritional causes are
important; it is well known that gonadal maturation and function will
not take place or be delayed unless the children are adequately
nourished and their somatic development reaches a certain critical
level. Most of the patients in this study had reduced body size and
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weight for age, and, therefore, nutritional factors were likely to
be a major cause of the delay in their sexual maturation. Another
possible explanation is the interference of uraemia, through unknown
mechanisms, with gonadal steroid production in response to circulating
gonadotroph!n. In male patients with chronic renal failure, decreased
testicular volume, normal sex hormone binding protein (SHBG) and a low
serum testosterone, which was not altered by gonadotrophin administration
have been reported (Stewart - Bently et al., 197^; Holdsworth et al.,
1977). The low plasma testosterone with elevated LH found in the boys
in the present study was, therefore, suggestive of a defect in testicular
steroidogenesis and might be associated with the retardation in their
sexual maturation. Most of the children exhibited hyperprolactinaemia
and since there is evidence that elevated plasma prolactin levels may
act at the gonadal level to block the action of gonadotrophins in both
men and women leading to gonadal hypofunction (Thorner and Besser, 1977;
Faglia et al.,1977). it is conceivable that the hyperprolactinaemia
was causally related to the delay in pubertal maturation of these
children. The tendency for the boys with higher prolactin to have
the low linear growth rate indirectly supports this view. If this
were so then lowering of prolactin levels should result in returning
gonadal function to normal, as indeed occurred in female patients
on regular haemodia 1ysis treated with bromocriptin (Wass et al. ,
1978). Obviously the role of hyperpro1 actinaemia in the delay
of sexual maturation of these children and its possible correction
warrants further investigations.
Although puberty and the mechanism of initiation of sexual
development are still unclear, it can be postulated that they are in
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part controlled by the hypothalamic LH - FSH releasing hormone (Roth
et al., 1973)- The blunted or delayed responses of LH to exogenous
LH/FSH - RH in few prepubertal boys tested in this study were indicative
of decreased pituitary responsiveness and since the magnitude of LH
and possible FSH responses induced by injected LH/FSH - RH seems to
be affected by the degree of prior stimulation of the pituitary by
endogenous releasing hormone (Roth et al., 1972), it may be postulated
that in the boys with chronic renal failure the delay in puberty might
be in part, due to hypothalamic - pituitary defect. However, pubertal
development is not related to changes in the gonadotroph in secretion
alone and must be considered as an integral part of the whole system of
hypothalamic, pituitary adrenal and gonadal interactions (Root, 1973).
Growth and plasma amino acids
As will be discussed later, the changes in plasma amino acid
concentrations seemed typical of a state of chronic protein catabolism.
The positive correlation between growth and certain branched-chain amino
acids, though weak and inconstant, was not entirely unexpected and could
be interpreted as indicating that as wasting of body protein continued,
the supply of certain amino acids such as the branched-chain ones became
rate limiting for growth. This does not necessarily mean a causal
relationship between linear growth rate and plasma branched -chain
amino acid concentrations but rather that growth was adversely affected
by the reduction in the availability of essential amino acids for
protein synthesis. Indeed, Aronson et al. (1975) have reported a
remarkable improvement in growth of a child with severe renal
insufficiency following essential amino acids supplementation. The
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causes for the accelerated protein breakdown have not been identified.
Although under-nutrition could not be excluded, uraemia-induced
alterations in energy metabolism might be involved. This latter
point required further investigation (see Chapter 8).
PLASMA LIPIDS
Raised plasma triglycerides have been commonly reported in adults
on regular haemodialysis (Bagdade et al., 1968: Gutman et al., 1973)
and recently Pennisi et al. (1976) and Broyer et al. (1976) reported
raised TG levels in children on dialysis. The group of children in
the present study showed a similar phenomenon. Type IV hyper-
1ipoproteinaemia is commonly found and the majority of the patients
exhibited this pattern. Raised TG levels in chronic renal failure
are considered to be due to both increased hepatic TG production
(Bagdade et al., 1968; Cramp et al., 1976) and decreased TG clearance
from plasma (Cattran et al,, 1976; Murase et al., 1975). The positive
correlation shown between plasma insulin and TG concentration is similar
to that found in uraemic adults (Bagdade, 1970) and it is possible that
hyperinsulinaemia stimulates an increased hepatic TG production, as
suggested for non-uraemic subjects (Reaven et al., 1967; Bierman and
Porte, 1968; Olefsky et al., 197*0. The similarities shown between
the patterns of change in plasma insulin and those for TG also suggests
close association. In uraemic adults an association between triglyceride
levels and the degree of glucose intolerance has also been demonstrated
(Sorge et a 1., 1975).
220
The role of diet in the pathogenesis of hypertriglyceridaemia
in chronic renal failure is not clear. No correlation existed between
total energy intake and TG concentration, though higher total energy
and protein intakes tended to be associated with lower levels. The
TG levels found in the patients of this study were about 65% lower
than those reported by Broyer et al. (1976) in children on dialysis,
and energy and protein intakes in our children were considerably greater
than in their study. However, other differences existed in the
management of these children, for instance, our patients dialyse for
about 30 hours a week compared with 16 hours a week. The proportion
of total energy intake derived from carbohydrate correlated
significantly with TG concentrations. Both Pennisi et al. (1976) and
Broyer et al. (1976) showed a similar relationship between dietary
carbohydrate and plasma TG concentration. More recently, Sanfelippo
et al. (1977) reported a reduction in plasma TG levels by feeding diet
low in carbohydrate and high in polyunsaturated fat. Unfortunately
it is not known from their study which of the two variables in the
diet altered the TG levels.
Plasma cholesterol concentrations are usually found to be normal
in uraemic adults whereas the children in the present study showed
considerable increases both compared with controls and with the children
reported by Broyer et al. (1976), though 6 of 17 children in the latter study
also had significantly increased levels. I was unable to show any
relationship between diet and plasma cholesterol, though Broyer et al.
suggested a relationship with fat intake. As our patients were taking
energy supplements based on food high in saturated fats, it is possible
that manipulation of the diet by increasing the polyunsaturated fat
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intake might lead to a fall in plasma cholesterol, and this was
attempted in the course of this study (see Chapter 10).
Although plasma NEFA concentrations have been reported to fall
more markedly in patients with chronic renal failure in response to
glucose load (Roth et al., 1973), basal levels were usually found to
be within normal limits or reduced (Persson, 1973). Ten of the patients
had levels below twice the standard error of the control mean in the
presence of elevated plasma insulin and blood glucose concentrations.
Intensive haemodia 1ysis lowers plasma insulin concentration and increases
insulin degradation rate (Hampers et al., 1970) and there is also
evidence that the low NEFA levels rise with adequate dialysis (Tsaltas
and Friedman, 1968). The reduced fasting plasma NEFA and low serum
glycerol concentration observed in this study might, therefore, be an
indication of a relative decrease of endogenous fat mobilization
(llpolysis) in uraemia as a direct consequence of basal hyperinsulinism.
Insulin is a potent anti1ipolytic hormone (Cahill, 1971) and also
promotes re-esterification of NEFA in adipose tissue, thereby reducing
further the quantities of NEFA released into the circulation. However,
the possibility of increased hepatic NEFA and glycerol uptake could
not be excluded.
PLASMA AMINO ACIDS
The individual amino acid concentrations for the controls were
similar to those previously reported from normal children (Armstrong
and Stave, 1973). Plasma amino acid concentrations in children are
lower than those in adults and increase with maturity (Scriver et al.,
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1971). There is, however, no evidence that significant changes occur
over the age range of the patients in this study who were, for
practical reasons, in the upper age range of childhood, and the controls
were of a comparable age and sex distribution.
The alterations in plasma amino acid concentrations were in
general similar to those previously found in adults with chronic
renal failure (McGale et al., 1972; Young and Parsons, 1970). There
are no published reports of plasma amino acids in uraemic children
on regular haemodialysis. The main abnormalities consisted of a
reduction in the branched-chain amino acids - valine, leucine and
isoleucine - and tyrosine and lysine, with a rise in the non-essential
amino acids, glycine and alanine. Histidine concentration has been
reported to be normal or decreased (Young and Parsons, 1970; Gulyassy
et al., 1970).
The reasons for these altered plasma amino acid concentrations
are poorly understood. Previous reports have indicated the similarity
between the plasma amino acid concentrations seen in uraemia and those
found in children with protein-energy malnutrition (Holt et al., 1963),
or adults with severe protein restriction (Swendseid et al., 1968).
in the present study overt clinical signs of malnutrition were not
present but growth retardation and delayed bone maturation frequently
were. Dietary intakes expressed according to height age seemed
adequate and the biochemical indices of nutritional status were within
normal range. While no amino acid correlated significantly with the
protein intake, plasma glycine related inversely to energy intake and
also tended to vary inversely with protein intake. In children
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suffering from protein malnutrition, plasma valine level is a function
of dietary protein intake. The distinct lack of correlation of valine
with diet in this study suggested that its alteration was due more to
effects of the uraemic state on protein metabolism.' The plasma
albumin concentration also did not correlate with diet and possibly
its positive relationship with plasma valine indicates that both
reflect the protein status of the individual whether there is protein
deficiency for metabolic or dietary reasons. The plasma glycine, on
the other hand, may be more responsive to alteration in the actual
dietary intake.
The efficacy of dialysis is difficult to measure. All children
were dialysed similarly for 30 hours each week with membrane of
appropriate size to body surface area and so the plasma urea was
probably influenced more by protein intake or endogenous protein
catabolism. Both plasma glycine and alanine concentrations showed a
significant inverse relationship with plasma urea, but no amino acid
correlated with plasma creatinine concentration. It is, therefore,
possible that the change in these two amino acids were independent
of the efficacy of the dialysis procedure (as evidenced by the plasma
creatinine) but that they may have been influenced by other factors
which could elevate the plasma urea, such as high protein intake or
endogenous protein catabolism. Kopple and Swendseid (1975) have
shown that the fall in valine/glycine ratio in patients on regular
haemodia 1ysis, whilst mimicked by a low protein diet, was much greater
in uraemics in spite of normal energy intake.
224
That abnormalities in plasma amino acids, typical of protein
energy malnutrition, may be seen in uraemic children consuming protein
intakes above recommended allowances suggests that these children may
have different protein requirements or else that the uraemic state
may lead in some way to a state of chronic protein depletion in spite
of apparent good food intake. Essential amino acid losses in the
dialysate are not greater than the non-essential amino acid losses
and are easily replaced by the diet (McGale et al., 1972).
In chronic catabolic states the branched-chain amino acids are
reduced (Baertl et al., 197^; Ruderman, 1975). This reduction is
considered to be a result of increased muscle protein breakdown and
preferential oxidation of the branched-chain amino acids for energy
production with increased flux of non-essential amino acids including
alanine and glycine into the circulation. Thus alanine formation
and branched-chain amino acids oxidation may be directly related with
alanine acting principally to remove the amino group from the deamination
of the branched-chain amino acids preliminary to their subsequent
oxidation (Garber et al., 1976).
Because the uraemic patient may have a decreased ability to
utilize conventional sources of energy, it is conceivable that tissues
such as muscle continue to utilize branched-chain amino acids as fuel
source resulting in an increased production of alanine and a decreased
release of the branched-chain amino acids. This may help explain the
observation made in the present study of the reciprocal changes in
plasma val ine and leucine concentration and plasma alanine levels.
The similarities in these patients' aminograms to those seen in protein-
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energy malnutrition may, therefore, be a result of protein
deficiency occurring for metabolic rather than dietary reasons.
It has been postulated that the increase in protein breakdown
and the use of muscle tissue amino acids as a fuel substrate is a
consequence of lack of insulin or resistance to the action of
insulin together with increased levels of catabolic hormones (Cahil
et al., 1972; Felig, 1975; Ruderman, 1975). The next study
(Study II) was undertaken to define further the hormone-fuel




HORMONAL AND METABOLIC RESPONSES TO INTRAVENOUS GLUCOSE.
In the preceding study various abnormalities of'the metabolic
hormones and energy substrates were observed. Most of the children
had poor growth despite apparently adequate supplies of dietary energy and
protein and were, therefore, insufficiently anabolic. The increased
catabolic responses to stress in uraemic rats (Holliday et al., 1977)
and the possibility of increased energy and protein requirements for
anabolism in acutely uraemic children (Abitbol and Holliday, 1976)
suggest the possibility of defective energy utilization for anabolism.
To characterise further the alterations in metabolic hormonesand
energy substrates, and to better understand the mechanisms governing
substrate utilization, the responses of the major fuel substrates, glucose,
non esterified fatty acids (NEFA) and amino acids (AA) and the more
important metabolic hormones, insulin (I RI) , growth hormone (GH) and
glucagon (IRG) following intravenous glucose, were investigated in the
same group of patients as in "Study I" and compared to values obtained
from a group of healthy children.
MATERIALS AND METHODS
Patients and controls
The same patients described in Study I were studied. All were stable
at the time of investigation and had been on dialysis for at least six
months (range 0.58 - 5.6 years). For ethical considerations entirely
healthy children could not be tested. Nine children, five boys and
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four girls with a mean age of 12.5 years (range 10 - 14.6 years) being
investigated for short stature which ultimately proved to be familial
were used as controls ; none of them had renal disease or any other
systemic disturbance or a known family history of diabetes. None of
them was socio-economica11y deprived and all were well nourished and
in good health at the time of the investigation.
Consent was obtained after full explanation of the test to parents
and children and the study was approved by Guy's Hospital Medical
School Ethical Committee.
Procedure and methods
Since there is doubt about the effect of chronic renal failure on
Intestinal absorption of nutrients, the proportion of an oral load
of glucose which reaches the circulation is unknown. Nor is anything
known of the effects of uraemia on intestinal factors which promote the
release of insulin. For these reasons the intravenous glucose
tolerance test (IVGTT) was used.
The patients and controls were admitted to hospital for the study
and the tests were performed in the morning following an overnight
fast of at least twelve hours, and in the case of the patients at
least 28 hours post dialysis.
IVGTT
After fifteen minutes rest period in the recumbent position 0.5 g
of glucose per kilogram body-weight was administered as a 50 per cent
solution over a period of three minutes through a butterfly needle
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inserted in cubital vein. Blood samples were taken through another
needle placed in the arterio-venous fistula or peripheral vein in the
opposite arm at 0, 5, 10, 15, 20, 30, 1+0 , 50, 60 and 90 minutes with the
child remaining in bed throughout the test. The sampling needle was kept
patent with the use of slow saline drip.
Sample preparations and analytical methods for BG, IRI, GH, !RG,
NEFA and AA were as described in "Methods" in Study I and in
"Analytical Methods" in Chapter 6.
After the rapid intravenous injection of glucose, the logarithm
of the blood glucose level declines linearly with time and the slope of
this line, expressed as the functional delay constant K, was used as an
index of glucose tolerance. K was calculated by the method of least
squares after logarithmic transformation of blood glucose concentration
and was multiplied by 100. Thus K x 100 represents the glucose
assimilation rate in per cent per minute (Lundback, 1962). Glucose
disappearance rate of less than 1.2 was taken to indicate glucose
intolerance (Franckson et al., 1962). The early insulin response
(0 - 10 minutes) was calculated by substracting the fasting value from
the mean of the 5 and 10 minute values. The mean of the absolute
values between 20 and 60 minutes following glucose injection was taken
to represent the late insulin response (DeFronzo, 1973)- The molar
ratio of insulin to glucagon was calculated by multiplying
plasma insulin (jju/ml) w u - l. tnnn , ,c by 23.33, which is based on 6000 molecular
plasma glucagon (pg/ml)
weight and 25 U per milligram biological activity for insulin
and 3500 molecular weight for glucagon (Anthony and Faloona, 197^).
Student 1t1 test was used to compare results in patients and
controls. The significants of changes in response to glucose was
assessed by paired t-test.
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RESULTS
Detailed clinical data of patients have already been shown
(Study I, Table I). Clinical data on the control group are shown
in Table 3 of Study i. The results of IVGTT in patients and controls
are presented in Tables 1, 2 and Figures 1, 2, 4, 5, 6.
Individual patient results are presented in Appendix B.
Blood glucose: Fasting blood glucose levels were significantly raised
in the patients compared with controls (P< 0.001). Figure I
illustrates theblood glucose response in the patients and controls after
intravenous glucose administration. In the normal subjects the glucose
disappearance (K^) ranged from 1.49 to 2.52 with a mean of 1.84 per cent
per minute. The mean for the patients was 1.09% /min. (range 0.46
to 1.51). This difference was significant (P<iL 0.001) (Table 3).
Ten of the patients (62.5%) had K„ values less than 1.2, the reportedb
lower limit of normal glucose tolerance (Franckson et al., 1962).
The degree of glucose intolerance did not correlate with clinical
parameters such as per cent ideal body weight, diet, blood pressure
and duration of dialysis. Nor was there any relationship with the
plasma ca 1 c i urn, potass i um, bicarbonate, urea or creatinine
concentrations.
PIasma insulin: Insulin responses to i.v. glucose are shown in
Table I and Figure 2. The fasting plasma insulin levels were
significantly elevated in the patients. Following glucose injection,
the early insulin response (0 - 10 minutes) was similar in patients
and controls but the late response (20 - 60 minutes) was significantly













BG(mmol/1) Patients(16) Controls(9) P
5.21i0.6 h.38-0.65 <0.001
11.77;.39 10.75-. 8 <0.05
10.132.14 9.44-1 08 NS
8.8721-13 8.1711 06 NS
7.84-1 2 7.17t0.65 NS
6.621.25 5.96-0 82 NS
5.8421 19 4.88-0.8 <0.05
5.29;0.96 4.08r0.65 <0.005




16.68;7 7 8.2-3 7 o -01
6022(k8 36.4•9.2 <0.02




24.4i1 .8 10.6-3.7 <0.02
21.732- 8.1-2 It <0.005
21.77.9 6.2-2.5 <0.001
19.929-5 6.2i2 1 <0.001
GH(mU/1) Patients(16) Controls(9) P
18.25-2. 7.014.3 <0.02
24.421.9 13.it-8.8 NS
25.66 it 11.1-5•'f NS
26.8-7 2 10.1-5.2 <0.1
2928-' 9.0-it8 <0.05
30.9231-5 7±5.2 <0.05
28.1-7 9 it.2-2.7 <0.02
25.8±8 5 5.511.>t <0.05
21.1'•,, 6.4-5.5 <0.1
16.5;1 7 11.4-2.5 NS
1RG(pmol/l) Patients(10) Controls(5) P
20.3;17-7 6.8-h 2 <0.005
-
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3.1*4-1 21 1.99-.26 <0.05
6.56-2.42 4.55"2. 0 <0.1
4.13-1 34 2.26-0 64 <0.001
1.09*0.28 1.84-0.3 <0.001
Table3:Mean-1S.D.ofplasmainsulin(mtl/1),thinsulin/glucoserati(m l/1permo /1) andtheglucosedisappearancer t(KG)%p rminu e)aftintraveno sglucos inpatientsandcontrols.
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Fig. 1. Mean ± 2 SEM of blood glucose values during
IVGTT in patients and controls.
PLASMA INSULIN CONCENTRATION (IVGTT)
6 Patients (16)












Fig. 2. Mean i 2 SEM of plasma insulin, fasting and in response
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FIG.3 Plasma insulin - blood glucose relation¬
ship in patients and controls. Each
line represents the mean of individual
slopes for each group.
m =. slope. Significance of difference
(p) between mean values for patients
and controls was analysed by Student's
t test.
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had an initial rapid increase in plasma insulin which was higher but
not significantly different from that seen in the normal group.
Starting from a mean fasting level of 16.7 ~ 7.7 mU/L, plasma insulin
increased to 60 - 24.8 mU/L at 5 minutes. During the next 10 minutes
the insulin levels fell rapidly but then declined at a much lower rate
so that during the later part of the test plasma insulin levels
remained significantly above normal. The peak insulin generally
coincided with and correlated with peak blood glucose (r = 0.5875,
P0.02). There was a positive relationship though not significant
between Kr and the early insulin response (r = 0.42, P^O.1). The
insulin response was further analysed by examining the insulinogenic
index (insulin / glucose ratio; Seltzer et al., 1967), and the
regression of plasma insulin on blood glucose. The early insulin to
glucose ratio was similar in patients and controls but the ratio in the
latter part of the test was significantly higher in the patients than
in controls (Table 3). The slope of plasma insulin - blood glucose
regression was 5.25 ~ 2.1 (SD) mU/L per mmol/1 for the patients and
3.93 " 1.5 mU/L per mmol/1 for the controls. This slope
was significantly greater in the patients than in controls (Figure 3).
Plasma growth hormone: Basal GH level and mean responses to i.v.
glucose in patients and controls are shown in Table 1 and Figure 4.
Fasting GH levels were significantly raised in the patients compared with
controls (Pc 0.02). In the control group there were initial increases
in GH levels following glucose administration then the levels gradually
declined to a nadir at 40 minutes post glucose injection with a rebound
between 60 and 90 minutes. In contrast, the patients as a group
exhibited a paradoxical rise in plasma GH after glucose with the maximum






5 10 15 20
1 1 1 I—
30 40 50 60
Time (minutes)
90
Fig. 4. Mean ± 2 SEM of plasma growth hormone, fasting
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Fig. 5. Mean ± 2 SEM of plasma glucagon, fasting and
in response to intravenous glucose in patients
and controls.
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at 30 minutes of IVGTT. There was, however, wide variation in the GH
levels observed in the patients. When the growth hormone responses of
the individual patients were compared with those of the normal group,
the levels were suppressed by glucose in three patients, unchanged in
three patients and the remainder (62.5% ) showed paradoxical rises.
There was no clear cut relationship between the abnormalities in GH
responses and the impairment in glucose tolerance, and no correlation
could be found between either fasting, peak values,or total responses
of plasma GH and the degree of glucose intolerance. Plasma GH levels
did not correlate with the duration of dialysis, urea or creatinine
concentrations. Nor was there any relationship between diet, plasma
albumin or transferrin concentrations (as indices of nutritional
status) and plasma GH levels.
Plasma Glucagon: Basal plasma immunoreactive glucagon levels were
significantly increased in the patients (P< 0 .005). After glucose
injection IRG fell significantly in the controls, but remained elevated
throughout the test in the patients (Figure 5). The basal molar
'nSU^'n
ratio was lower in the patients than in controls but the
g1ucagon
difference was not statistically significant (t = -1.492, P<"0.1).
I RI
However, the per cent increase in M at 10 and 60 minutes
I RG
following glucose administration was significantly increased in the
normal subjects compared with patients (P < 0.05 and P< 0.02 respectively)
(Table 4). No relationship between !RG levels and the degree of glucose
intolerance could be found. The elevated basal IRG did not correlate
with the duration of dialysis, plasma urea, plasma creatinine, or




































Table4:Mean-1S.D.ofPlasmaInsulin()jU/m1)/PlasmaGlucagon(pg ml) molarratio,fastingandinre ponsetoin r v n uglucose inpatientsandcontrols.
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Fig. 6. Percentage fall (mean ± 1SD)
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FIG.7 Relationship between plasma insulin
peak increment and maximum fall in
plasma non-esterified fatty acids (NEFA)
following iv. glucose
Plasma non-esterified fatty acids: The mean fasting level of NEFA
in the patients was significantly lower than in controls (P < 0.001).
Following i.v. glucose, NEFA level fell more markedly and for longer
in the patients than in the controls; the percentage fall being
significantly more at 40 and 60 minutes (Figure 6). There was a
significant inverse relationship between the peak increment in plasma
insulin level and the maximum percentage fall in plasma NEFA
concentration (r = -0.581, P< 0.02 (Figure 7). No correlation was
noted between fasting NEFA concentration and the degree of glucose
intolerance. Basal GH levels related positively but not significantl
with fasting plasma NEFA concentrations (r = +0.44, P<0.1).
P1asma ami no acids: The means and standard deviations of plasma amino
acid concentrations in the fasting state and 60 minutes after intra¬
venous glucose in the patients and controls are shown in Table 2.
Significant decreases in fasting plasma amino acid concentrations,
compared with controls, were found in valine, 1eucine , isoleucine,
lysine, histidine, tyrosine and serine; and increases in glycine,
and citrulline. There was a significant mean reduction in the
concentration of valine, leucine and isoleucine, tyrosine, alanine,
lysine and serine 60 minutes after glucose injection. Other amino
acids also fell in concentration, but not significantly. These
changes did not correlate with the peak, or the 60 minutes plasma
insulin concentrations. The changes in plasma amino acid
concentration in the controls are also shown in Table 2, and there
were significant reductions in valine,leucine, isoleucine, glycine,
alanine and tyrosine.
r = + 0.644
y = 22x +64
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Glucose disappearance rate during IVGTT
. 8. Relationship between the percentage
fall in plasma alanine concentration
60 minutes after glucose injection



















Glucose disappearance rate (kG)
1.5
Fl G. 9 Relationship between glucose disappearance rate
and fasting plasma alanine concentrations.
The concentration of alanine 60 minutes after glucose
injection was expressed as a percentage of the fasting level and
compared to the glucose disappearance rate (K„) during the IVGTT.
U 4
There was a close linear relationship between the percentage reducti
and Kg values (Figure 8). The fasting concentrations of alanine
correlated inversely with Kg values (r = -0.62; P 0.05) (Figure 9
thus, the worse the glucose tolerance, the higher the fasting
concentration of alanine and the greater its fall after glucose.
Those with better glucose tolerance had normal plasma alanine
concentrations, which showed little or no change following i .v.




This study confirms the findings of others that impaired carbohydrate
tolerance is very common in patients with chronic renal failure and
extends it to children on haemodialysis. Blood glucose was measured
by an automated ferricyanide reduction method (Auto-analyser ,Technicon),
which is not specific for glucose and certain non-glucose reducing
substances are also measured. Powell and Djula (1971) have shown this
method to result in higher values in uraemia compared with glucose-
oxidase method. However, the interfering substances do not change during
the glucose tolerance test and therefore the dynamic changes of blood
glucose during the test are valid (Briggs et al., 1967; Richards et
al., 1977).
The data clearly indicate that the patient's ability to secrete
insulin, particularly in the first few minutes following an intravenous
glucose load, is normal. This excludes a defect in pancreatic insulin
secretion as a cause of the glucose intolerance. The observation of
others (Garcia et al., 1966) that it is the magnitude of early
that
secreted insulin in IVGTT/is best correlated with the rate of glucose
utilization, supports this conclusion. Furthermore, as an index of the
appropriateness of any given insulin response, the early insulin to glucose
ratio was found to be normal in this study. This is in accordance with
the findings of most investigators (Briggs et al., 1967; Lowrie et al.,
1970; Spitz et al., 1970). Plasma insulin level is a function of both
insulin secretion and degradation rate. During thd latter part of the
test the patients maintained plasma insulin levels and insulin/glucose
ratio that were significantly greater than normal. Although this
elevation could be due in part to a decreased insulin clearance rate
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(a well established fact in uraemia), continued stimulation of insulin
secretion could also have occurred. The present study was not
designed to separate these two functions. A more important factor in
the development of an abnormal carbohydrate tolerance in uraemia
appears to be the peripheral resistance to insulin action particularly
in muscle (DeFronzo, 1978). In the present study this was manifested
by the raised blood glucose concentrations inspite of elevated plasma
insulin levels, the presence of high insulin/glucose ratio and the
greater slope of the insulin-glucose regression in the patients
compared with controls. Thus, each increment in blood glucose was
correlated with a greater increment in plasma insulin. The degree
of glucose intolerance did not correlate with plasma GH, IRG or NEFA
and the precise nature of this resistance remains obscure.
It is of interest that fasting plasma NEFA levels were significantly
lower in the patients and fell more markedly following glucose
administration. This suggests a decrease i n 1ipolysis and/or increased
re-esterification of NEFA in the uraemic state due to high insulin levels,
and that there seems to be no decrease i n sensitivity of adipose tissue.to
the anti1ipolytic action of insulin. This relative sensitivity of
adipose tissue has been shown to occur in catabolic situations
characterised by carbohydrate intolerance such as peritonitis (Ryan
et al., 197*0 and following thermal injury (Batstone et al., 1976).
Some indication of a decrease in NEFA mobilisation from adipose tissue
in the uraemic state was also shown in studies by Nitzan et al. (1968);
when rats were made uraemic and then subjected to two days fasting period
they exhibited hyperglycaemia and hyperinsu1inaemia and had levels of
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NEFA that were significantly lower than those measured in sham-operated
controls submitted to an equal fasting period. Similar metabolic state
was also described in starved-septic rats (Blackburn and Flatt, 1974).
Because the uraemic patient may have a decreased ability to mobilize
endogenous fat for energy production in the face of a decrease in
glucose utilization, the supply of metabolic fuels to tissues such as
muscle is reduced, except for amino acids the intracellular pool of
which is continuously fed by protein breakdown. This will result in
an increase in protein degradation to supply the substrate. It is known
that certain amino acids particularly the branched-chain amino acids
can be rapidly oxidised in muscle (Manchester, 1965), and if their
catabolism is increased a concomitant increase in the formation of
alanine will ensue (Garber et a 1,1976).Thus disproportionately high levels
of alanine are found in the plasma under conditions of protein wasting
(Felig et al., 1970; Adibi, 1976). The basal reduction of the plasma
branched-chain amino acids and the elevation of alanine observed in the
patients of this study might therefore be an indication of increased
oxidation of essential amino acids with increased alanine formation and
peripheral release. This is in keeping with the correlation found
between fasting plasma alanine levels and the degree of glucose
intolerance.
The fall in plasma amino acid concentrations after glucose in the
patients and controls was similar to that described in healthy adults
(Crofford et al., 1964). It is considered to be insulin-mediated as
it does not occur with insulin deficiency (Diabetes) (Zinneman et al.,
1966). The results have demonstrated that the metabolic reactions
initiated by a glucose load, which leads to the removal of essential
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amino acids from plasma under the influence of insulin is operative
In children on haemodia 1ysis for chronic renal failure. If the
disappearance of plasma amino acids is directly linked with the synthesis
of protein by muscle, as implied by many authors, (Swendseid et al.,
1967), it would mean that the mechanisms for protein synthesis are
maintained, though not necessarily normally, in the muscle of uraemic
children. The fall in the concentration of alanine (from high to
normal levels) is of interest. In normal subjects, no change or even
an increase after glucose or insulin has been reported (Crofford et al.,
1964; Felig et al., 1969). This could not be related to the key role
of this amino acid in gluconeogenesis where a higher level would have
been expected from a "shutting off" of this mechanism after glucose load.
The fall in circulating alanine levels suggested that alanine formation
and/or release in the periphery had been influenced by glucose
administration. Similar fall in plasma alanine concentration has been
described in malnourished children in response to oral glucose load,
but this effect did not occur after recovery (Grimble and Whitehead,
1971).
Basal hyperglucagonaemia is well recognised in uraemic adults
and is due probably to increased secretion as well as decreased
degradation of plasma glucagon (Bilbrey et al., 1974; Sherwin et al.,
1976). Although noh-suppressab1e in this study, Kuku et al. (1976),
in demonstrating that it is a heterogeneous molecule, showed that the
fragment which corresponds to the biologically active glucagon did fall
in concentration after glucose. The assay for glucagon used in the
present study was not specific for the active component and the persistently
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elevated levels during IVGTT might be due to non suppressibi1ity
of the other fragment. It isnotknown why glucagon secretion is increased
in chronic renal failure. It could be a consequence of continuous supply
of glucagon-stimulating amino acids entering the circulation}mainly
alanine, a known potent stimulant of glucagon secretion, or it may be that
glucagon, in response to a relative "glucose - lack" induced by failure
of normal glucose transport and metabolism, is secreted in an attempt to
correct that "lack" via hepatic gluconeogenesis as in diabetes mellitus
(Unger et al., 1970), or due to direct stimulation by retained nitrogenous
compounds mainly guanidines (Cohen, 1976). Whatever the cause, the
uraemic state is characterized by markedly elevated basal glucagon levels
and hyposuppressibi1ity of the pancreatic alpha cells by glucose,
resistance to insulin, and hypersensitivity to glucagon (Sherwin et
al., 1976).
According to the concept that glucagon is a hormone of catabolism
and that on molar basis it is more powerful than insulin with respect to
its action on hepatic glucose balance (Unger, 1971), therefore, the
inability of the patients in this study to increase the insulin to
glucagon molar ratio in a normal manner following exogenous glucose
(assuming that the measured plasma IRI and IRG were biologically active)
is indicative of reduced anabolism despite the supply of exogenous source
of energy. This may help explain the observation made in Study I why
some of these children failed to sustain growth in spite of seemingly
adequate caloric intake.
Alanine, the major gluconeogenic substrate, was found to be high
in those patients with poor glucose tolerance. Since substrate availability
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is the main drive for hepatic g1uconeogenesis (Felig et al., 1969;
Exton, 1972), and in keeping with hyperglucagonaemia, gluconeogenesis
might be increased in these children and could have contributed to the
glucose intolerance. Recent studies by Garber and his colleagues (1978)
support this notion. They demonstrated increased alanine production
and release from skeletal muscle of chronically uraemic rats.
However, the negative correlation between plasma alanine and found
in the present study may not be a cause and effect relationship but a
reflection of abnormalities of both variables associated with the severity
of the disease.
In prolonged starvation hypoa1 aninaemia is the rule with a decrease
in gluconeogenesis as a result of increasing utilization of endogenous
fat for energy and, therefore, sparing body protein . Such a metabolic
adaptation process may be denied to the uraemic patient because of
reduced availability of endogenous fat and perhaps even a defect in
its oxidation (Williams and Luft, 1976, abstract). It follows that
the catabolic response to fasting will be more profound in uraemia.
This has been shown to be true in the uraemic rat model (Hoiliday et
al., 1977).
As previously discussed, the elevated plasma GH levels are due to
increased secretion rather than impaired plasma clearance. It is
possible that the intracellular energy supply is deranged in uraemia
and that GH secretion is increased in an attempt to mobilize fat for
energy production and preserve body protein. The rise in GH levels
a
after glucose is interesting and/similar phenomenon has been described
in a variety of catabolic illnesses. Although a clear explanation of
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this phenomenon does not exist, various suggestions have been made ;
(1) The stimulatory effect of chronic protein depletion upon GH
secretion overrides the inhibitory effect of the induced hyperglycaemia
(Pimstone et al., 1967)> and (2) An abnormality exists in hypothalamic
function (Alvarez et al., 1972). It is possible, however, that the
normal GH response to glucose is ablated in uraemia because the marked
fall in NEFA levels/ due to hyperinsulinaemia, stimulates its secretion.
There is evidence that plasma NEFA have a regulatory effect on GH
secretion (Blackard, 1973).
The use of intravenous glucose as a tool to investigate hormonal
and metabolic interrelationships has reveafed different responses in
children with chronic renal failure, compared with healthy children.
On the basis of these findings I speculate that the prime defect is
a failure of normal glucose uptake by cells and decreased fat
availability for energy production leading to increased protein
degradation and in the case of children failure of growth. More
detailed metabolic studies , perhaps in animal model, are required to
elicit further the hormonal and fuel homeostasis in uraemia. This will
be of great help in the practical treatment of these children




OXYGEN CONSUMPTION AND BODY COMPOSITION.
Energy equilibrium in a normal child is the balance between energy
intake and energy expenditure. The latter relates to physical activity,
basal metabolism and growth.
The observation made in Study I that statural growth of uraemic
children remained poor despite apparently adequate energy intake suggest
that chronic renal failure per se may increase maintenance energy
requirement above normal, either by decreasing the efficiency of energy
utilization at a cellular level or by increasing basal energy
expenditure or both.
Recent investigations have shown a close relationship between
basal energy expenditure and protein turnover particularly in individuals
recovering from catabolic conditions (Kien et al., 1978) and children
recovering from protein-energy malnutrition (Brooke and Ashworth,
1972). Knowledge of energy requirements for basal metabolism in children
with chronic renal failure will, therefore, be important in order to
estimate the energy intake required to maintain energy balance and net
protein anabolism. This study evaluated basal energy expenditure in
this group of children on haemodialysis by measuring basal oxygen
consumption.
Adult patients with chronic renal failure have an abnormally high
content of body water and most of this excess is believed to be in the
extracellular phase (Coles, 1972; Comty, 1968). As basis of
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of reference, therefore, the body cell mass is preferable to the
body weight. For this reason and to evaluate the effects of chronic
renal failure on body composition in children, concomitant studies were
made of total body water (TBW) and extracellular water (ECW), and the
oxygen consumption was considered in terms of the metabolically
active body cell mass (BCM).
MATERIALS AND METHODS
Patients and Controls
Body composition and basal oxygen consumption studies were carried
out during the period of growth observation referred to in
Study I. Body composition was determined in 13 of the 16 patients.
All were clinically stable and none was oedematous or hypertensive at
the time of the investigations. The mean interval between the last
dialysis session and commencement of the study was 1A.8 hours. Patients
number 1, 7 and 8 refused the investigations. For ethical reasons
body composition studies could not be carried out in normal children
and the patients acted as their own controls (see Methods).
With the exception of patient number 15 who was not available for
the study, basal oxygen consumption was determined in all cases
approximately within two weeks of the body composition study. As the
patients were growth retarded, control values were obtained from ten
healthy children matched for height. Four of the controls were
children with familial short stature but otherwise entirely normal.
The remainder were normal healthy children. Clinical data of the control
group are shown in Table I.
Clinical data and management of the patients have already
been described (Chapter 7).
TABLE I
No. Sex Age We ight Height
(yrs) (kg) (cm)
1 M 12 27.5 133
2 M 12 30 139
3 M 11 20 110
4 F 12.5 27 135
5 M 13.5 34 138
6 F 13.6 48 165
7 F 11 45 140
8 F 13.4 51 138
9 F 11.5 48 146.5
10 M 14 55 163




Height and weight were recorded at the commencement of the
study. Triceps and subscapular skinfold thickness were measured
using a Harpenden skinfold caliper, according to the method of
Tanner and Whitehouse (1975).
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Total body water (TBW) was measured using tritiated water
dilution techniques. A dose of 3 m cu/kg body weight tritiated water
was administered intravenously by a syringe weighed before and after
the injection. Blood samples were taken hourly from two to six
hours, during which nothing was permitted by mouth. As the patients
were anuric, no allowance was made for urinary loss. Plasma water
was extracted from plasma by vacuum distillation under acetone and
dry ice (Moss, 1964), and counted in an LKB- Walloc 81 000 liquid
scintillation counter. The tritium activity was assayed with the
use of a liquid scintillation system (Langham et al., 1956) and
allowance was made for quenching by internal standards. Counting
efficiency was approximately 25%. TBW was calculated using the usual
isotope dilution formula (Forbes, 1962). Equilibrium appeared
complete by three hours : the two hour and three hour samples were
significantly different (paired 't' test, p<0.02), whereas no
difference was detected between the three and six hour plasma samples.
TBW was, therefore, taken as the mean of the three to six hour samples.
Extracellular water (ECW) was estimated from the bromide
distribution space using a fluorescence excitation of non-radioactive
bromine method (Kaufman and Wilson, 1973)- Non-radioactive sodium
bromide, 3% solution at a dose of 0.4 meq/kg body weight, was given
intravenously immediately after the tritiated water and blood samples
taken at four and six hours. Plasma bromide was measured by
fluorescence excitation in a nuclear data 100 multichannel analyser,
using a cadmium source (Kaufman and Wilson, 1973). As there was
no significant difference between the four and six hour samples,
ECW was estimated from the four hour sample.
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Derived Data
(i) Intracellular water (ICW) was calculated by subtracting
ECW from TBW (TBW-ECW).
(ii) Total body solids were calculated from the formula :
TBS (kg) = BW (kg) - TBW (1)
where BW = body weight.
(iii) Total body fat (TBF) was calculated from the nomogram
for the variable hydration of the fat-free body (FFB)
of Moore et al. (1963) using the ratios ICW/TBW and
ECW /ECW , where ICW-intracel1ular water, TBW-total
o p'
body water, ECWq - observed extracellular water,
ECW - predicted extracellular water:
P
TBF =. body weight - FFB
(iv) Fat-free solids (FFS) were calculated from the formula :
FFS (kg) = FFB (kg) - TBW (L)
(v) Body cell mass (BCM) was estimated from a linear regression
equation relating it to intracellular water (ICW). The
equation was calculated from the reported regression of
ICW on whole body exchangeable potassium (ke) and a direct
proportionality constant relating Ke and body cell mass
(Moore et a 1., 1963) :
BCM ^ 9.1 Ke and Ke = 0.1^9 ICW + 0.061
thus, BCM - 1.356 ICW + 0.5551 .
Predicted Data
Normal body composition was predicted for each patient from the
observed body weight and height at the time of assessment, and the
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results obtained were expressed as a ratio of observed/predicted:
(i) TBW - predicted value for TBW was obtained from the
following multiple regression equations on both
height and weight for normal boys and girls (Cheek, 1968):
Boys -
(a) Ht ^ 137-22 cm :
TBW = 0.381 (wt) + 0.257 (Ht) - 28.985
(b) Ht ^ 137-22 cm :
TBW = 0.397 (wt) + 0.067 (Ht) - 2.778
Girls -
Ht^ 1 13.02 cm :
TBW = 0.320 (wt) + 0.135 (Ht) + 9-577
(ii) Cheek (1978) has shown that intracel1ular water (ICW)
has a strong linear relationship to the cube of the
height in both prepubertal children and pubertal children
with little variation in males and females. Therefore,
ICW was predicted from the following regression equation
relating it to the cube of the height (Cheek, 19/8 ):
ICW = 3-782 (Ht)3 + 1.753
(iii) Extracellular water was predicted from the formula :
ECW TBW - ICW.
(iv) Fat-free body (FFB) was predicted from the formula :
FFB = —
0.73
assuming that, in normal individuals, FFB has 73%
water content.
(v) Predicted values for TBS, FFS and TBF were obtained as
described for derived data above.
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Oxygen Consumption Measurement
Oxygen consumption measurements were made with a 'flow through'
gas analyser, Noyons Diaferometer (MG4 Universal Diaferometer,Kipp
and Zonen, Deft, Hoi 1 and)(Fig.1). This utilizes an open system in
which the subject breathes, under translucent plastic hood over the
head and neck, room air that is suctioned through at a rate appropriate
for size. The instrument analyzes difference in the oxygen and
carbon dioxide concentration of inspired and expired air by measuring
differences in heat conductivity. The principle of the method is
fully described by Kleiber (1961). The diaferometer was calibrated
at regular intervals with O^and CO2 at known flow rates.
Procedure
The morning after an overnight fast of not less than 12 hours
the children were rested for at least one hour prior to the
commencement of the study. The chi1d,dressed in light clothing,
lies with the head and the neck under a plastic hood. A suction
pump draws room air into the hood around a loose neck seal, over the
subject's face, and through a corrugated tube into the gas analysing
system. Air-flow rate of 50 1/min and hood size appropriate for
children were used. After approximately 15 minutes, allowing
the child to get used to the test, measurements were carried out
according to the following procedure :
1 - Room temperature and barometer pressure were read.
2 - The instrument was set on "base line" and room air was
analyzed continuously for 0^ and CO^ with readings
FIG . 1 . APPARATUS USED FOR THE MEASUREMENT OF
OXYGEN CONSUMPTION
FIG.2 Typical graph obtained for base and deflection iines
for Oxygen uptake measurement.
253
taken every minute for five minutes after the galvanometers
have reached a stable position. The readings were plotted
on the mm - grid of graphical paper, the horizontal axis
being used as time axis (e.g. 1 cm for 1 minute).
3 - The instrument was then set on "deflection" for analysis of
the mixture of expired air and room temperature, and the
positions of the galvanometers were taken again every
minute until the deflections were constant. These readings
were also plotted.
k - Subsequently, the instrument was set back to "base line"
and the position of the galvanometer was read every minute
until the deflection was again constant. The base line and
the deflection line are parallel, and the two parts of the
base line obtained before and after the deflection line
form a straight line. The vertical distance between the
two lines gives the value of the deflection in mm (Fig. 2).
Two measurements were made for each child and the average taken.
The percentage differences between the two values ranged from 2-8%.
None of the children were restless and most of them fell asleep
during the test.
Calculations of Results
The results were obtained in terms of mm deflection for oxygen.
The temperature during the measurements was indicated by a
thermometer on the instrument and the corresponding calibration
constants, listed by the manufacturers, were used in the evaluation
of results.
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The concentration difference for oxygen in the sample stream
with respect to the reference air was calculated by multiplying
the measured deflections with the calibration constant:
1 - percentage oxygen decrease 0^) :
§2 ~ constant 0^ x deflection C^.
The oxygen uptake of the subject was evaluated from the measured
oxygen percentage and the flow rate used in the measurement.
2 - Oxygen uptake :
1 i tres 0^ / min = flow rate (l/min) x^O^/lOO x/i.
By means of the correction factor y the measured litres were
converted to normal litres (at 0° centigrade and 760 mm Hg barometric
pressure). A nomogram for the evaluation of jj from room temperature
and barometric pressure was supplied with the diaferometer.
The values for oxygen uptake were expressed in terms of body
surface area, height and body cell mass for both patients and
controls.
For ethical reasons, body composition studies on control
children were not carried out. Intracellular water (ICW) was
therefore estimated from a linear regression equation relating it
to the cube cf the height (Cheek, 1978) and body cell mass was then




Anthropometric measurements of the patients at time of study
are shown in Table 2.
The observed, derived and predicted values of body composition
determinants in the patients are shown in Table 3. The relationships
between observed body composition and predicted normal values for the
same weight and height are presented in Table b.
Total Body Water (TBW)
Total body water ranged from 5^.2 to 73.^% of body weight with
a mean of 63.03%. The TBW ratio was increased in ten patients
(1.01 to 1.19) and was reduced in three patients (0.92, 0.98 and
0.98), as seen in Table b. Variations in TBW ratios did not parallel
ECW ratio deviations, and were always less marked. The difference
between the observed and the predicted TBW was of a borderline
significance (p 0.05).
Extracellular Water (ECW)
Extracel1ular water ranged from 23.6 to 37.1 per cent of body
weight (mean 30.61). ECW ratio was increased in variable degree in
all patients ranging from 1.11 to 1.62 (mean 1.27).
Intracellular Water (ICW)
As shown in Table 3, ICW ranged from 27-3 to b2 per cent of body
weight (mean 32.5%). ICW ratio was reduced in eight of the patients
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TABLE 2
Case Sex Height We i ght Puberty Skinfold thickness (mm)
No. Status T riceps Subscapu1ar
2 M 144.1 42.0 PUB 18.0 16.0
3 F 154.4 48.0 PUB 27.6 20. 1
4 M 162.5 45.7 PUB 4.5 6.1
5 M 142.5 29.5 PRE 14.5 4.2
6 F 143.0 31 .2 PRE 12.5 5.3
9 F 129.1 22.5 PRE 7.5 5.7
10 M 142.1 55.5 PUB 7.6 7.7
11 M 149.0 38.7 PUB 13.4 6.3
12 F 128.7 25.9 PRE 7.1 5.1
13 M 130.5 31.4 PRE 15.3 13.9
14 M 131.1 31.5 PUB 11.2 10.7
15 F 140.6 51.0 PUB 21 .3 24.9
16
■
F 141.3 41.5 PUB 14.1 15.6




Case TBW ECW ICW BCM
No.
1itres %BW litres %BW litres %BW kg %BW
2 25.13 59.8 11.30 26.9 13.83 32.9 19.3 45.9
3 26.85 55.9 13.18 27.5 13.67 28.5 19.1 39.8
4 33.56 73.4 14.35 31.4 19.21 42.0 26.6 58.1
5 19-64 66.6 10.05 34.1 9.59 32.5 13.5 45.7
6 19.33 61.9 10.80 34.6 8.53 27.3 12.1 38.8
9 15.52 68.9 8.34 37.1 7.18 31.9 10.3 45.8
10 22.62 63.7 10.81 30.4 11.81 33.3 16.5 46.5
11 23.62 60.9 12.53 32.3 11.28 29.1 15.8 40.8
12 18.78 72.5 9.14 35.3 9.64 37.2 13.6 52.5
13 17-02 54.2 8.89 28.3 8.13 25.9 11.5 36.6
14 20.02 63.6 9.03 28.7 10.99 34.9 15.4 48.9
15 30.75 60.3 12.08 23.6 18.67 36.6 25.8 50.6
16 23.90 57.6 11.48 27.7 12.42 29.9 17.4 55.2





3.73 4-5 5.04 6.5
Table 3: Results of body composition in absolute values and
as percentage of body weight.
TBW - total body water; ECW - extracellular water;
!CW - intracellular water; BCM - body cell mass;
TBS - total body solids; FFS - fat-free solids;
TBF - total body fat; BW - body weight.
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TABLE 3 (continued)
Case TBS FFS TBF
No.
-
kg %BW kg %BW kg %BW
2 16.9 40.2 9.3 22.1 7.6 18
3 21.2 44.1 8.5 17-7 12.7 26.4
4 12.2 25.7 10.0 21.9 2.6 4.7
5 9.8 33.4 5.6 18.9 4.3 14.5
6 11.8 38.1 5.2 16.6 6.7 21.5
9 6.9 31.1 4.1 18.2 2.9 12.9
10 12.9 36.3 6.4 18.0 6.5 18.3
11 15.1 39.1 7.1 18.3 8.1 20.8
12 7.1 27.5 5.0 19-3 2.1 8.1
13 14.4 45.8 5.7 18.1 8.7 27.7
14 11.5 36.4 6.7 21.3 4.8 15.6
15 20.2 39.7 11.6 22.7 8.9 17.5
16 17.6 42.4 8.0 19-3 9.6 23.1
Mean 13.66 36.9 7.1 1 a 4 6.5 17.8


























































































































Table4:Relationshipbetweenobserv d(0)ndpredictedPb y compositionvalues.
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(0.66 - 0.98), increased in four patients (1.05 ~ 1.52), and was normal
in one. ICW/TBW ratio was reduced in ten of the patients. This,
associated with the high ECW ratios, suggested that reduction in ICW
maintained a relatively lower TBW than would have been anticipated
from the increased ECW.
Body Cell Mass (BCM)
The mean derived BCM was 46.5% of body weight (range, 36.6 -
58.1%). BCM ratio was reduced in eight patients (0.67 " O.98),
increased in four patients (1.05 ~ 1.5), and unchanged in one. The
changes in BCM were closely related to changes in ICW.
Total Body Sol ids (TBS)
Body solids were reduced in nine patients. This was due to
reductions in body fat or fat-free solids, or both. In four patients
(3, 6, 11, 13) TBS were not reduced although FFS ratios and BCM ratios
were low, but body fat ratios were increased.
Fat-Free Solids (FFS)
Reduced FFS ratios were found in eleven patients ranging from
0.71 - 0.97. The remaining two patients had increased FFS ratios
(1.04 and 1.22) (Table 4).
Total Body Fat (TBF)
Total body fat ranged from 4.7 - 11.1% of body weight (average
17.8%). Only two patients had body fat percentage below the third
2
percentile for age according to Cheek's normal values for children
(Cheek, 1968). TBF ratios were reduced in seven patients (53-9%)
and increased in six patients (46.1?). The changes in TBF ratios
did not parallel FFS ratio deviations; six patients with low FFS
ratios had increased TBF ratios. Body fat, in absolute values
and as percentages of body weight, correlated significantly with









Triceps 0.851 <: o.ooi 0.680 <0.01
Subscapular 0.788 <0.005 0.514 <0.05
Table 5- Correlation between total body
fat (TBF), in absolute amount (kg)
and as percentage of body weight
(BW), and triceps and subscapular
skinfold thickness.
Fig. 4 shows the triceps skinfold thickness of the patients
plotted against their height age on standard centile charts for normal
British children (Tanner and Whitehouse, 1975). Nine of the thirteen
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FIG. 4 Triceps skinfold thickness of boys (A) and
girls (B) plotted against their height age
on standard Centile charts (Tanner and
Whitehouse, 1975). Circled values rep¬
resent children with reduced body cell
mass.
none was below the 3rd centile for height age. There was a tendency,
in the boys, for prepubertal children to have the greater skinfold
thickness. Values circled are from patients with reduced body cell
mass. A similar pattern (not shown) was found with subscapular
skinfold thickness.
Effect of Puberty on Body Composition
Comparisons of body composition changes in pubertal and
prepubertal children are shown in Table 6. ICW, BCM and FFS ratios
were significantly higher in pubertal than in prepubertal children.
The deviations of these variables from the predicted normal values
were significant in the prepubertal but not in the pubertal children
indicating improvement in lean body mass with the onset of puberty.
ECW ratios were significantly higher in prepubertal compared
with pubertal children but no significant difference was found in TBW
ratios. TBF ratios though greater in prepubertal children, the
difference did not reach significance (P < 0.1).
(B) OXYGEN CONSUMPTION
Basal oxygen consumption (V0^) in litres per hour is recorded
for each patient and control subject in Table 7. Brasel (1968),
using the same method of measurement, found no sex difference in basal
oxygen consumption for all indices used in the present study. Thus,
















































Table 6: Body composition ratios in pubertal and
prepubertal patients (mean - 1 S.D.
Abbreviations as in Tables 3 and A.
Observed values significantly
different from predicted normal:









1 10.83 1 7.90
2 11 .06 2 6.76
3 10.38 3 6.32
4 12.41 4 8.78
5 7.75 5 8.36
6 10.25 6 9.86
7 9.80 7 8.15
8 7.84 8 10.34
9 7.07 9 8.35







Table J: Basal oxygen consumption
(VO^), in litres per hour,
in patients and controls.
Basal oxygen consumption values in patients and normal subjects,
expressed in relation to body surface area, height and body cell mass,
are shown in Table 8 and Fig. 5. In the control group the average
oxygen uptake per 100 cm height was similar to that reported by Brasel














p < 0. 02
Fig. 5. Basal oxygen consumption (VO2)
in litres per hour per kg. body
cell mass in patients (P) and
controls (C).





Ht (m) SA (m*) BCM(kg)
Patients 6.93 " 8.51 " 0.66 -
(15) 0.95 1.11 0.13
Controls 6.32 - 7.37 ± 0.52 -
1 .2 1.14 0.09
t 1.371 2.431 2.725
P <0.2 <0.05 C 0.02
Table 8: Oxygen consumption (VO^) in litres per hour
in patients and controls expressed in terms of
height (ht) , surface area (SA) and body cell
mass (BCM). Values are mean - 1 S.D.
Significance of difference was analysed by
student 't'-test for unpaired data.
measurement. Standard oxygen consumption, in terms of both body surface
area and body cell mass, was significantly greater in patients compared
to controls and although, in terms of height, it was higher in the patients
than controls, the difference was not statistically significant.
In Table 9 the correlation coefficients between oxygen consumption
and four reference standards in patients and controls are shown. As




r P r . P
V02 vs Wt. 0.697 <0.01 0.809 <0.005
V02 vs Ht. 0.546 <0.05 0.720 <0.02
V02 vs SA 0.659 <0.02 0.799 <0.01
V02 vs BCM 0.746 <0.01 0.7^3 <0.02
Table $: Correlations between oxygen consumption in
litres per hour (VO^) and body weight (Wt.),
height (Ht.), surface area (SA) , and body cell
mass (BCM) in patients and controls.
oxygen uptake in the normal children, whereas body cell mass provided
the highest correlation coefficient in the patients.
Relation of Oxygen Uptake to Body Cell Mass
Im Fig. 6 the oxygen consumption in litres per hour per kg body cell
mass was plotted against body cell mass as a percentage of predicted
normal, and it can be seen from the figure that the more wasted the
child, the higher the oxygen uptake. Excluding the two patients with

















r = -0.5079 (-0.785)
n = 12 (10)
p = 0.1 (<0.01)
_L
70 80 90 100
Body cell mass (% normal)
110 120
Fig. 6. Relationship between oxygen consumption in litres
per hour per kg. body cell mass and body cell
mass as a percentage of predicted normal.
Circled values represent the 2 cystinotic patients.
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DISCUSSION
The impact of chronic renal failure on whole body composition in adult
patients and the changes that occur on the institution of regular
haemodialysis have been reported (Comty, 1968; Coles, 1972). Basically
these reports have shown a relative increase in total body water
largely due to an excess of extracellular fluid, a decrease in intra¬
cellular water and a variable reduction in fat-free solids and body fat.
With the exception of one report on a 16 year old boy on haemodialysis
(Wilson et al., 1973), there have been no studies on body composition in
children with chronic renal failure. The results of the present study
largely confirm the results obtained for adult patients and extend
them to chi1dren.
The most marked and constant abnormality was ECV expansion.
Although ECV expansion may indicate true overhydration, it is also a
common compensatory response to a reduction in body cell mass as in
children suffering from protein-energy malnutrition (McCance S Widdowson,1951).
Decreased ICW and the low ICW/TBW ratios indicated a loss of cell
mass. Total body water (TBW) was only slightly increased despite marked
increases in ECW. This suggested that extracellular overhydration and
expansion due to loss of cell mass, on one hand, were offset by loss
of cell mass and intracellular water on the other.
Eleven of the patients (84.6%) showed a decreased proportion of
fat-free solids (FFS) when observed values were compared with predicted
values (Table 4). FFS reflect body cell mass (Moore et al., 1963)
and in the present study FFS ratios were in general closely related to
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BCM ratios (Table 4) and there was a strong linear correlation between
FFS and BCM (r = 0.95). The equations given by Moore et al. (1963)
for the estimation of BCM and used in the present study is valid if
the intracellular potassium concentration is normal, which is said
to be the case even in extreme pathological disturbances (Moore et
al., 1963). The high correlation coefficient (0.95) obtained from
the regression on FFS, derived from the variable hydration of fat-free
body, gives credibility to this assumption.
An absolute increase in body fat occurred in six patients (46.2%)
despite reduction in BCM and 69% of the patients had skinfold thickness
above 50th centile for height age. This is contrary to the previously
held view that chronic renal failure is associated with reduction in
total body fat (Comty, 1968; Coles, 1972). Such observations were
based on studies of patients who were undoubtedly malnourished. However,
Comty (1968) has noted an absolute and relative increase in body fat
with accompanying loss of fat-free solids in 36% of her non-dialysed
patients and Coles (1972) reported an increase in body fat following
regular haemodialysis treatment. Although none of the available methods
for estimation of body fat are entirely satisfactory (Forbes, 1962), the
body water method using Moore's nomogram of variable hydration of fat-
free body (Moore et al., 1963) correcting for the possible deviation from
normal of the water content of fat-free body in these patients seemed
justified. Body fat estimated by skinfold thickness agreed well with
simultaneous estimation by body water method in children (Brook, 1971)
and the strong linear correlation between body fat and skinfold
thickness found in the present study supports the validity of the method.
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The gain in body fat and the loss of FFS observed in some of
these children whose dietary intake of energy and protein were adequate
suggest a defect in intermediary metabolism with a decrease in the
utilisation of endogenous fat for energy production and a decrease in
net protein anabolism. This is in keeping with the observations made
in the preceding study (Study 2) and gives support to the hypothesis
made that the prime defect seems to be a failure of utilization of
conventional sources of energy substrates consequent upon tissue
insulin resistance, among other things, leading to increased body protein
depletion.
The finding of significantly greater deficit of body cell mass in
the prepubertal compared with pubertal children is interesting and may
help to explain the better growth performance of the pubertal children
observed in Study I. Analysis of growth in a large number of children
on haemodialysis in Europe showed similar results (Chantler et al., 1977).
Therefore, the decreased growth velocity of children in renal failure
may be associated with decreased cell mass and it is possible that the
increased androgen production of pubertal children is associated with
an increased growth velocity and body cell mass. With this in mind,
we have treated a group of prepubertal boys on haemodialysis for chronic
renal failure with an anabolic steroid (oxandrolone) with improvement
in body composition and growth velocity (Carter et al., 1978).
Oxygen consumption
Standard oxygen consumption, which reflects basal energy
expendi ture,was found to be higher in these patients than in controls
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matched for height and studied under the same conditions, both in
terms of body surface area and body cell mass. Whether a true
hypermetabolism existed in these children was difficult to ascertain.
An increase in oxygen consumption per unit body cell mass might have
been merely a reflection of a relative increase of the metabolica1ly
active tissues (internal organs) and a reduction in the proportion
of tissues of low metabolic activity (fat and muscle). However, this
seemed unlikely as body fat was found to be normal or even increased
in most of the children and when height, which reflects organ size
(Holliday, 19 71), was used as reference standard, the difference
in oxygen uptake persisted although it did not reach the conventional
level of significance.
Basal energy expenditure in children recovering from protein
energy malnutrition is increased and is directly proportional to the
degree of protein depletion (Montgomery, 1962). Brook and Ashworth
(1972) have suggested that the marked increase in oxygen consumption
during recovery from malnutrition is related to the high energy
requirements for protein synthesis. This may account for the high
energy costs of growth in previously malnourished children (Ashworth
et al., 1968). Similarly Kein et al. (1978) have recently demonstrated
an increase in BMR in children recovering from burn injury and suggested
that the basal energy expenditure is directly associated with energy
needs for whole protein synthesis and breakdown. It is conceivable
that the increased oxygen consumption of the children in the present
study was due to increased protein turnover and were, in this respect,
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not unlike those children recovering from malnutrition or catabolic
injury. The inverse relationship between oxygen uptake and the
per cent deficit in body cell mass suggests that this may indeed fcre
the case. Energy and protein requirements must therefore be increased
to support the rate of protein synthesis that would equal or exceed
protein degradation for net protein gain. However, it must be
recognised that the present data is too limited to permit exploration
of the relationship between basal oxygen consumption and protein
turnover status in these children and, therefore, the foregoing
conclusion must be regarded as tentative. Obviously, further study
will be needed to, (a) determine if the increase in basal metabolism
is due to a greater amount of metabolica11y active tissue or to a
change in the metabolic activity of the muscles and organs and
(b) to assess the relationship between basal energy expenditure and
whole body protein synthesis. Such studies will help to determine





EFFECT OF DIET ON PLASMA LIPID LEVELS
Concern is developing that an accelerated rate of atherosclerosis is
occurring in adult patients on regular haemodialysis and is resulting
in premature deaths from cardiovascular disease (Lindner et al., 197*0.
In view of this and the relationship between hyper 1ipidaemia and cardio¬
vascular disease shown in normal population (Kannel et al., 1971;
Carlson and Bbttinger, 1972), the findings of increased plasma
triglycerides and cholesterol levels in the group of children under
study (see Study I) were disturbing. Uraemic patients are atrisk of
for several other reasons including hypertension, hyperuricaemia and
carbohydrate intolerance.
Although the exact mechanism of the hyper 1ipidaemia is not well
understood, it is obviously of practical importance to attempt to reduce
the lipid levels in these patients,particu1arly the cholesterol levels,
as their reduction is known to improve mortality from cardiovascular
disease (Mie tt ien ,1972) . The use of clofibrate is contraindicated
in end stage renal failure as it is excreted by the kidney. Dietary
treatment is, therefore, of prime importance. In this group of
patients the principle therapeutic step would be to reduce carbohydrate
and to increase the polyunsaturated/saturated fatty acid ratio (P/S
ratio) in the diet. This in normal subjects lowers the plasma
cholesterol and plasma triglycerides.
The purpose of this study was (l) to further evaluate the
relationship between dietary intakes of carbohydrate, fat and protein
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and plasma lipid levels and (2) to determine whether a diet low in
saturated fats and high in polyunsaturated fats results in lower
levels of plasma lipids or not. If it does, then long term treatment
on such a diet would be a reasonable measure to reduce at least one of
the risk factors in these young patients.
METHODS
Patients and Procedure
Clinical data and management of the patients were as described
in Study I.
Two periods of observation were allocated. During the first period
of one year, all the patients (16) were allowed free diet and an energy
supplement based on a glucose polymer (caloreen) containing 17 Kj/g and
and saturated fat in the form of double cream (4 Kcal/ml).
During a second period of one year the energy supplement was altered
in that the saturated fat was replaced by a recipe high in poly¬
unsaturated fats based on sunflower seed oil which has a high energy
density (37 Kj/g). The supplement was designed to increase the poly¬
unsaturated fats/saturated fats ratio (p/s) in the diet. Detailed
description of the recipe is given in Table I, Appendix (C).
Although the children were not obliged to follow a rigid dietary
regime and took the energy supplements in varied amounts in both periods,
adherence to the prescribed supplement was considered essential and they
were strictly supervised by a trained dietician. The dietary intakes
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were monitored by means of a weighed dietary intake as described in
Chapter 5. At the end of each period, plasma triglycerides (TG)
and cholesterol (CHOL) concentrations were determined by the methods
outlined in Chapter 6.
For the purpose of this study, the intakes recorded closest to
blood sampling were used for analysis. During the second period
four patients did not tolerate the oil supplement and had nausea and
vomiting and three patients did not adhere to it and were excluded
from the study. Only nine patients completed the study satisfactorily
and analysis, therefore, was restricted to these nine patients.
The patients acted as their own controls and plasma lipid
levels were also compared to normal control values shown in Study !.
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RESULTS
Clinical data of the patients are shown in Table I of Study I.
Nutrient Intakes
The mean intakes of total energy, carbohydrates, fats and protein
in absolute amounts and as a percentage of recommended daily allowance
{% RDA) for height age in the first period (p^) and second period (p^)
are shown in Table I. The proportions of energy derived from
carbohydrates, fats and protein are also shown in the table. Data for
individual patients is presented in Table 2 of Appendix (C). Total
energy, carbohydrate, total fat and protein intakes were similar in
both periods. In the second period, the percentage of energy derived
from carbohydrate was significantly higher (p< 0.05) (Fig. 1).
The percentage from fat was higher but not significantly (p<^ 0.1), and
the percentage from protein was significantly lower (p < 0.02). The
p/s ratio in the diet was significantly higher in the second period
compared to the first period (p < 0.05) (Fig. 1).
Plasma Lipid Levels
Figure 2 shows the plasma triglyceride and cholesterol levels
in the first and second period and in relation to control values.
Plasma triglyceride and cholesterol concentrations were significantly
elevated in both periods compared to controls. In the second period
mean plasma TG was higher but not significantly (p<"0.l), whereas
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Fig. 1. Carbohydrate intake ( % of total
energy ) and polyunsat. to sat. fat
intake ratio in first and second















































Relationship between diet and Plasma Lipids
In Table 2, the correlation coefficients between dietary intakes
and plasma TG and CHOL levels in the first period (p^) and the second
period (p^ are shown. In both periods there was an inverse
relationship between fat intake and TG levels (p < 0.01 and p < 0.02,
respectively) and in the second period an inverse relationship between
total energy intake and TG levels was present (p <1 0.05). In both
periods the percentage of energy from carbohydrate correlated
directly with plasma TG levels (p< 0.02 and p < 0.05 respectively).
In the second period plasma TG correlated inversely with protein intake
(p < 0.02). Plasma CHOL did not correlate with diet in the first
period but in the second period an unexpected inverse relationship
















P2 -0.3^90 -0.6808 *
Protein % RDA
pl -0.637 -0.28A9
P2 -0 - 7973 0.0022
Fat % energy
P1 -0.7209" -0.03^9











Table 2: Correlation coefficients (r) between plasma
lipids and dietary intake, expressed as %
recommended for height age (RDA), in first
period (p^) and second period (p^)•
* p<0.05; ** p < 0.02; aaa p< 0.01
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DISCUSSION
As pointed out in Chapter 3, patients with chronic renal
failure commonly develop type IV hyperlipidaemia which does not
improve but is, if anything, accentuated on haemodialysis. It has
already been noted (Study I) that the hyper 1ipidaemia of uraemia is
as much a problem for children as it is for adults and the results
of the present study indicated that it is a persistent abnormality.
Although recent literature (Bagdade et al., 1978) suggests that
defective clearance of the triglyceride-rich very low density lipo¬
protein (VLDLP) from plasma is the major cause of the hyper-
trig 1 yceri daemi a in uraemic patients, increased hepatic production of
triglycerides, as a result of hyperinsulinism and carbohydrate
intolerance, plays a contributory role in its pathogenesis (Bagdade,
1970; Sanfellippo et al., 1977). When the proportion of energy
from carbohydrate increased in the second period, compared to the
first period, plasma TG levels also increased. This and the
persistently significant correlation found between plasma TG and energy
derived from carbohydrate suggest that dietary carbohydrate is a factor
in the pathogenesis of the hypertriglyceridaemia. Others (Pennesi
et al., 1976; Broyer et al., 1976) have reported similar results in
children on regular haemodialysis. Although it will not correct the
abnormality, reduction of precursors of triglycerides such as dietary
carbohydrates may therefore effect a decrease in plasma TG levels in
this respect. Sanfellippo et al. (1977) have reported a prompt
reduction in plasma TG levels in their uraemic patients following
a relatively short period of time (eleven days) on a diet low in
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carbohydrate, possibly secondary to a decrease in insulin
concentrations elicited by that diet.
Prospective epidemiological and other studies (Kannel et al.,
19715 Dayton et al., 1970) have shown that hypercholesterolaemia
is an independent major risk factor in cardiovascular disease.
Therefore, the finding of a high plasma cholesterol level in these
children awaiting renal transplantation is disturbing and therapeutic
approaches for amelioration of this abnormality are needed. Although
no direct correlation between fat intake and plasma cholesterol could
be demonstrated in this study, the significant increase in the
polyunsaturated/saturated fats ratio (p/s) in the diet in the second
period was associated with a significant decrease in plasma cholesterol
levels. In normal individuals an increase in p/s ratio lowers both
plasma cholesterol and plasma triglycerides. The absence of a lowering
effect on plasma TG levels in the patients suggests different
mechanisms for the two abnormalities. However, the purpose of this
study was not to define the discrete dietary variable responsible for
hypercholesterolaemia in these patients. Rather an attempt was made
to determine whether plasma cholesterol levels in these patients would
respond to relatively simple dietary modification.
The disparity between dietary intake and requirements is often
greater in uraemic children than in adults, because of their increased
energy needs in relation to body size and the need to ensure adequate
nutrition in children with renal failure has already been emphasized.
The results of this study suggest that restriction of dietary energy,
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protein and fat may exacerbate rather than ameliorate hyper-
triglyceridaemia in uraemic children but dietary carbohydrate is
associated with elevation in plasma TG concentration, and that an
increase in p/s ratio in the diet reduces plasma cholesterol level.
However, further studies of the effect of various dietary constituents
on plasma lipids are required, but in the meantime it seems reasonable
to try to ensure an adequate intake of total energy and protein.
Regular diet surveillance is important and for those children with
raised lipid levels, the proportions of carbohydrate and saturated fat
in the diet need to be controlled.
In conclusion, therefore, dietary management of hyper-
lipidaemia in uraemic children ensuring adequate energy intake,
primarily from polyunsaturated fat, and reducing carbohydrate
intake, may be important as a primary longitudinal approach to
reduction of the increased atherosclerotic risk in these patients.
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CHAPTER 11
GENERAL DISCUSSION AND CONCLUSIONS
This thesis did not aim to identify a single cause for the growth
retardation of children with chronic renal failure but rather to obtain
a general view of nutritional, hormonal and metabolic disturbances, their
interrelationships and relevance to growth. The observations made
appear helpful in further understanding the pathogenesis of this problem,
and provide information which may be important in the strategy for
nutritional therapy in these children.
Linear growth rate of most patients was subnormal with variable
delay in skeletal maturation and no catch-up growth was observed.
In general pubertal children grew better than prepubertal children and
continued to grow at an age when growth would be expected to cease in
normal children. However the data indicated that skeletal maturation
(bone age) advanced more rapidly than did linear growth (height age);
consequently growth potential was progressively lost. Thus, attempts
to maximise growth in early childhood before the institution of dialysis
by adequate nutritional therapy, careful control of renal osteodystrophy,
acidosis, hypertension and anaemia is very important. Regular
assessment of skeletal maturation and height age is important, and
when growth potential is clearly reduced, early renal transplantation
is indicated to improve ultimate height.
Puberty, particularly in boys, was delayed and the results indicated
that this might be related to gonadal dysfunction at least in relation
to chronological age. However the delay in the initiation of sexual
development might also be the result of a hypothalmic-pituitary
defect secondary to uraemia. Hyperprolactinaemia might also be
implicated in the pathogenesis of the delayed puberty but further
studies are required.
Energy and protein intake of most patients appeared adequate in
relation to normal children of the same height age, but data obtained
from basal energy expenditure assessment and the relationships between
metabolic hormones and energy substrates would suggest that there
was an additional demand for energy over and above that required in
normal children. Studies in acutely uraemic children (Abitbol and
Holliday, 1976) and in chronically uraemic rats (Mehls et al., 1978)
support the concept of increased energy requirements in uraemic
children. The reason for the increase in energy requirements is
obscure and further studies are required to examine the efficiency
of energy utilization for protein synthesis in these children.
It was speculated that the prime cause of energy deficit was
failure of utilization of glucose by cells and decreased fat
availability for energy production as a result of peripheral insulin
resistance and hyperinsulinaemia. It was further speculated that
the requirement of energy from protein was increased leading to an
increase in essential amino acid catabolism, an increase in alanine
release from muscle, enhanced g1uconeogenesis and body protein
depletion. An increase in protein catabolism and/or a decrease
in protein anabolism might therefore be secondary to the need
284
of energy production from protein. Thus a failure of normal energy
metabolism or an increase in the energy cost of metabolism will
reduce protein anabolism and presumably growth. Clearly the need
for adequate energy and protein intake to fulfil the requirements
is very important.
The metabolic and hormonal changes described in this thesis were
in many respects similar to the changes seen in other catabolic states
such as sepsis, burns or major trauma. The metabolic effects of
uraemia tend to alter the balance between protein anabolism and
catabolism in favour of catabolism and produce hormonal changes which
reflect and aid this alteration.
The studies on body composition demonstrated that intracellular
water or cell mass was reduced especially in the prepubertal children.
In spite of the reduction in cell mass some children were obese with
an increase in body fat derived from body water measurements or
assessed from skinfold thickness. Energy supplements, as carbohydrate,
may therefore increase body fat without increasing muscle mass.
The pubertal children grew better and had more normal body composition
than prepubertal children, and a positive correlation existed
between growth velocity and plasma sex hormone levels in the pubertal
but not in the prepubertal children. It was speculated that the
difference in body composition was determined by a lower anabolic
drive before puberty and it was suggested that anabolic steroids
might have a place in the treatment of prepubertal children with
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chronic renal failure. This awaits further studies.
Hyper 1ipidaemia was common in these children and the results
indicated that the hypertriglyceridaemia was associated with the
proportion of carbohydrates in the diet and increasing the poly-
unsaturated/saturated fat ratio in the diet had a lowering effect on
the elevated plasma cholesterol levels. In view of the high
incidence of atherosclerosis and premature deaths reported in adults
on maintenance haemodialysis ; it would seem desirable to reduce
dietary carbohydrates and to supply significant proportion of dietary
energy as polyunsaturated fats.
Many biochemical, metabolic and hormonal changes were demonstrated
in the present study, but it proved difficult to relate the abnormalities
found to growth, perhaps because growth is influenced by multiple
factors. It was unlikely that a single factor was responsible for the
growth failure in these children. A positive relationship was found
between growth velocity and the plasma levels of the branched chain
amino acids, valine and leucine. Growth may have been adversely
affected by the reduction in the availability of the branched-
chain amino acids for protein synthesis, or the low levels may
reflect energy deficit, secondary to uraemia, which in turn affected
growth. It was suggested that the provision of extra essential
amino acids or their ketoanalogues in the diet might improve protein
synthesis and growth if nitrogen toxicity is reduced, by lowering
protein intake, and adequate energy intake ensured. In this respect,
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short-term results reported recently by Giordano et al. (1978)
were encouraging but long-term studies are awaited.
Many statistically significant correlations were found between
the large numbers of variables studied. It is stressed, however,
that such correlations do not prove a cause and effect relationship,
particularly in a disease like uraemia which affects a wide
spectrum of interdependent and independent metabolic activities.
They are only a guide to the direction of future research.
The results suggested that the cause of growth retardation of
children with chronic renal failure is multifactorial and is a
cumulative effect of complex and interrelated metabolic and
hormonal derangements. A solution to this problem will most
likely be forthcoming only after the basic cellular defects in
energy and protein metabolism are elucidated. Means of improving
the insulin resistance and altering the balance between anabolism
and catabolism should also be studied.
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No. S M E S M E S M E
1 152 145 160 4.2 3.6 4.6 - 106 -
2 230 240 220 4.1 4.5 4.0 - 94 -
3 280 170 300 4.4 4.5 4.2 - 132 -
4 340 155 250 4.4 4.5 4.3 - 100 -
5 390 150 270 3.8 4.1 4.2 - 106 -
6 160 170 240 4.2 3.8 4.4 - 75 -
7 200 180 190 4.4 3.9 4.0 - 78 -
8 120 180 145 3.5 3.6 3.4 - 87 -
9 160 110 240 3.7 4.0 5 - 132 -
10 210 170 130 4.3 4.1 4.1 - 94 -
11 170 OCMca 270 3.8 4.5 4.3 - 86 -
12 145 280 195 4 3.8 4 - 115 -
13 120 350 190 4.2 4.0 3.5 - 116 -
14 310 320 210 4.9 5-3 4.5 - 116 -
15 195 320 250 4.0 4.4 | 4.3 - 92 -












No. S M E S M E S M
I
E
1 - 14 16 12 37 22 - 309 234.6
2 14 26 18 10 12 7 496.8 430.6 607.2
3 - 18 12 - 11 11 - 270.5 358.8
4 15 12 17 13 15 17 648.6 449.9 334
5 16 22 18 4 5 9 552 665.2 386.4
6 21 18 11 14 7 15 229 276 262
7 - 15 16 - 9 7 - 507.8 394.7
8 20 18 8 11 10 18 717.6 543.7 240
9 17 14 16 23 26 25 389.2 505 634.8
10 21 16 18 7 2 7 626.8 364.3 524.4
11 37 24 20 19 21 14 662.4 623.7 593.4
12 19 12 12 27 17 19 524.4 358.8 543.7
13 21 28 25 28 20 38 516 449.9 320.2
I ^ 12 31 18 10 7 18 347.8 ! 303.6 510.6
15 27 45 27 12 6 8 703.8 469.2 441 .6
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Case No. 0' 10' 30' 60' 90'
1 12 12 8 13 17
3 13 7 11 8 5
6 30 30 27 27 28
7 33 32 22 30 40
9 23 48 35 39 35
10 21 24 14 15 26
12 9 9 5 6 17
13 25 26 23 21 27
14 18 20 23 17 16





















0' 20' 40' 60'
862 506 372 353
610 338 269 325
732 541 405 321
774 424 330 378
830 464 328 370
584 458 279 298
597 328 240 288
717 410 280 326
732 360 252 313
630 354 269 239
696 377 312 360
620 413 212 340
762 310 190 260
544 260 164 330




Energy supplement during the 2nd period of the study.
SPECIAL MOUSSE
a) Recipe (10.5 oz Portion):
3Og skim milk powder
133 mis water
1 level teaspoon Custard Powder
150 mis sunflower seed oil
sugar to taste
flavouring and colouring.
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Hyperlipidaemia in children on regular haemodialysis
M. EL-BISHT1, R. COUNAHAN, R. J. JARRETT, L. ST1MMLER, V. WASS, AND C. CHANTLER
From Evelina Children's Department, Guy's Hospital, London
summary Fasting plasma concentrations of triglycerides (TG), cholesterol, immunoreactive
insulin (1RI), and blood glucose were raised in 16 children with chronic renal failure on regular
haemodialysis compared with 18 healthy children. In the patients plasma IRI correlated positively
with plasma TG, while blood glucose did not correlate with 1RI or lipid concentrations. Dietary
intake, expressed as percentage of recommended intake for height-age, did not correlate
with plasma lipids, but there was a positive correlation between plasma TG and the proportion of
calories derived from carbohydrate. The children were not malnourished as evidenced by normal
plasma albumin and transferrin concentrations.
The mechanism of the hyperlipidaemia is unclear but it may be related to the glucose intolerance
with hyperinsulinaemia which is found in uraemia. In view of the risk of premature atherosclerosis,
plasma lipid concentrations should be monitored in children with chronic renal failure and attempts
made to ameliorate hyperlipidaemia with appropriate dietary manipulations.
Hyperlipidaemia is a frequent finding in uraemic
adults (Bagdade et al., 1968; Gutman et al., 1973;
Ibels et al., 1975). Many children with chronic renal
failure are now being treated by regular haemo¬
dialysis and are often encouraged to take carbo¬
hydrate and fat supplements in their diet in an attempt
to improve growth. An assessment of plasma lipids,
particularly in relation to diet, therefore becomes
important for rational management of these children.
We report plasma concentrations of triglycerides
(TG) and cholesterol in children on regular haemo¬
dialysis with particular reference to diet, nutritional
status, plasma concentrations of immunoreactive
insulin (IRf), and blood glucose levels.
Patients
Sixteen children, 9 boys and 7 girls, with a mean age
of 14 years (range 11-17 years) were studied. All
patients were stable at the time of investigation and
had been on dialysis for more than 6 months (range
7 months-6 years). None had the nephrotic syn¬
drome, clinical or biochemical evidence of diabetes
mcllitus, or liver disease, or a known family history
of hyperlipoproteinaemia. All the children were
dialysed overnight at home for 30 hours per week
in three sessions, 13 using Meltec Multipoint dialys-
ers, 2 using Watson- Marlow Kiil type dialysers, and 1
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using a Travenol Ultra-Flow dialvser. The dialvsate
had a dextrose concentration of 200 mg/100 ml.
Apart from strict fluid and some sodium and potas¬
sium restriction, they ate a free diet with varying
amounts of energy supplements based on a glucose
polymer (Caloreen. Milner Scientific and Medical
Research Co., Liverpool) and added double-cream
(4 kcals/rr.l; 17 kJ/ml). Control values were
obtained from 18 healthy British children in fasting
state, 12 boys and 6 girls with a mean age of 12-3
years (range 10-17) requiring venepuncture for other
reasons while inpatients for minor surgery. None had
renal disease or systemic illness. They took a normal
diet but intakes were not formally assessed. Consent
was obtained in writing from the children's parents
after full explanation of the procedures to both
parents and children and the study was approved
by the Medical School Ethical Committee.
Methods
Clinical. All patients were studied as outpatients at
least 28 hours after dialysis and after an overnight
fast of more than 12 hours. Blood samples were
taken without stasis for the estimation of plasma
concentrations of TG, cholesterol, IRI. albumin and
transferrin, and blood glucose. The blood was im¬
mediately separated and plasma for 1RI measure¬
ment was frozen at 20 C until assayed. Samples for
plasma lipids were kept at 4 C and estimations and
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;erum lipoprotein electrophoresis were carried out on
he same day. Diet was assessed by prospective 3-day
weighed records. All items of food and fluids taken
>y the child 011 three successive days, including one
iialysis day, each month were recorded. Nutrient
ntakes were calculated from the diet records using
tandard tables (McCance and Widdowson, 1969).
;or this investigation the intake record closest to the
ime of study was used and was within 3 weeks of the —
ilood specimens being obtained. The dietary intakes
^ere expressed as a percentage of the recommended
Pake ("/„ Rl) for the height-age of the child
Department of Health and Social Security, 1969).
nalytical. Plasma TG was measured by the semi-
utomated fluorimetric method of Cramp and Rob¬
eson (1968) and plasma cholesterol by the auto-
tated method of Levine and Zak (1964). The
ouble-antibody immunochemical technique was
sed to measure 1R1 (Morgan and Lazarow, 1963).
lasma transferrin was determined by a single radial
imunodiffusion using Immuno-Plate III (Hyland).
lasma albumin was measured by autoanalyser
romocresol dye-binding method, Technicon).
ipoprotein electrophoresis was performed on
■.arose gel. Blood glucose was measured by auto-
talyser (ferricyanide method, Technicon).
Statistical. Student's t test was used to compare
plasma lipids, IRI, albumin, transferrin, and glucose
in patients and controls. The relationship between
plasma lipids and nutrition, !RI and TG, were ana¬
lysed by least squares linear regression.
Results
Clinical data of the patients are given in Table 1.
Table 2 gives the plasma lipids, IRI, albumin, and
transferrin concentrations and blood glucose levels
in the patients and controls. There were significant
increases in both the plasma TG and plasma
cholesterol concentrations in the patients compared
with controls. No relationship was found between
plasma lipid levels and age or sex'of the patients or
their ideal body weight for height-age. No patient
had detectable chylomicrons or a broad beta-band
on lipoprotein electrophoresis. Type IV hyper-
lipoproteinaemia was the predominant finding,
occurring in 10 of the children. Four had type lib
and 2 had normal patterns. There was a significant
increase in basal 1RI and fasting blood glucose in the
patients compared with controls. The fasting plasma
TG was positively correlated with basal IRI (Fig. 1),
but not with fasting blood glucose. IRI and fasting
blood glucose were not correlated. Plasma albumin
ible 1 Clinical data ofpatients
Sex Renal disease Age Height Height Weight Duration on
(yrs) (cm) centHe (kg) dialysis (yrs)
F Reflux nephropathy 17 8 1511 <3rd 40 3-5
F 12-4 152-1 75th 45 1-0
M 120 132-1 <3rd 28-7 5-5
F 12 8 127-4 <3rd 23 3-0
F 113 128-1 3rd 24-5 0-58
M Focal glomerulosclerosis 160 143-6 <3rd 56-9 2-0
M 12 3 141-4 25th 29 1-0
F 14 1 139-9 <3rd 41 3-0
M Chronic glomerulonephritis 150 160-1 50th 45 1-5
M 14-6 139-1 <3rd 35-5 6-5
F Juvenile nephronophthisis 12 8 142-1 10th 30-4 2-5
F 14-9 140-1 <3rd 49-2 0-75
M Single dysplastic kidney 160 148-0 <3rd 40 1-5
M Obstructive uropathy 14 8 136-6 <3rd 29-5 1-5
M Cystinosis 14-5 127-4 <3rd 31 1-0
M 117 129-3 <3rd 32 2-0
lie 2 Biochemical results in patients and controls (meanflSD)
n TG Cholesterol JRI Blood glucose Plasma albumin Plasma
(mmol/l) (mmol/l) (mU/l) (mmol/l) (8/1) transferrin
(.?//)
mis 16 1-9744 0-92 6 • 27 i 1-27 20-74:8-7 5-07 4-0-38 42 ±4-8 2-41 4:0-91
trols 18 0-8384 0-25 4-49 10-82 8-44 5-2 4-28±0-54 43 4.-1-9 2-46 ±0-52
ilicance of difference, P <0 001 <0-001 <0 001 <0 001 NS NS
triglycerides; IRI immunoreactive insulin.
crsion: SI to traditional units—Triglyceride: 1 mmol/1 80-5 mg/100 nil. Cholesterol: I mmol/1^38-6 mg/100 ml. Blood glucose:
nol 1^ 18 mg/100 ml.
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Fig. I Plasma triglyceride (TG) concentrations related
to plasma immunoreactive insulin (IRI) levels in 16
children on regular haemodialysis.
and transferrin concentrations, as indices of nutri¬
tional state, were similar in patients and controls
and did not correlate with plasma lipid levels.
Effect of diet. The dietary intakes of total energy,
carbohydrates, total fat and proteins expressed as
% RI for the height-age are presented in Table 3.
The relationship between the dietary intakes and
plasma TG and cholesterol concentrations in the
patients is shown in Table 4. There was a tendency
for those children with lower intakes of total energy,
fats, and proteins to have higher TG levels but TG
and carbohydrate intake were poorly correlated.
However, when expressed as a percentage of the
total energy intake, there was significant positive
correlation between plasma TG concentration and
percentage of calorics derived from carbohydrate
(Fig. 2). No correlation between plasma cholesterol
concentration and food intakes could be shown.
Discussion
Raised plasma triglycerides have been commonly
reported in adults on regular haemodialysis (Bagdade
el a!., 1968; Gutman et a!., 1973) and recently
Pennisi et al. (1976) and Broyer et al. (1976) re¬
ported raised TG levels in children on dialysis. Our
groupofchildren showed a similar phenomenon. Type
IV hyperlipoproteinaemia is commonly found and
the majority of our patients exhibited this pattern.
Raised TG levels in uraemia are considered to be due
to both increased hepatic TG production (Bagdade
et al., 1968; Cramp et al., 1976) and decreased TG
clearance from plasma (Cattran et al., 1976; Murase
et al., 1975). Our finding of high basal plasma insulin
levels in the face of raised fasting blood glucose is
indicative of glucose intolerance. The positive
Table 3 Diets of children on dialysis
Case Energy Protein Carbohydrate Fat
kJjday °oRI glday %RI g/day °,oRI glday -oc >3
1 9 520 99 60 103 303 101 97 114
2 12 127 126 132 228 244 82 156 184
3 14 102 134 84 133 378 109 171 184
4 10 964 125 56 106 321 118 128 162
5 15911 181 118 183 396 132 198 251
6 11 693 112 79 125 ill 101 135 145
7 10 983 105 77 122 246 102 150 161
8 12 493 130 64 110 389 130 215 253
9 12 001 102 66 88 265 80 173 166
10 4 886 47 46 73 136 42 51 55
12 10 306 107 68 117 297 109 116 136
13 18 684 159 128 70 389 107 268 258
14 6415 61 46 73 183 56 71 76
15 9 175 104 55 104 237 87 116 147
16 8 010 91 18 34 302 111 76 96
RI percentage of recommended intake.
Conversion. SI to traditional units—Energy: 1 kJ^^0-239 kcal.
Table 4 Relationship between diet (as % of RI for height-age) and plasma lipid concentrations
Total energy Fat Carbohydrate Protein
r P r P r P r P
Triglyceridcs - 0-37 NS - 0-46 <01 012 NS -0-38 NS
Cholesterol -013 NS -0 06 NS 018 NS + 013 NS




u - | , 1 1
20 40 60 70
Carbohydrate intake (% of energy)
2 Plasma triglyceride concentrations related to
bohydrate intake (% of total energy intake) in 15
Idren on regular liaemodialysis.
relation shown between plasma insulin and TG
icentration is similar to that found in uraemic
tits (Bagdade, 1970) and it is possible that hyper-
tlinaemia might stimulate an increased hepatic
production, as suggested for nonuraemic sub-
s (Reaven et al., 1967; Olefsky et ai, 1974).
he role of diet in the pathogenesis of hyper-
lyceridaemia in uraemia is not clear. No correla-
existed between total energy intake and TG
tentration, though higher total energy and pro-
intakes tended to be associated with lower levels.
TG levels reported here are about 65% lower
those reported by Broyer et ah (1976) in
iren on dialysis, and energy and protein intakes
ur children were considerably greater than in
study. However, other differences exist in the
tgement of these children, for instance our
ren dialyse for about 30 hours a week compared
16 hours a week. The proportion of total energy
c derived from carbohydrate correlated signi-
ly with TG concentrations. Both Pennisi et ah
) and Broyer et al. (1976) showed a similar
onship between dietary carbohydrate and
la TG concentration. More recently, Sanfelippo
et al. (1977) reported a reduction in plasma TG levels
by feeding diet low in carbohydrate and high in
polyunsaturated fat. Unfortunately it is not known
from their study which of the two variables in the
diet altered the TG levels.
Plasma cholesterol concentrations are usually
found to be normal in uraemic adults whereas our
patients showed considerable increases both com¬
pared with controls and with the children reported
by Broyer et al. (1976), though 6 of 17 children in the
latter study also showed significantly increased levels.
We were unable to show any relationship between
diet and plasma cholesterol, though Broyer et al.
suggested a relationship with lipid intake. As our
patients were taking energy supplements based on
food high in saturated fats, it is possible that manipu¬
lation of the diet by increasing the polyunsaturated
fat intake might lead to a fall in plasma cholesterol,
and we are attempting this at present.
The finding of hyperlipidaemia in children on
regular haemodialysis awaiting transplantation is
disturbing in view of the relationship between hyper¬
lipidaemia ana arterial disease shown in prospective
studies of normal populations (Kannel et a!., 1971;
Carlson and Bottiger, 1972) and the increased
incidence of premature atherosclerosis and cardio¬
vascular disease reported in adult patients on long-
term haemodialysis (Lowrie et al., 1973; Lindner
et al., 1974; Bagdade, 1975). Pennisi et al. (1976)
studied the morphology of coronary arteries in
children who died while on regular haemodialysis
for renal failure. In comparison with children dying
of other diseases at a similar age, there were changes
suggestive of fat deposition in the arterial walls.
While the exact mechanism of the hyperlipidaemia
remains obscure, it obviously is important to measure
TG and cholesterol concentration both in children
on haemodialysis and in children with chronic renal
insufficiency who have not yet required dialysis or
transplantation. If raised levels are found, attempts
can be made to lower them by dietary manipulation
or increased dialysis. The need to ensure adequate
nutrition in children in renal failure has been em¬
phasized (Chantler and Holliday, 1973). Further
studies of the effect of various dietary constituents on
plasma lipids are required, but in the meantime it
seems reasonable to try to ensure an adequate intake
of total energy and protein. Regular diet surveillance
is important and for those children with raised lipid
levels the proportion of carbohydrate and saturated
fat in the diet may need to be controlled.
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Hormonal and metabolic responses to
intravenous glucose in children on regular
hemodialysis1, 2
Mohamed M. El-Bishti,3 M.B., Ch.B., D.C.H., Ralph Counahan,4 M.R.C.P., D.C.H.,
Stephen R. Bloom,'' M.R.C.P., and Cyril Chanller,6 M.A., M.D., M.R.C.P.
ABSTRACT Blood glucose, plasma nonesterified fatty acids, amino acids, immunoreactive
insulin, growth hormone, and immunoreactive glucagon responses to intravenous glucose were
determined in 16 children on regular hemodialysis for chronic renal failure and nine healthy
children. In the patients the fractional disappearance rate of glucose was significantly reduced,
basal immunoreactive insulin was significantly raised, and while the early immunoreactive insulin
response to glucose was similar in patients and controls, the late response was increased. Basal
growth hormone was elevated in the patients and rose paradoxically following glucose. Fasting
immunoreactive glucagon was significantly higher in the patients and was not suppressed by
glucose. Plasma nonesterified fatty acid levels were lower in the patients and fell more markedly
after glucose. Alanine levels, which were significantly raised in those with poor glucose tolerance,
fell to normal after glucose and did not vary in those with mere normal glucose tolerance. It is
speculated that the metabolic and hormonal alterations may be interrelated and result from failure
of normal glucose utilization. Am. J. Clin. Nutr. 31: 1865-1869, 1978.
Most children with chronic renal failure
fail to grow normally and are, therefore, in¬
sufficiently anabolic. An adequate supply of
dietary energy and protein may improve
growth rate but does not ensure it (1). The
increased catabolic responses to stress in
uremic rats (2) and the possibility of increased
mergy and protein requirements for anabo-
ism in acutely uremic children (3) suggest
he possibility of defective energy utilization
esulting in altered protein metabolism (4).
The responses of the major fuel substrates,
jucose (BG), nonesterified fatty acids
NEFA) and amino acids (AA) and the more
mportant metabolic hormones, insulin,
rowth hormone (GH), and glucagon (IRG)
allowing intravenous glucose, were studied
l a group of children on regular hemodi-
lysis for renal failure in an assessment of
ormone-fuel interrelationships.
laterials and methods
Sixteen children, nine boys and seven girls, with mean
e of 13.9 years were studied. All were stable at the time
investigation and had been on dialysis for at least 6
tilths (range 0.58 to 5.6 years). None had the nephrotic
ldrome. clinical or biochemical evidence of diabetes
rllitus, or liver disease. All were diaiyzed with a glucose
concentration of 200 mg/dl. Apart from fluid, sodium,
and potassium restriction, they ate a free diet with vary¬
ing amounts of energv supplements based on a glucose
polymer (Caloreen; Milner Scientific and Medical Re¬
search Co.. Liverpool. England), and double cream (4
kcal/ml). Controls were nine healthy children, five boys
and four girls, with a mean age of 12.5 years. Studies
were performed after an overnight fast of at least 14 hr,
and at least 28 hr postdialysis.
Glucose. 0.5 g/kg of a 50% solution was injected
intravenously over a period of 3 min and blood samples
were taken at 0, 5. 10, 15, 20, 30, 40, 50, 60, 90, and 120
min. BG was measured by autoanalyser (Ferricyanide
method, Technicon). Radioimmunoassay techniques
were used for the determination of insulin (5), GH (6),
and IRG (7). Plasma NEFA was measured by a semiau-
tomated fluorimetric method (8). The plasma amino
acids methodology and results have been reported (4).
Glucose disappearance rate (K) was calculated by the
method of least squares regression after logarithmic
transformation. The early insulin response (0 to 10 min)
'From the Evelina Children's Department, Guy's
Hospital, London, SE1 9RT, England.
"Supported by grants from Gar Yunis University,
Benghazi, Libya (M.M.E1-B) and the National Kidney
Research Fund (R.C.).
3 Honorary Lecturer, Department of Pediatrics. Guy's
Hospital. Author to whom requests for reprints should
be addressed. J Honorary Lecturer, Department of
Pediatrics, Guy's Hospital. ''Consultant Physician,
Hammersmith Hospital, London. 6 Consultant Pedia¬
trician, Guy's HospitaL
? American Journal ofClinical Nutrition 31: OCTOBER 1978, pp. 1865-1869. Printed in U.S.A. 1865
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was calculated by subtracting the fasting value from the
means of the 5 and 10 min values. The later insulin
response was calculated as the means of absolute values
between 20 and 60 min following glucose injection.
Student's / test was used to compare results in patients
and controls. The significance of changes in response to
glucose was assessed by paired l tests.
Results
Clinical data on the patients have been
published (4). Fasting BG was significantly
raised in the patients (P < 0.001) and the rate
of glucose disappearance (K value) signifi¬
cantly reduced (Fig. 1 and Table 1). Fasting
insulin levels were significantly elevated in
the patients (P < 0.01). Following glucose
injection, the early insulin response (0 to 10
min) was similar in patients and controls. The
late response (20 to 60 min) was significantly-
raised in the patients (Fig. 2 and Table 1).
0 5 10 15 20 30 40 50 60
Time (minutes)
FIG. 1. Mean ± 2 SEM of blood glucose values
during IVGTT in patients and controls.
Fasting Gil levels were significantly raised in
the patients (P< 0.02) and rose paradoxically
following intravenous glucose (Fig. 3). Basal
plasma 1RG levels were significantly in¬
creased in the patients (P < 0.005). After
glucose injection 1RG fell significantly in the
controls, but remained elevated throughout
the test in the patients (Fig. 4). Fasting NEFA
were significantly reduced in patients, and
fell more markedly and for longer in response
to intravenous glucose; the levels being sig¬
nificantly lower 40 and 60 min after the glu¬
cose injection (Fig. 5). Reductions in AA
compared with normal, were found in valine,
leucine, isoleucine. lysine, histidine, tyrosine,
and serine; and increases in glycine, citrulline,
proline, and 1- and 3-methyl histidine. Acute
reductions in AA concentrations occurred in
response to intravenous glucose similar to
those reported in normal adults (9), but
plasma alanine, which was significantly
raised in those with poor glucose tolerance,
fell to normal, and did not vary in those with
more normal glucose tolerance.
Discussion
Carbohydrate intolerance is well docu¬
mented in adult uremic patients and periph¬
eral insulin resistance seems to be the chief
cause (10). The glucose disappearance rate
(K) was reduced in the majority of our pa¬
tients. The basal differences in BG concen¬
tration could be partly due to the nonspecific
method of measurement used. However, in¬
terfering substances do not change during the
glucose tolerance test and so the dynamic
changes of BG during the test are valid (11).
The' normal early insulin response found
in this study excludes a defect in pancreatic
TABLE 1
Mean ± 1 SD of plasma insulin (munits/liter) in response to intravenous glucose in children on
hemodialysis and controls
_ Early response Late response „ , c ,
Fasl,ns (Q-10 min) (20-60 min) K va,uc for glucose
Patients (16) 16.7 ± 33.2 ± 25.7 ± 1.09 ±
7.7 13 12.7 0.28
Controls (9) 8.2 ± 24.6 ± 11.8 ± 1.84 ±
3.7 11.2 3.6 0.30
Significance of differ- <0.01 NS" <0.005 <0.001
ence (P)
" Not significant.
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insulin secretion as a cause of the glucose
intolerance. However, the raised BG levels,
in spite of elevated plasma insulin is indica¬
tive of peripheral resistance to insulin. The
degree of glucose intolerance did not corre¬
late with plasma GH, 1RG, or NEFA and the
precise nature of this resistance remains ob¬
scure. It is of interest that fasting plasma.
NEFA levels were significantly lower in the
-patients and fell more markedly following
^glucose. This suggests a decrease in lipolysis
tnd/or increased reesterification ofNEFA in
he uremic state due to high insulin levels,
tnd that adipose tissue is not resistant to the
iction of insulin.
Elevated plasma GH has been reported in
0 10 20 30 40 50 60
Time (minutes)
FIG. 2. Mean ± 2 SEM of plasma immunoreactive
isulin, fasting and in response to intravenous glucose in
atients and controls.
FIG. 3. Mean ± 2 SEM of plasma growth hormone
ncentrations, fasting and in response to intravenous





FIG. 4. Mean ± 2 SEM of plasma immunoreactive
glucagon, fasting and in response to intravenous glucose
in patients and controls.
FIG. 5. Percentage fall (Mean ± 1 SD) of plasma
nonesterified fatty acids following intravenous glucose.
adults with chronic renal failure and is due
to increased secretion, as shown by the
prompt reduction in levels following soma¬
tostatin administration (12, 13). Wright et al.
(12) suggested that it could be due to protein
malnutrition but Davidson et al. (14) found
no correlation between GH concentration
and dietary protein; nor could we demon¬
strate any correlation between plasma GH
concentration and either plasma albumin or
transferrin as indices of nutritional status, or
with dietary protein. It is possible that the
intracellular energy supply is deranged in
uremia and that GH secretion is increased in
an attempt to mobilize fat for energy and
preserve body protein. The rise in GH after
glucose is interesting. Is the normal GII re¬
sponse to glucose somehow ablated in uremia
and the falling plasma NEFA levels stimu¬
lating its secretion? There is evidence that
1868 EL-B1SMT1 ET AL.
plasma NEFA have a regulatory effect on
GH secretion (15).
If both endogenous fat mobilization and
NEFA oxidation are decreased in uremia (16,
17) in the face of a failure of glucose utiliza¬
tion, this might lead to increased utilization
ofAA as energy substrate. We reported these
children to have a significant reduction in the
branched-chain AA (4) which are known to
be oxidized in muscle (18). Alanine, the major
gluconeogenic substrate, was found to be high
in those patients with poor glucose tolerance.
This might be an indication of its increased
peripheral release as essential amino acids
were used up for energy and broken down
for gluconeogenesis.
Hyperglucagonemia is well recognized in
uremic adults and is due probably to in¬
creased secretion as well as decreased degra¬
dation of glucagon (19, 20). Although non-
suppressible in our study, Kuku et al. (21), in
demonstrating that it was a heterogeneous
molecule, showed that the fragment which
corresponds to standard glucagon did fall in
concentration after glucose, though not to
normal levels. Sherwin et al. (20) also suggest
that tissue sensitivity to glucagon is increased
in uremia. It is not known why glucagon
secretion is increased in uremia but it may be
stimulated by the retention of nitrogenous
compounds (22) or a response to glucopenia
induced by failure of normal glucose trans¬
port or metabolism.
Increased protein breakdown, alanine
release, and gluconeogenesis (23) are in keep¬
ing with hyperglucagonemia. Felig et al. (24)
have shown that in fasted man, hepatic glu¬
coneogenesis is limited by substrate availa¬
bility. In prolonged starvation adaptive
mechanisms which conserve protein come
into play and substrate supply for gluconeo¬
genesis is decreased. There is increased utili¬
zation of fat for energy. Such an adaptation
may be denied to the uremic patient.
The use of intravenous glucose as a tool to
investigate hormonal and metabolic interre¬
lationships has revealed different responses
in children with chronic renal failure com¬
pared with healthy children. On the basis of
these findings we speculate that the prime
defect is a failure of normal glucose uptake
by cells and decreased fat availability for
•energy production leading to increased pro¬
tein catabolism and in the case of children,
failure of growth. £2
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Plasma amino acids in children and adolescents on
hemodialysis
Ralph Counahan, Mohamed El-Bishti, Brian D. Cox, Chisholm S. Ogg and
Chantler
Departments of Paediatrics and Medicine and the Renal Unit, Guv's Hospital, London, England
Plasma amino acids in children and adolescents on hemodialysis.
-asting plasma amino acid concentrations were measured in 16
hildren on regular hemodialysis for renal failure. Reductions
ompared to normal were found in valine, leucine, isoleucine,
vsine. histidine. tyrosine, and serine; and increases were found in
lycine, citrulline. proline, and I- and 3-methylhistidine. Acute
eductions in amino acid concentrations occurred in response to
v. glucose, similar to those reported in normal adults, but plasma
lanine. which was raised only in those with poor glucose toler-
nce. fell to normal and did not vary in those with normal glucose
iterance. No correlations were found with growth, but the plasma
ycine concentration was highest in those patients with poorest
lergy intakes. Plasma alanine concentrations correlated with
ised triglyceride concentrations. It is suggested that many of the
tnormalities are due to the excessive utilization of protein for
tergy because of impaired availability of conventional energy
urces in uremia.
Acides amines du plasma chez les enfants et adolescents en hemo-
tlvse. Les concentrations des acides amines du plasma ont ete
isurees a ieun chez 16 enfants en hemodialyse iterative pour
ufhsance renale. Par comparaison avec des sujets normaux, des
ninutions ont ete constatees pour valine, leucine, isoleucine,
ine, histidine, tyrosine et serine et des augmentations pour gly-
e, citrulline, proline et 1- et 3-methylhistidine. Des dimunutions
ues des concentrations d'acides amines ont ete observees en
ponse a I'administration intraveineuse de glucose, semblable a
!es rapportees chez les adultes normaux, a l'exception de
anine dont la concentration n' a pas ete modifiee chez les sujets
nt une tolerance au glucose normale et a ete abaissce a des
;urs normales, a partir d'une valeur elevee, chez les sujets ayant
tolerance au glucose diminuee. Aucune correlation n' a ete
ervee avec la croissance mais la concentration plasmatique de
'ine est la plus elevee chez les malades dont l'apport energetique
le plus faible. Les concentrations plas matiques d' alanine sont
elees avec 1'augmentation de la concentration des triglycerides,
st suggere que beaucoup de ces anomalies sont liees a
lisation excessive des proteines comme source d'energie en
in de la diminution des sources d'energie conventionnelles an
s de l'uremie.
lasma amino acid concentrations are abnormal in
nic adults even after treatment by hemodialysis
, 3], The concentrations of some essential amino
s are frequently reduced and those of nones-
ved for publication April 29, 1976;
n revised form July 29, 1976.
6, by the International Society of Nephrology.
sential amino acids are normal or increased. Certain
changes, such as the reduced ratio of tyrosine to
phenylalanine [4], decreased valine/glycine ratio [5],
and increased citrulline concentrations [6] are charac¬
teristic, while others such as alterations of histidine
and phenylalanine concentrations vary from study to
study. Some of these changes are also seen in energy-
protein malnutrition and it has been difficult to dis¬
tinguish whether changes in uremia reflect a specific
metabolic disturbance, or are secondary to malnutri¬
tion.
There is little published information on the
changes in children. We have measured plasma
amino acid concentrations in a group of children on
regular dialysis and related them to growth, nutri¬
tion, and other biochemical parameters.
Methods
Subjects. Sixteen children, 9 boys and 7 girls with a
mean age of 14 years (11 to 17 years) who had been
on regular hemodialysis in the home for more than
six months (seven months to six and one-half years),
were studied (Table 1). None had any systemic dis¬
ease and all were stable at the time of investigation.
They dialyzed for ten hours overnight on three nights
of each week, 13 using Meltcc Multipoint dialysers,
two using Watson-Marlow Kiil type dialyzers and
one using a Travenol Ultra-Flo dialyzer. The dialy-
sates had a glucose concentration of 200 mg/100 ml.
Normal meals were eaten and dietary restrictions
were confined to sodium and potassium, where neces¬
sary, and fluid intake was limited to approximately
300 ml per day. Each child also took a variable
amount of a highly concentrated energy mixture
based on double cream and a glucose polymer (Calo-
reen", Milner Scientific and Medical Research Com¬
pany, Liverpool, England). Control values were ob¬
tained from children having venepuncture for other
reasons while inpatients for minor surgery. None had
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Table 1. Clinical data of children on hemodialysis
I leight eentile Height velocity, cm/yri Duration on
Age, Bone 1 leight. chron. bone expected lor dialysis
Renal disease yrs age cm age age actual bone age yr
Reflux nephropathy 17.8 15.0 150.1 <3rd 3rd-10th 1.0 1.2 3.5
Reflux nephropathy 12.4 13.5 152.3 75th 25th-50th 6.5 4.5 1.0
Reflux nephropathy 12.0 8.0 132.1 <3rd 75th-90lh 4.2 5.5 5.5
Reflux nephropathy 12.8 8.5 127.4 <3rd 50th 3.4 5.4 3.0
Reflux nephropathy 11.3 11.0 128.1 3rd 3rd 4.1 6.1 0.58
Focal glomerulosclerosis 16.0 14.0 143.6 <3rd <3rd 1.1 7.3 2.0
Focal glomerulosclerosis 12.3 12.5 141.4 25th 25th 1.9 5.5 1.0
Focal glomerulosclerosis 14.1 8.0 139.9 <3rd >97th 2.6 5.5 3.0
Chronic glomerulonephritis 15.0 15.0 160.1 50th 50th 5.8 5.8 1.5
Chronic glomerulonephritis 14.6 10.0 139.1 <3rd 50lh-75th 6.2 5.1 6.5
Juvenile nephronophthisis 12.8 12.0 142.1 10th 25th 1.6 5.0 2.5
Juvenile nephronophthisis 14.9 15.0 140.1 <3rd <3rd 2.6 1.1 0.75
Single dysplastic kidney 16.0 — 148.0 <3rd — — — 1.5
Obstructive uropathy 14.8 10.0 136.6 <3rd 50th — — . 1.5
Cystinosis 14.5 11.5 127.4 <3rd <3rd 5.5 4.9 1.0
Cystinosis 11.7 11.0 129.3 <3rd 3rd 2.3 5.0 2.0
disease or systemic disturbance, and no dietary
nation was available.
: study was approved by the Medical School
il Committee and consent obtained in writing
the children's parents after full explanation to
rarents and children.
thods. After an overnight fast of at least 14 hr
on, 24 to 48 hr after finishing a dialysis, blood
es were collected without stasis in the resting
'rom the venous side of arteriovenous ftstulae
eparinized tubes. Thirteen of the children also
/. glucose tolerance tests (IVGTT = 0.5 g of
ucose per kg of body weight) and blood sam-
r amino acid analysis were obtained after fast-
d at one hour after glucose injection. The
s were separated promptly, deproteinized with
fie acid, to which norleucine had been added as
1 standard and stored at —20°C prior to analy-
nino acids were measured by ion-exchange
itography on an automatic amino acid ana-
.KB 3201). A three sodium buffer step system
;d with a constant operating temperature of
\liquots of plasma were also analyzed for
rides by a semiautomated method [7], for cho-
by the automated method of Levine and Zak
for nonesterified fatty acids (NEFA) by a
omated fluorimetric method [9]. Blood glu¬
ts measured by autoanalyzer (ferricyanide
Technicon). plasma albumin by autoanaly-
mocresol dye-binding method, Technicon),
trea by autoanalyzer (diacetylmonoxine reac-
tsnta creatinine by autoanalyzer (Technicon,
1 lb), plasma transferrin by single radial im-
'usion, and plasma insulin by double an-
dioimmunoassay [10],
Linear growth was measured according to the
method of Tanner, Whitehouse, and Takaishi [11],
and bone age was assessed by independent observers
using the method of Greulich and Pyle [12],
Food intakes were assessed by three-day prospec¬
tive weighed recordings done at home, usually on
Friday, Saturday, and Sunday and including one
dialysis day (Table 2). These are performed regularly
and the intakes used for this study were all recorded
within three weeks of the blood samples being ob¬
tained. The dietary intakes were expressed as a per¬
centage of the recommended dietary allowance [13],
according to the height age of the child.
Statistical methods. Student's t test was used to
compare amino acid concentrations in patients and
controls. The relationships between amino acids and
growth, nutrition, and other biochemical parameters
were analyzed by least squares linear regression. The
significance of changes in amino acid concentrations
in response to glucose was assessed by paired t tests.
Results
The means and standard deviations of plasma am¬
ino acid concentrations in patients and controls are
shown in Table 3. Values are not shown for threon¬
ine. because of its poor separation from glutamine;
tryptophan, because of its appreciable reduction by
the use of picric acid as a deproteinizing agent [14];
and glutamine because of its cyclization to pyrroli¬
dine carboxylic acid known to occur at the column
temperature used [15],
There were significant reductions in concentrations
of valine, leucine, isoleucine, lysine, tyrosine, serine,
and histidine. Glycine, citrulline, proline, and 1- and
3-methylhistidine were significantly elevated, while
Plasma amino acids in renalfailure 473
Table 2. Diets of children on dialysis
Rnergy Protein Carbohydrate Fat
Patient No. kjoules/day %RDA" g/day %RDA" g/day %RDA" g/day %RDA"
1 9520 99 60 103 303 101 97 114
2 12127 126 132 228 244 82 156 184
3 14102 134 84 133 378 109 171 184
4 10964 125 56 106 321 118 128 162
5 15911 181 118 183 396 132 198 251
6 11698 112 79 125 327 101 135 145
7 10983 105 77 122 246 102 150 161
8 12493 130 64 110 389 130 215 253
9 12001 102 66 88 265 80 173 166
10 4886
1 1
47 46 73 136 42 51 55
I 1
12 10306 107 68 117 297 109 116 136
13 18684 •59 128 70 389 107 268 258
14 6415 61 46 73 183 56 71 76
15 9175 104 55 104 237 87 116 147
16 8010 91 18 34 302 111 76 96
" RDA = Recommended Daily Allowance.
the remainder were within normal limits. Alanine was at the 5% level. A direct linear relationship was
at the upper limit of normal. The ratio of tyrosine to shown between the plasma citrulline concentration
phenylalanine was consistently reduced, mainly due and energy and protein intake (Table 4). Other amino
to the reduction in tyrosine concentration. The va¬ acid concentrations did not correlate at the 5% level
line/glycine ratio was also low because of the reduced with albumin and there was no correlation between
valine concentration and raised glycine concentra¬ amino acid concentrations and transferrin and hemo¬
tion. globin concentrations. The plasma albumin concen¬
Effect of diet and nutritional stale. There was an trations were all within the normal range (3.6 to 5.3
inverse linear relationship between glycine concentra¬ g./100 ml) and did not correlate with diet.
tion and fat and energy intakes (Table 4). The va- Amino acids and growth. Each amino acid was ana¬
line/glycine ratio showed a similar, though not as lyzed in relation to the degree of growth failure,
:lose a relationship, and the plasma valine concentra- growth velocity, and bone maturity and no signifi-
ion was not influenced by diet at all. However, there cant associations were found.
vas a direct linear relationship between the plasma Amino acids and lipids. Full results of piasma lipid
/aline concentration and plasma albumin, significant determinations will be published elsewhere. Plasma
Table 3. Plasma amino acid concentrations in patients and controls
Patients Controls
Mean Mean
Amino acid No. nmol/ml SD No. nmol/ml SD P
Valine 16 145 29 8 207 27 <0.001
Leucine 16 69 13 8 102 16 <0.001
Isoleucine 16 42 13 8 52 7 <0.05
Lysine 15 155 23 8 181 26 <0.05
Methionine 14 14 4 7 17 2 NS
Phenylalanine 16 39 9 8 40 5 NS
11 istidine 16 70 11 8 86 19 <0.05
Alanine 16 380 150 8 275 49 NS
Glycine 16 405 113 8 224 30 <0.001
Citrulline 16 89 22 8 78 7 <0.001
Serine 15 83 21 7 163 27 <0.001
Tyrosine 16 23 6 8 40 8 <0.001
Cystine 15 56 15 2 35 3 NS
Ornithine 15 62 15 8 59 18 NS
Arginine 13 74 21 8 70 10 NS
Proline 15 231 105 7 133 37 <0.05
Tyrosine/phenylalanine 16 0.61 0.12! 8 0.99 0.17 <0.001
Valine/glycine 16 0.39 0.14 8 0.93 0.19 <0.001
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As percentage of Recommended Daily Allowance for height and age.
Table 4. Relationship between diet" and plasma amino acid concentrations
Amino acid
Protein Fat Carbohydrate 1 inergy
r P r P r P r P
Glycine -0.41 NS -0.60 <0.05 -0.25 NS -0.55 <0.05
Valine + 0.19 NS + 0.14 NS + 0.14 NS + 0.22 NS
Valine/glycine + 0.34 NS + 0.56 <0.05 + 0.19 NS + 0.55 <0.05
Cilrullinc + 0.52 <0.05 + 0.48 0.1 + 0.43 0.1 + 0.54 <0.05
triglyceride concentrations were significantly raised
and correlated with plasma alanine (r = +0.55; N =
16; P < 0.05). Plasma cholesterol concentrations
were also significantly raised and correlated inversely
with plasma proline (r = —0.57; N = 15; P < 0.05)
and plasma proline concentrations correlated directly
with plasma nonesterified fatty acids (NEFA) (r =
+ 0.61; A' = 15; P < 0.05). The NEFA tended to be
low, but not significantly so.
The effect of glucose. There was a significant mean
reduction in the concentrations of valine, leucine and
isoleucine, tyrosine, alanine, lysine, ornithine and se¬
rine 60 min after glucose injection (Table 5). Other
amino acids also fell in concentration, but not signifi¬
cantly. These changes did not correlate with the peak,
or the 60 min plasma insulin concentrations;
The concentration of alanine 60 min after glucose
injection was expressed as a percentage of the fasting
level and compared to the glucose disappearance rate
(A) during the 1VGTT. There was a close linear rela¬
tionship between the percentage reduction and the K
values (Fig. 1). The fasting concentrations of alanine
correlated inversely with the K values for glucose
Table 5. Plasma amino acid concentration during fasting and










Valine 13 164 10 146 9 <0.001
Leucine 13 73 5 62 4 <0.001
Isoleucine 13 44 3 37 3 <0.01
Lysine 11 159 10 148 9 <0.05
Methionine 9 11 2 9 1 NS
Phenylalanine 13 38 2 38 2 NS
1 listidine 13 69 5 69 4 NS
Arginine 13 75 5 76 5 NS
Glycine 12 392 30 385 28 NS
Alanine 13 337 39 298 27 <0.05
Serine 13 84 6 75 4 <0.05
Cystine 11 60 6 58 6 NS
Ornithine 11 60 5 53 3 <0.05
Tyrosine 13 21 1 17 1 <0.01
Citrulline 13 92 4 84 4 NS
(r = —0.62; A7 = 13; P < 0.05); thus, the worse the
glucose tolerance, the higher the fasting concentra¬
tion of alanine and the greater its fall after glucose.
Those with better glucose tolerance had normal
plasma alanine concentrations, which showed little or
no change when glucose was injected. These findings
did not apply to any of the other amino acids,
Amino acids and residual renal mass and uremia.
Two patients were anephric and analysis of their
results showed no significant difference in com¬
parison to the remainder. No plasma amino acid
concentration correlated with that for creatinine but
the plasma urea concentration correlated inversely
both with the plasma glycine (r = —0.6031; P < 0.05)












r = + 0.644
y = 22x + 64
I
2.0
_j j —] | , -j- , r
0.4 0.8 1.2 1.6
Glucose disappearance rate [K) during i.v.
glucose tolerance test
Fig. I. Relationship between the percentage of reduction in plasma
alanine' concent ration 60 minutes after glucose injection and the K
values for glucose during i.v. glucose tolerance tests.
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Discussion
These patients were at the upper age range of child¬
hood for practical reasons; live were pubertal, four
were in early puberty, and the remainder were pre¬
pubertal. Most had a retarded bone age (Table 1).
While age does influence plasma amino acid concen¬
trations, there is no evidence that significant changes
occur over the age range we studied, and the controls
were of a comparable age.
Comparison with similar reports on adults on
hemodialysis shows how much interstudy variation
exists. Direct quantitative comparisons are restricted
by dilferences in methodology, such as sample prepa¬
ration and analytical procedures. In most reports
there is little information on dietary intakes and it is
likely that considerable variation exists. The effect of
heterogeneity of body composition is not known, nor
are the effects of residual renal mass. Our data do
not show significant differences between anephric
patients and others but are too scanty in this respect
to be helpful.
Reductions in the concentrations of the brancbed-
:hain amino acids—valine, leucine and isoleucine—
ind tyrosine and lysine are the changes most consist-
■ntly found. McGale, Pickford. and Aber [17] have
ound glycine to be increased as we have, whereas
leld et al [3] have reported a reduction not only in
lycine. but also in alanine and phenylalanine,
'henylalanine has been most frequently reported to
e normal in concentration in uremic patients, both
n and off dialysis [1], Histidine concentrations may
e normal [2], or reduced [1], while 1- and 3-meth-
Ihistidine concentrations are typically increased [1,
, 17]. The ratio of essential to nonessential amino
fids is reduced in uremia, but we have not analyzed
lis. because Kopple and Swendseid [5] have shown
lat this ratio is a function of protein intake, rather
an uremia. In addition we have excluded some
nino acids from analysis for technical reasons and
is would affect the ratio. We suggest that the differ-
ces found from study to study are more influenced
nutrition (and perhaps body composition),
lereas the similarities could be the consequence of
emia, with malnutrition playing a less important
—He.
Both plasma glycine and alanine concentrations
rvvcd a significant inverse relationship with the
tsma urea, but no amino acid correlated with the
sma creatinine concentration. The efficacy of
lysis is difficult to measure. All the children were
lyzed similarly for 30 hr each week with mem¬
oes of appropriate size to body surface area and
the plasma creatinine and urea are probably in-
nced more by the patients' muscle mass and pro¬
tein intake, respectively. Notwithstanding this, it is
possible that the changes in these two amino acids
were independent of the efficacy of the dialysis pro¬
cedure (as evidenced by the plasma creatinine), but
that they may have been influenced by other factors
which could elevate the urea, such as high protein
intake or endogenous protein catabolism. While nei¬
ther amino acid correlated significantly with the pro¬
tein intake. Table 4 shows that the plasma glycine
concentration tended to vary inversely with the pro¬
tein intake.
In the present study overt clinical signs of malnu¬
trition were not present, but growth retardation and
delayed bone maturation frequently were. Dietary
intakes recorded in our children and expressed ac¬
cording to actual body weight or height age seem
adequate, but in the face of chronic malnutrition
there may be greatly increased energy requirements
for catch-up growth [18], which, given the other con¬
straints of uremia, may be difficult to satisfy. When
the dietary intakes are expressed in relation to chro¬
nological age they are inadequate. The dietary re¬
cording was not supervised and the mean coefficient
of variation in five diet assessments per child was 15%
(range, 6 to 28%) but despite this the plasma glycine
still falls as energy intake rises, even when the mean
of several plasma glycine estimations over a six-
month period for each child is analyzed in relation to
the mean of the intakes over the same period. In fact,
the correlation between plasma glycine concentration
and fat and energy intake then becomes significant at
the 1% level and protein intake also becomes a signifi¬
cant factor [19], We do not know which method of
dietary assessment is most representative.
In contrast to our findings on valine and glycine,
Kopple and Swendseid [5] have shown that the
plasma valine/glycine ratio was affected both by
dietary protein and by uremia, being most reduced in
subjects on hemodialysis consuming a low-protein
diet. It is not clear whether the ratio was altered by
changes in glycine or valine concentration, or both,
and whether the diet had any effect on the plasma
valine concentration at all. Swendseid et al [20] have
shown that the plasma valine concentration falls rap¬
idly in young healthy adults when their protein intake
is sharply reduced. We have found that in a group of
uremic children, despite considerable variation in
protein intake (0.5 to 4.8 g/kg of body wt/day), the
plasma valine concentration did not show related
variation, although it was reduced in the group as a
whole. It may be that, taking each child as his own
control, a further reduction in plasma valine concen¬
tration might occur if protein intake is sharply re¬
duced, but the distinct lack of correlation of valine
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with diet suggests that its alteration is due more to
effects of the uremic state on protein metabolism. The
plasma albumin concentration also did not correlate
with diet and possibly its relation to plasma valine
indicates that both reflect the nutritional state of the
individual whether there is protein deficiency for
metabolic or dietary reasons. The plasma glycine on
the other hand may be more responsive to alterations
in the actual dietary intake.
If it is accepted that the intakes of these children,
while not fulfilling the requirements for much catch¬
up growth, are adequate according to body size, then
the changes in the amino acid concentrations we have
found may be metabolic in origin. Essential amino
acid losses in the dialysate are not greater than nones¬
sential amino acid losses and are easily replaced by
the diet [17],
There is evidence that glucose [21] and lipid metab¬
olism [22] are abnormal'in uremia, with peripheral
resistance to insulin and thus impaired utilization of
glucose with hvperinsulinemia. Either secondarily or
independently, lipid uptake appears to be reduced
[23] and lipolysis may also be reduced [24], These
may interfere with the supply of energy substrate, and
amino acids may be diverted from protein production
to energy, a paradoxical finding in the face of hyper-
insulinemia which stimulates the cellular uptake of
amino acids. However, a similar metabolic state is
seen in sepsis accompanied by acute starvation [25],
In chronic protein wasting states, as in uremia, the
plasma concentrations of the branched-chain amino
acids are reduced [26], Preferential oxidation of the
branchcd-chain amino acids to C02 occurs in muscle
[27] and we suggest that with impaired utilization of
conventional energy sources in uremia, oxidation of
the branched-chain amino acids occurs to provide
energy, leaving a surfeit of other nonessential amino
acids. The raised plasma alanine concentrations in
some patients may be an indication of its increased
peripheral release as essential amino acids are used
jp for energy. Disordered lipid metabolism is in part
Town by high concentrations of plasma triglycerides
TG) and we have found that as energy intakes in-
reased TG concentrations tended to fall [19], The
nean plasma alanine concentration at the upper limit
f normal disguises how several patients had consid-
rably elevated concentrations (Fig. 2), which were
ssociated with elevated TG concentrations. How-
/er, diet had no effect on alanine concentration and
tesc abnormalities may be present for unrelated rea¬
ms, although it seems appropriate to try and explain
em by a single hypothesis of altered energy metab-
ism.
The fall in plasma amino acid concentrations after
glucose in the present study is similar to that de¬
scribed in healthy subjects [28]. It is insulin-con¬
trolled and does not occur in insulin-dependent dia¬
betes [29]. The fall in alanine concentration, which
we found, is not typically found in response to glu¬
cose, or insulin, where no change or even an increase
may occur [28, 30. 31], In three of the children its
concentration did rise after glucose. We have found
that those patients with the poorest glucose uptake
had the highest fasting alanine concentrations, with
the greatest reductions (to normal levels) after glu¬
cose. Possibly those patients with the poorest glucose
tolerance were those who used up more essential
amino acids for energy. When augmented insulin se¬
cretion in response to glucose occurred, there was a
resurgence of protein synthesis with a reduction in
the release of previously unusable nonessential amino
acids, including alanine.
Raised citrulline concentrations in uremia appear
to be a consequence of reduced extrahepatic utiliza¬
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and subsequent intrahepatic metabolism normal in
uremia [6]. Its direct relation to protein intake sug¬
gests that as intake improves either its production
increases, or by some "toxic" efTect its utilization is
further reduced.
Certain correlations between some biochemical
and other changes in uremia have been demonstrated
in this study and we have suggested that some of
these are causally related. It is true that our com¬
parisons are of variations in a heterogenous group of
patients and without controlled variation of a single
parameter they must be interpreted cautiously. A
more precise study is needed, therefore, to determine
these individual aspects, and to determine whether a
single hypothesis of disturbed energy metabolism is
tenable.
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